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FUNCTIONAL SIMILARITY OF PRD-CONTAINING VIRULENCE REGULATORS IN  
BACILLUS ANTHRACIS  
Malik Jamaal Raynor, B.S. 
 
Advisory Professor: Theresa M. Koehler, Ph.D. 
 
 Bacillus anthracis produces three regulators, AtxA, AcpA, and AcpB, that control 
virulence gene expression and are members of an emerging class of regulators termed 
“PCVRs” (Phosphoenolpyruvate-dependent phosphotransferase regulation Domain-Containing 
Virulence Regulators). AtxA controls expression of the toxin genes; lef, cya, and pag, and is the 
master virulence regulator and archetype PCVR. AcpA and AcpB are less well studied. AcpA 
and AcpB independently positively control transcription of the capsule biosynthetic operon 
capBCADE, and culture conditions that enhance AtxA activity result in capBCADE transcription 
in strains lacking acpA and acpB. RNA-Seq was used to assess the regulons of the paralogs in 
strains producing individual PCVRs at native levels. Plasmid- and chromosome-borne genes 
were PCVR-controlled, with AtxA, AcpA, and AcpB having a ≥4-fold effect on transcript levels 
of 145, 130, and 49 genes respectively. Several genes were co-regulated by two or three 
PCVRs. Results from transcriptional reporters of PCVR-regulated promoters fused to 
promoterless lacZ genes largely mirrored RNA-Seq data showing AtxA alone had activity on 
Plef-lacZ, and AcpA and AcpB had more activity than AtxA on PcapB-lacZ. Studies to test the 
effect of AtxA levels on virulence and sporulation used atxA mutants. A mutant that 
overexpressed atxA and exhibited elevated AtxA and toxin levels in vitro, was not increased for 
virulence in a murine anthrax infection model. AtxA levels also affected sporulation efficiency. 
Culture of B. anthracis in medium containing bicarbonate and elevated carbon dioxide 
increased PCVR activity compared to culture in ambient air in medium lacking bicarbonate. 
However, neither the solubility nor stability of the regulators was affected by carbon dioxide 
concentration. AcpA and AcpB form homomultimers and multimerization was dependent on the 
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EIIB-like domains, as shown previously for AtxA. Heteromultimers of AtxA-AcpA were detected 
and in co-expression experiments, AcpA activity was reduced by increased levels of AtxA. An 
AtxA orthologue in Bacillus cereus, AtxA2, had less activity than AtxA from B. anthracis 
potentially due to reduced dimer formation. The results provided in this dissertation increase 
our knowledge of virulence gene expression in B. anthracis, while advancing our understanding 
of this newly-discovered class of transcriptional regulators.  
v 
 
Table of Contents 
Approval Sheet..............................................................................................................................i 
Title Page......................................................................................................................................ii 
Abstract........................................................................................................................................iii 
Table of Contents.........................................................................................................................v 
List of Figures.............................................................................................................................viii 
List of Tables................................................................................................................................x 
 
Chapter I: Introduction...............................................................................................................1 
1.1 Gene expression modulated by environmental conditions.........................................2 
1.2 PRD-containing virulence regulators..........................................................................5 
1.3 Bacillus anthracis and anthrax disease......................................................................7 
1.4 Virulence factors in anthrax pathogenesis.................................................................9 
1.5 AtxA: the most well-characterized PCVR.................................................................11 
1.6 AcpA and AcpB: regulators of capsule expression...................................................14 
1.7 AtxA2, an AtxA homologue in Bacillus cereus strain G9241....................................14 
1.8 Gaps in knowledge and significance of this work.....................................................15 
Chapter II: Materials and Methods..........................................................................................17 
 2.1 Culture conditions.....................................................................................................18 
 2.2 Strain construction....................................................................................................18 
 2.3 Native and IPTG-induced PCVR expression............................................................21 
 2.4 RNA isolation for RNA-seq.......................................................................................21 
 2.5 Creation of Next Generation Sequencing (NGS) libraries for RNA-seq 
  and sequencing..................................................................................................22 
 2.6 RNA-seq and bioinformatic analysis.........................................................................23 
 2.7 Western blotting........................................................................................................24 
 2.8 India ink exclusion assay..........................................................................................25 
vi 
 
 2.9 Co-affinity purification...............................................................................................25 
 2.10 AcpA-His and AcpB-His purification.......................................................................26 
 2.11 Bis-maleimidohexane crosslinking.........................................................................26 
 2.12 Mouse infections.....................................................................................................27 
 2.13 Heat-resistant CFU determination..........................................................................27 
 2.14 Real-time quantitative PCR (RT-qPCR).................................................................28 
Chapter III: Regulons of PRD-containing Bacillus anthracis virulence regulators  
         reveal overlapping but distinct functions..........................................................35 
 3.1 Introduction...............................................................................................................36 
 3.2 Results......................................................................................................................38 
  3.2.1 Amino acid sequence and predicted domain similarity of the  
           B. anthracis PCVRs...................................................................................38 
  3.2.2 Native PCVR protein and transcript levels.................................................41 
  3.2.3 Overlapping regulons of AtxA, AcpA, and AcpB........................................45 
  3.2.4 Loci of PCVR-regulated genes..................................................................49 
  3.2.5 Effects of individual PCVRs on established virulence genes.....................54 
 3.3 Discussion................................................................................................................58 
Chapter IV: Carbon dioxide, protein stability, and PCVR interactions...............................63 
 4.1 Introduction...............................................................................................................64 
 4.2 Results......................................................................................................................66 
  4.2.1 Induced expression of acpA and acpB in B. anthracis 
           cultures......................................................................................................66 
  4.2.2 AcpA and AcpB activity in B. anthracis cultures........................................68 
  4.2.3 Carbon dioxide effect on regulator activity.................................................69 
  4.2.4 Relative activities of the B. anthracis PCVRs on in vivo 
           reporters....................................................................................................74 
  4.2.5 B. anthracis PCVR homomultimerization and the role  
           of the intrinsic functional domains..............................................................77 
  4.2.6 Heteromultimerization of PCVRs...............................................................90 
vii 
 
 4.3 Discussion................................................................................................................93 
Chapter V: The roles of AtxA orthologs in an anthrax-like Bacillus cereus strain............98 
 5.1 Introduction...............................................................................................................99 
 5.2 Results....................................................................................................................102 
  5.2.1 Activity of AtxA and AtxA2.......................................................................102 
  5.2.2 Multimerization of AtxA proteins..............................................................102 
 5.3 Discussion..............................................................................................................109 
Chapter VI: Dual role for AtxA: control of sporulation and anthrax toxin production....112 
 6.1 Introduction.............................................................................................................113 
 6.2 Results....................................................................................................................118 
  6.2.1 AtxA modulates sporulation efficiency through SkiA...............................118 
  6.2.2 Elevated atxA expression does not result in increased virulence............122 
 6.3 Discussion..............................................................................................................122 
Chapter VII: Discussion.........................................................................................................127 
 7.1 Noteworthy results and significance of B. anthracis PCVRs..................................128 
 7.2 Model for virulence gene regulation in B. anthracis................................................129 
 7.3 AtxA, AcpA, and AcpB: a case for divergent evolution...........................................132 
 7.4 Evolutionary advantage to cross-talk between genetic elements...........................135 
 7.5 PCVR paralogues in other organisms may have shared functionality....................136 
 7.6 Concluding remarks................................................................................................137 
References..............................................................................................................................142 
Vita...........................................................................................................................................159 
  
viii 
 
List of Figures 
Figure 1-1. The phosphoenolpyruvate-dependent phosphotransferase system.........................4 
 
Figure 1-2. PRD-Containing Virulence Regulators......................................................................6 
 
Figure 1-3. Model for virulence gene regulation in B. anthracis................................................12 
 
Figure 3-1. Amino acid sequence alignment and structures of Bacillus anthracis PCVRs........40 
 
Figure 3-2. In vivo activity of recombinant His-tagged and FLAG-tagged AcpA and AcpB.......42 
 
Figure 3-3. Native PCVR expression and capsule production..................................................44 
 
Figure 3-4. PCVR transcript levels............................................................................................46 
 
Figure 3-5. Venn diagrams of PCVR regulons..........................................................................48 
 
Figure 3-6. Sequencing reads mapping to PCVR-regulated loci...............................................51 
 
Figure 3-7. Heat map and dendrogram of hierarchical  clustering among PCVR regulons.......53 
 
Figure 3-8. Edema Factor Production by the individual PCVRs................................................55 
 
Figure 3-9. Capsule production by the individual PCVRs..........................................................57 
 
Figure 4-1. Induced PCVR expression......................................................................................70 
 
Figure 4-2. In vivo activity of AcpA-His and AcpB-His...............................................................72 
 
Figure 4-3. AcpA and AcpB CO2-dependent activity.................................................................75 
 
Figure 4-4. Effects on steady state protein levels by culture in CA-Air vs. CACO3...................76 
 
Figure 4-5. Stability of AcpA-FLAG and AtxA-FLAG in CACO3 and CA-Air..............................78 
 
Figure 4-6. Activities of B. anthracis PCVRs on PcapB-lacZ and Plef-lacZ..............................79 
 
Figure 4-7. Homomultimerization AcpA and AcpB....................................................................82 
 
  Figure 4-8. Multimerization and activity of AcpA and AcpB EIIB-like domain 
        truncation mutants...................................................................................................85 
 
Figure 4-9. AtxA crystal structure and structural models of B. anthracis chimeric PCVRs.......86 
 
Figure 4-10. Dose-dependent expression and activity of PCVR chimeras...............................87 
 
Figure 4-11. PCVR chimera multimerization.............................................................................89 
 
Figure 4-12. Heteromultimerization by PCVRs..........................................................................91 
 
Figure 4-13. AtxA effect on AcpA and AcpB activity..................................................................92 
 
ix 
 
Figure 5-1. Amino acid alignment of AtxA homologues...........................................................103 
 
Figure 5-2. In vivo activity of AtxA-His and AtxA2-His.............................................................104 
 
Figure 5-3. Dimerization of AtxA2............................................................................................107 
 
Figure 5-4. Specific binding of AtxA2-His to AtxA-FLAG.........................................................108 
 
Figure 6-1. Schematic representation of the atxA promoter region.........................................119 
 
Figure 6-2. Spore quantification and skiA transcript levels in PA-air.......................................120 
 
Figure 6-3. Spore quantification and skiA transcript levels in CACO3.....................................123 
 
Figure 6-4. Virulence of parent and atxA mutants...................................................................124 
 
Figure 7-1. Comprehensive model of virulence gene regulation in B. anthracis.....................130 
 
Figure 7-2. Phylogram of AtxA, AcpA, and AcpB....................................................................133 
 
Figure 7-3. PCVR locus-activity relationships.........................................................................140 
  
x 
 
List of Tables 
 
Table 2-1.  B. anthracis strains and plasmids............................................................................30 
 
Table 2-2. Primers used in this dissertation...............................................................................33 
 
Table 3-1. Genes most highly regulated by the PCVRs............................................................50 
 
  
1 
 
 
 
Chapter I. 
 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
1.1 Gene expression modulated by environmental conditions 
 Bacteria occupy diverse habitats and must respond to changing environmental 
conditions, which may include nutrient availability, cell density, temperature stress, UV 
radiation, and desiccation, among others. To survive, bacteria may adapt to these conditions by 
altering their physiology through changes in gene expression. Environmental sensing and gene 
expression are often linked by specialized mechanisms that include cell surface receptors, 
phosphorelay pathways, and transcriptional regulators.  
 In quorum sensing, small molecules released into the extracellular medium by bacteria 
stimulate cell-surface or intracellular receptors and initiate gene expression changes. The 
concentration of these small molecules function as a proxy for cell density and modulate gene 
expression networks that produce phenotypes that could be beneficial when produced by many 
cells (1, 2). Quorum sensing coordinates processes related to biofilm formation, virulence, and 
antibiotic resistance in response to the local density of the bacterial population (3). 
 While quorum sensing enables bacterial communities to coordinate changes in gene 
expression, two-component systems allow bacteria to sense and respond to changes in the 
environment in a manner largely independent of other bacteria. These systems typically consist 
of a membrane-bound histidine kinase that responds to a specific environmental signal such as 
a nutrient, and a cognate response regulator that confers a cellular response, typically through 
regulation of target gene expression (4). Upon stimulation by an environmental signal the 
histidine kinase autophosphorylates a specific histidine and the cognate response regulator 
transfers the phosphate to a specific aspartate residue on the response regulator. The 
phosphorylated response regulator undergoes a conformational change that allows for 
activation (or repression) of target genes (5). Two-component systems have been adapted to 
sense and respond to changes in osmolarity, antibiotics, temperature, chemo attractants, and 
pH, in addition to other environmental conditions and stresses (6). 
 A third system, the phosphoenolpyruvate (PEP)-dependent phosphotransferase system 
(PTS), functions specifically as a carbohydrate sensor and is responsible for expression of 
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genes involved in both the uptake and catabolism of certain sugars (Figure 1-1). Glucose, 
mannose, fructose, and cellobiose are some of the sugars imported into bacteria by the PTS 
(7). The PTS has two general cytoplasmic components: Enzyme I (EI) and Histidine Protein 
(HPr) (Figure 1-1). EI autophosphorylates at a specific histidine in the presence of PEP aiding 
in the conversion of phosphoenolpyruvate to pyruvate (8). Phosphorylated EI transfers the 
phosphate to HPr at a specific histidine. HPr can then phosphotransfer to a carbohydrate-
specific Enzyme II (EII) complex which consists of one or two integral membrane domains 
(domains C and D) and two cytoplasmic domains (domains A and B). The multiple EII domains 
work together to transport and phosphorylate carbohydrates across the bacterial membrane to 
be used in catabolic pathways such as glycolysis (7). 
 In response to the availability of carbohydrates in the environment the PTS regulates 
the expression of catabolic genes. Phosphorylated HPr and several phosphorylated EIIBs, in 
addition to their role as phosphocarriers to phosphorylate imported carbohydrates, can 
phosphorylate transcriptional regulators to control their activity (Figure 1-1). These 
transcriptional regulators control expression of operons encoding carbohydrate-specific PTS 
components. Many of these PTS-controlled transcriptional regulators have similar domain 
organization. The amino termini contain motifs for nucleic acid binding, followed by two PTS 
regulation domains (PRD). The carboxy termini of these regulators generally contain motifs 
with homology to components of the EII complex (EIIA or EIIB). The homologous EII region of 
the transcriptional regulators often contain residues that can act as phosphoryl acceptors. In 
the absence of a cognate sugar to import some regulators are phosphorylated by membrane-
bound EII components sequestering them to the membrane where they remain inactive (9). 
The PRDs are unique domains with the specific function of controlling transcriptional activity of 
these proteins. PRDs are generally found in tandem pairs with each domain containing two 
histidine residues that can be phosphorylated by HPr or EIIB. 
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Figure 1-1. The phosphoenolpyruvate-dependent phosphotransferase system 
The phosphotransferase system is responsible for import and metabolism of many 
carbohydrates in both Gram + and Gram – bacteria. The system consists of two general 
proteins, Enzyme I (EI) and HPr and an Enzyme II complex usually consisting of 3 
components, EIIA, B, & C which are specific for each sugar imported. This cartoon depicts the 
glucose-specific EII. To begin the cycle, EI autophosphorylates using a phosphate from 
phosphoenolpyruvate or PEP, which is a product of glycolysis. The phosphate is transferred 
from EI to HPr. HPr transfers the phosphate to the sugar-specific EIIA. EIIA then transfers the 
phosphate to the sugar specific EIIB. EIIC is membrane spanning and translocates glucose 
inside the cell at which point EIIB phosphorylates the sugar leading to glucose-6-phosphate. G- 
6-P can then enter glycolysis continuing the cycle. HPr can also phosphorylate transcriptional 
regulators that control the expression of genes needed for cognate carbohydrate metabolism. 
Phosphorylation of these regulators occurs at conserved histidines within phosphotransferase 
regulatory domains, or PRDs.  
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Phosphorylation within PRDs can either be stimulatory or inhibitory with regard to 
transcriptional activity (7). 
 The PTS, in addition to two-component and quorum sensing systems, together 
represent some of the multitude of environmental sensing networks that are coupled with 
manipulation of gene expression, and underscore the importance of these networks for survival 
of bacteria in the environment. For pathogenic bacteria, the host environment represents a 
harsh environment lacking readily available nutrients such as iron. Many of these 
environmental sensing networks have evolved to function within the host environment. 
Moreover, in pathogens such as group A Streptococcus and uropathogenic Escherichia coli, 
the PTS has been associated with virulence. 
1.2 PRD-containing virulence regulators 
 Within the last several years a subset of PRD-containing transcriptional regulators has 
been associated with virulence (Figure 1-2). These PRD-Containing Virulence Regulators 
(PCVR) are present primarily in Gram-positive pathogens. In Streptococcus pyogenes, a group 
A Streptococci, the transcriptional activator Mga is required for adhesion, internalization, and 
immune evasion (10). The amino acid sequence of Mga is predictive of an amino terminal 
conserved Mga domain (CMD) and DNA-binding region, followed by two PRDs, and finally a 
carboxy-terminal domain with homology to EII of the PTS. Phosphorylation of Mga by the PTS 
has been demonstrated, and phosphomimetic mutations affect DNA-binding affinities of Mga-
regulated promoters (11). The RivR regulator, also in GAS, has two putative DNA-binding 
domains at the amino terminus followed by two PRDs. Expression of the protein-G-related α2-
macroglobulin-binding protein (GRAB), a cell wall-anchored virulence factor involved in 
inhibition of proteases in human plasma, and hyaluronic acid capsule are negatively regulated 
by RivR (12). The amino acid sequence of RivR has 22% identity and 49% similarity to that of 
Mga in S. pyogenes, and predicts two amino terminal helix-turn-helix domains in addition to a 
PRD (13). In Streptococcus pneumoniae, the MgaSpn transcriptional regulator plays a  
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Figure 1-2. PRD-Containing Virulence Regulators 
The AtxA crystal structure contains five domains: a winged helix-turn-helix (WH) motif, a helix-
turn-helix (HTH) motif, two PTS regulation domains (PRD1 & PRD2), and an Enzyme IIB-like 
(EIIB-like) motif. Cartoons of other PCVRs are shown for comparison to AtxA and many show 
similar domain organization. Mga contains a conserved Mga domain (CMD) that plays a role in 
target specificity. Phosphorylated histidines are indicated for PCVRs in which the 
phosphorylation state is known. A green label indicates a positive effect on activity, whereas a 
red label denotes a negative effect on activity. 
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significant role in both nasopharyngeal colonization and progression to pneumonia in murine 
infection models (14). The amino acid sequence of MgaSpn has 21.4% identity and 42.6% 
similarity to that of Mga produced by S. pyogenes. A putative domain search using the amino 
acid sequence of MgaSpn also predicts similar domains to Mga, including two PRDs. In 
uropathogenic Escherichia coli (UPEC), PafR is a transcriptional regulator with antiterminator 
activity, and is required for optimal urinary tract colonization in a murine infection model. PafR 
also inhibits biofilm formation and motility in UPEC (15). In silico analysis of the PafR amino 
acid sequence reveals at least one PRD. 
 Bacillus anthracis, the etiologic agent of anthrax, possesses three such PCVRs; AtxA, 
AcpA, and AcpB, that control expression of the major virulence determinants. The presence of 
three PCVRs in B. anthracis presents a unique opportunity to study the activity and interactions 
of multiple similar regulators that are native to a single organism. The work I present in this 
dissertation specifically examines PCVR activity, providing a global and specific analysis of the 
role of each B. anthracis PCVR homologue in virulence gene expression. 
 
1.3 Bacillus anthracis and anthrax disease 
 B. anthracis is a Gram-positive spore-forming bacterium that is commonly found in the 
soil. The genome consists of a 5.23-Mb chromosome and two large plasmids, pXO1 (182 kb) 
and pXO2 (96 KB) (16). Genes encoding the major virulence factors are located on the 
plasmids. The anthrax toxin structural genes; pagA (Protective Antigen, PA), cya (Edema 
Factor, EF), and lef (Lethal Factor, LF) are located on pXO1. The genes required for capsule 
biosynthesis (capBCADE) are encoded in an operon on pXO2 (17). 
 Plasmids with similarity to pXO1 and pXO2 have been found in other closely related 
Bacillus species. B. anthracis is a member of the Bacillus cereus group species which includes 
Bacillus cereus, a causative agent of food poisoning and opportunistic infections, and Bacillus 
thuringiensis, an insect pathogen. Plasmids similar to pXO1 and pXO2 have been identified in 
B. cereus strains (18–20). Given that all three species share DNA sequence similarity and gene 
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synteny, it is likely that horizontal gene transfer is a mechanism for sharing plasmids among 
closely related soil pathogens (21). 
 The soil habitat presents challenges such as temperature variation, desiccation, UV 
irradiation, and nutrient deprivation. B. anthracis forms spores to survive adverse 
environmental conditions. Spores exhibit minimal metabolic activity and retain viability when 
faced with multiple environmental challenges (22). In the soil environment, alkaline pH, high 
organic content, moisture, temperatures above 15˚C, and exudates from plant roots have been 
reported to promote spore germination (23, 24). 
 The B. anthracis spore is the infectious form of the bacterium. Spores can enter the 
body through cuts or scrapes on the skin, inhalation, or ingestion with each route of entry 
leading to a specific anthrax disease pathology. Regardless of the route of infection, B. 
anthracis spores are thought to be transported by macrophages to regional draining lymph 
nodes and then enter the blood stream, resulting in systemic dissemination (25). Cutaneous 
anthrax results from spore entry through skin abrasions and accounts for 95% of all anthrax 
cases (26). Patients with cutaneous anthrax present with a small blister surrounded by swollen 
tissue that develops into a painless black ulcer called an eschar (25). Gastrointestinal and 
inhalational anthrax result from ingestion or inhalation of spores, respectively. Gastrointestinal 
anthrax results in gastrointestinal pain, vomiting of blood, severe diarrhea, acute inflammation 
of the digestive tract, and loss of appetite (27). Inhalational anthrax symptoms are very similar 
to cold and flu symptoms and include fever, shortness of breath, cough, fatigue, and chills. 
Inhalational anthrax is distinguished by a characteristic widening of the mediastinum. 
Inhalational anthrax has the highest mortality rate of all forms of the disease, 45% with 
antibiotic therapy and more than 97% without treatment. Gastrointestinal has a similar mortality 
rate to inhalational anthrax, and cutaneous anthrax has the lowest mortality rate, 1% with 
antibiotic treatment and 20% with no treatment (28).  
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1.4 Virulence factors in anthrax pathogenesis 
 Following germination in the host, B. anthracis vegetative cells synthesize several 
factors associated with pathogenesis. Two of the most studied virulence factors are a tripartite 
toxin and a poly-γ-D-glutamic acid (PDGA) capsule. Capsule-negative or toxin-deficient 
mutants are highly attenuated in some animal models for anthrax (29, 30). 
 The anthrax toxins are classified as A/B-type bacterial toxins, with LF or EF comprising 
the enzymatic activity, or (A) moiety, and PA representing the binding component (B) (31). 
Initially, PA binds either of two proteinaceous cellular receptors; ANTXR1 and ANTXR2 (32), 
and is cleaved by a furin protease. PA is cleaved into two fragments, PA20 (20 kDa) and PA63 
(63 kDa) (33). PA63 remains bound to the cellular receptor and spontaneously heptamerizes on 
the cell surface (34). EF and LF bind to heptameric PA63 and the complex enters the cell by 
endocytosis (35–37). Once the endosome matures, the pH drops following the reversal of 
proton pumps in the endosomal membrane. Low pH triggers a conformational change in the PA 
complex resulting in the formation of a pore and escape of EF and LF  from the endosome (38, 
39). Lethal factor is a Zn2+ metalloprotease that cleaves mitogen-activated protein kinase 
kinases which results in suppression of pro-inflammatory cytokines and may induce apoptosis 
(40). Edema factor is a calmodulin- and Ca2+-dependent adenylate cyclase that elevates the 
intracellular cAMP concentration (41). Edema factor has been shown to inhibit phagocytosis of 
spores by human polymorphonuclear leukocytes in an in vitro infection model (42). 
 The proteinaceous PDGA capsule of B. anthracis is uncommon in bacteria, but is 
essential for establishing infection leading to anthrax. In vitro experiments show that the PDGA 
capsule is antiphagocytic, similar to capsule function in other bacteria (43, 44). The capBCADE 
operon on pXO2 encodes proteins required for capsule synthesis. CapB is an ATP-dependent 
ligase and functions with CapC to synthesize PDGA (45). Polymers of Ƴ-linked D-glutamic acid 
residues can reach up to 216 kDa (46). Polymers of PDGA are transported across the cell 
membrane by CapA and CapE (47). CapD is a γ-glutamyl transpeptidase (GGT)-family protein 
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that cleaves the γ-linked peptide bond of the polyglutamate capsule which is thought to serve 
two roles; anchoring capsule polymers to the cell wall, and the release of small PDGA polymers 
into the extracellular environment; the latter function is required for full virulence (47–49). The 
release of small PDGA polymers may contribute to pathogenesis by suppressing the responses 
of immune cells and disrupting the maturation of immature dendritic cells (50). 
 Although toxin and capsule are considered the primary virulence factors required for B. 
anthracis pathogenesis, several other factors may contribute to overall disease progression. 
The secreted chaperone/protease HtrA, for High temperature requirement A, is thought to aide 
in survival during heat, oxidative, ethanol, and osmotic stress. htrA mutants exhibit delayed 
growth in a macrophage infection assay, in addition to a ≥6-fold decrease in virulence relative 
to the parent strain in a guinea pig model of anthrax (51). MntA is the solute-binding component 
of a Mn2+ ATP-binding cassette transporter and is involved in optimal growth and survival of B. 
anthracis when incubated with cultured macrophages, or when the bacteria are exposed to 
oxidative stress. Moreover, the lethal dose (LD50) of mntA-null mutants was reported to be 104-
fold higher than that of the parent strain in a guinea pig model for anthrax in which spores were 
injected subcutaneously (52). The regulatory ATPase subunit of the ClpXP protease, ClpX, is 
required for hemolytic and proteolytic phenotypes observed when B. anthracis is cultured on 
blood and casein solid agar media, respectively. Strains lacking ClpX are attenuated in murine 
and guinea pig models of anthrax. Host substrates for extracellular proteolytic activity requiring 
ClpX functionality include cathelicidin and alpha-defensin antimicrobial peptides, in addition to 
lysozyme (53). Additionally, B. anthracis produces two siderophores, bacillibactin and 
petrobactin, but only petrobactin has been shown to be required for full virulence in a murine 
infection model (54). Lastly, the surface adhesin BslA, a protein found in the S-layer, a 
paracrystalline matrix distal to the peptidoglycan, is required for sufficient adhesion to host 
cells. Deletion of bslA results in a substantial increase in LD50, mean time-to-death, and 
decreased bacterial burden in host organs (55). So while the toxin and capsule may be the 
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major contributors to anthrax pathogenesis, other virulence determinants play smaller roles that 
contribute to overall disease progression. 
 
1.5 AtxA: The most well-characterized PCVR 
 The Anthrax Toxin Activator AtxA (56 kDa) is the master virulence regulator in B. 
anthracis, and controls expression of the anthrax toxin genes lef, cya, and pagA (49, 56, 57) 
(Figure 1-3). In addition to positive regulation of toxin gene expression, microarray studies to 
determine the AtxA regulon indicate that expression of the capsule biosynthesis operon and at 
least 38 other genes are affected by AtxA (56). How AtxA initiates transcription is unknown and 
a consensus sequence within AtxA-regulated promoters has not been identified. However, 
intrinsic curvature in AtxA-regulated promoters may play a role in AtxA-mediated gene 
expression (58). In agreement with positive regulation of toxin and capsule, an atxA-null mutant 
exhibits attenuated virulence in a murine model of anthrax (30). 
 Expression of atxA is governed by environmental signals and other trans-acting factors. 
Cultures of B. anthracis cultivated at 37˚C produce more atxA transcripts and higher AtxA 
protein levels than cultures incubated at 28˚C (59). Two small c-type cytochromes, which 
influence cellular redox state, were found to affect expression of atxA. Deletion of genes 
encoding c-type cytochromes and other constituents in the cytochrome c biogenesis pathway 
cause atxA expression to be dysregulated, and transcripts of atxA and toxin components were 
produced earlier in growth phase relative to the parent strain (60). Similar growth phase-
dependent dysregulation of atxA expression is mediated by AbrB. A well-characterized 
homolog of AbrB in Bacillus subtilis governs the timing of expression of multiple genes by 
binding to DNA sequences near the transcriptional start site and occluding RNA polymerase 
(61). In B. anthracis, AbrB is the only trans-acting factor known to interact directly with the atxA 
promoter to affect transcription. In batch culture, AbrB represses atxA during exponential 
growth and repression is relieved in transition-to-stationary phase (62).  Nutrient conditions also 
influence atxA expression. In batch culture the presence of glucose 
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Figure 1-3. Model for virulence gene regulation in B. anthracis 
AtxA is the master virulence regulator and controls expression of the anthrax toxin genes in 
addition to the capsule biosynthetic operon via transcriptional control of atxA. The atxA gene is 
located on plasmid pXO1. Culture in elevated CO2 atmosphere in medium containing dissolved 
bicarbonate increases AtxA activity and AtxA positively regulates expression of the anthrax 
toxin genes cya, pagA, and lef located on pXO1. In these culture conditions AtxA also positively 
affects expression of acpA located on pXO2. AcpA positively affects expression of capBCADE. 
There is a weak transcriptional terminator downstream of capE, but ~10% of transcripts include 
acpB. AcpB also promotes capBCADE expression resulting in a positive feedback loop. The 
overexpression of AtxA has on capBCADE expression when cultured in 20% atmospheric CO2  
is represented by the hashed red arrow.  
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increases atxA transcript levels in a catabolite control protein A (CcpA)-dependent manner 
indicating carbon catabolite activation (CCA) is involved (63). 
 The crystal structure of AtxA has been solved and functional roles for each of the five 
domains have been defined (Figure 1-2). A winged helix-turn-helix motif and a helix-turn-helix 
motif are present near the amino terminus indicative of a DNA-binding domain. The central 
region of the protein has two adjacent PRDs that govern AtxA activity. A domain with homology 
to Enzyme IIB of the PTS is located near the carboxy terminus and functions in 
homodimerization (64, 65). 
 Post-translational modifications, environmental conditions, and metabolic state affect 
AtxA activity. Histidines at position 199 in PRD1 and 379 in PRD2 are phosphorylated (Figure 
1-2). Phosphomimetic and phosphoablative mutations at positions 199 and 379 affect AtxA 
activity and suggest that phosphorylation at H199 allows AtxA to be active while 
phosphorylation at H379 functions as a dominant negative, with regard to the phosphorylation 
state of H199, and abolishes AtxA activity (65, 66). AtxA activity is also affected by in vitro 
culture conditions, specifically elevated carbon dioxide (CO2)/bicarbonate. Expression of AtxA-
dependent genes, including the anthrax toxin genes, is enhanced when cells are cultured in 5% 
atmospheric CO2 in medium containing dissolved bicarbonate, compared to culture in air in 
medium without bicarbonate added (56, 67). The increase in AtxA activity in response to 
culture in CO2/bicarbonate correlates with an increase in the AtxA dimer-to-monomer ratio. 
AtxA dimerization is imperative for activity, and mutants of AtxA that cannot dimerize have no 
activity (64). The elevated CO2/bicarbonate signal is thought to mimic the host physiological 
environment, and could provide a signal to promote virulence gene expression. AtxA steady 
state levels are affected indirectly by a transcriptional regulator, CodY. Studies in B. subtilis 
have elucidated factors influencing CodY activity as well as CodY-regulated genes. CodY 
senses the metabolic state of the cell by binding to GTP and branched chain amino acids 
(BCAA), two effectors that influence CodY DNA binding. CodY regulates expression of genes 
needed for survival in nutrient limited conditons, such as genes involved in sporulation and 
14 
 
survival in stationary phase (68). Deletion of codY in B. anthracis results in a decrease in AtxA 
steady state levels. Transcription and translation efficiency of atxA are unaffected in this mutant 
indicating that CodY affects AtxA post-translationally through an indirect mechanism (69). 
 
1.6 AcpA and AcpB: regulators of capsule expression 
 While regulation of atxA and factors that govern AtxA activity have been studied in great 
detail, less is known about the AtxA paralogues, AcpA and AcpB. The genes encoding AcpA 
and AcpB flank the capBCADE operon and control its expression via an unknown molecular 
mechanism (Figure 1-3). Either regulator can independently increase capBCADE transcript 
levels. AtxA positively regulates capsule gene expression via transcriptional control of acpA. 
Transcriptional read-through of capBCADE results in elevated expression of acpB and a 
positive feedback loop (29, 70). Overexpression of atxA, in the absence of acpA and acpB, has 
also been reported to produce capsular material when B. anthracis is cultured in 20% CO2 (71). 
Clues to understanding how the capsule regulators function may be gleaned from information 
obtained from AtxA. AtxA shares 26% amino acid sequence identity and 50% sequence 
similarity with each of the capsule regulators. Bioinformatic analyses indicate that both AcpA 
and AcpB possess amino terminal putative DNA-binding domains similar to that of AtxA. 
Specific DNA binding has not been tested with either capsule regulator. Two putative PRDs 
exist in the central region of both proteins, but the phosphorylation state of either protein has 
not been determined. Similar to AtxA, AcpA and AcpB also have carboxy termini with homology 
to Enzyme IIB. 
 
1.7 AtxA2, an AtxA homologue in Bacillus cereus strain G9241 
 Bacillus cereus, a pathogenic Bacillus species closely related to B. anthracis, is a 
frequent cause of food poisoning and has been associated with various opportunistic and 
nosocomial infections (72). Within the last 15 years, B. cereus strains carrying pXO1- and 
pXO2-like plasmids have been isolated from non-human primates and humans that succumbed 
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to an anthrax-like illness (18, 19, 73). B. cereus strain G9241 was recovered from a welder in 
Louisiana who presented with a severe anthrax-like respiratory illness. Strain G9241 contains 
two virulence plasmids, pBCXO1 that is highly similar to pXO1 and contains the three anthrax 
toxin genes in addition to a gene with sequence identity to atxA called atxA1, and pBC210 that 
encodes a protective antigen paralog, the ADP-ribosyltransferase Certhrax, and an AtxA 
homolog AtxA2. Plasmid pBC210 bears little sequence homology to pXO2 from B. anthracis. 
pBCXO1-encoded AtxA is identical in sequence to that from B. anthracis, and atxA2 79% 
identical and 91% similar  compared to B. anthracis AtxA (73). Finally, the B. cereus G9240 
genome does not code for AcpA and AcpB homologs.is  and no proteins with homology to 
AcpA and AcpB have been identified in the B. cereus G9241 genome. It is unclear how AtxA1 
and AtxA2 function in regulation of B. cereus virulence genes. 
 
1.8 Gaps in knowledge and significance of this work 
 AtxA, AcpA, and AcpB have some functional and amino acid sequence similarities, yet 
the regulons of these trans-acting factors are dissimilar. AtxA regulates 38 genes located on 
the virulence plasmids and the chromosome, while AcpA and AcpB are thought to affect 
expression of only a few genes. Previous PCVR regulon studies used PCVR-null mutants to 
detect global changes in gene expression (56). Given the interdependency of PCVR 
expression, it is difficult to discern the effects individual PCVRs have on global gene 
expression. Moreover, the relationship between PCVR loci and linkage of regulated genes has 
yet to be determined. Each regulator shares high amino acid identity and putative domains with 
homology to PTS components. AcpA and AcpB share more amino acid identity with each other 
than either does with AtxA. Whether greater sequence identity correlates with regulon similarity 
is unknown. Furthermore, it is unclear whether the DNA-binding regions alone are sufficient to 
provide target specificity to these regulators, or whether input from other intrinsic domains are 
required.  
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 B. anthracis is a model candidate for studying PCVRs because it presents a unique 
opportunity to study three of these regulators in the same organism. For my thesis work I have 
determined the regulons of each PCVR and identified relationships between PCVR amino acid 
sequence similarity and PCVR-controlled gene expression, including discernment of specific 
and co-regulated gene targets. I assessed PCVR multimerization states and determined how 
multimerization affects activity. These studies define PCVR roles in culture conditions that 
mimic the host environment, and provide data suggesting how these regulators may function. 
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2.1 Culture conditions 
 B. anthracis strains were cultivated at 37˚C in Brain Heart Infusion (BHI) (Becton, 
Dickson and Company, Franklin Lakes, NJ) or Casamino Acid medium containing 0.8% sodium 
bicarbonate (CA CO3) (74, 75). BHI broth cultures were incubated with agitation (200 r.p.m.) in 
air. CA broth cultures were shaken in 5% atmospheric CO2. Cells from stationary phase BHI 
cultures were sub-cultured into fresh CACO3 to an optical density at 600 nm (OD600) of 0.08. 
For strains harboring atxA, acpA, and acpB alleles under control of the hyper-spank promoter 
(Phyper-spank) (76), expression was induced with isopropyl β-D-thiogalactoside (IPTG) during 
early exponential phase at 2 h and harvested at early stationary phase at 4 h. Optical densities 
for early exponential phase cultures ranged from OD600 0.25-0.35, and early stationary phase 
cultures ranged from 1.2 to 1.7.  
 Cultures were supplemented with antibiotics when appropriate at the following 
concentrations: spectinomycin (MP Biomedicals, Solon, OH) (50 µg ml-1 for  E. coli and 100 µg 
ml-1 for B. anthracis), erythromycin (Fisher Bioreagents, Fair Lawn, NJ) (150 µg ml-1 for E. coli 
and 10 µg ml-1 for B. anthracis), and carbenicillin (Research Products International Corp, Mt. 
Prospect, IL) (100 µg ml-1 for E. coli). 
 
2.2 Strain construction 
 B. anthracis strains and plasmids are shown in Table 2-1. The virulent Ames strain 
(pXO1+ pXO2+) (77) and isogenic mutants were used for RNA-Seq experiments and the 
assessment of capsule and edema factor production. The attenuated ANR-1 strain (Ames 
nonreverting) (pXO1+ pXO2-) and isogenic mutants were used for all other experiments. 
Escherichia coli strains TG1 (78), GM2163 (79), and SCS110 (Stratagene, San Diego, CA) 
were employed for cloning plasmids. General laboratory practices were used for amplification, 
manipulation, and purification of plasmid DNA. Non-methylated plasmid DNA was isolated from 
E. coli GM2163 or SCS110 for electroporation into B. anthracis (57, 79), (Stratagene).  
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 The Ames atxAacpAacpB-null mutant (UTA40) was created by sequential deletion of 
each gene using a markerless temperature-sensitive integration system described previously 
(80). Initially, the atxA coding sequence was removed using pUTE937. Details regarding 
pUTE937 construction can be found in Hammerstrom et al. (64). Subsequently, to remove 
acpA from the atxA-null strain Ames genomic DNA was amplified using the polymerase chain 
reaction (PCR) and primers MJR014-JR175a to produce a 990-bp DNA fragment 
corresponding to sequence -1 to -991 relative to the acpA translational start site. Primers 
MJR017-JR176s were used to amplify a 1021-bp DNA fragment corresponding to sequence 
+1452 to +2473 relative to the acpA translational start site. The two DNA fragments were fused 
via splicing by overlapping extension PCR (SOE-PCR) (81) and inserted into pHY304 using a 
SacII restriction enzyme site. pHY304 is a temperature-sensitive E. coli - B. anthracis shuttle 
vector that encodes an erythromycin-resistance cassette (80). B. anthracis containing the 
pHY304-derived construct was cultivated at 41˚C (the non-permissive replication temperature) 
in medium supplemented with erythromycin to select for isolates in which the plasmid 
incorporated into one of the acpA flanking regions via homologous recombination. Cultures 
were passaged successive times at 30˚C or 37˚C in medium lacking antibiotic to allow excision 
of the pHY304 derivative from the acpA locus. Individual colonies were tested using the PCR 
and sequencing to confirm removal of the acpA coding sequence. Finally, removal of the acpB 
coding sequence from the atxAacpA-null strain was accomplished in a manner similar to 
deletion of acpA. Primers MJR002-MT06 were used to amplify a 1008-bp DNA sequence -1 to -
1009 relative to the acpB translational start. A 1006-bp DNA sequence corresponding to 
sequences +1445 to +2441 from the acpB translational start site was amplified using primers 
MJR003-MT09. DNA fragments were joined by SOE-PCR, cloned into pHY304, and used to 
remove acpB as described above. 
 UT423 harbors the capB promoter sequence fused to a promoterless β-galactosidase 
gene (lacZ) incorporated into the plcR locus, a nonfunctional gene in B. anthracis. To construct 
UT423, a DNA fragment corresponding to approximately 1.2 kb upstream of the capB 
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translational start (-1 to -1249) was amplified using primers AB142 and AB143 and inserted into 
pHT304-18z (82) using BamHI and SacI restriction enzyme sites upstream of a plasmid-borne 
lacZ. The DNA sequence inclusive of the upstream capB region and lacZ gene was excised 
using XhoI and EcoRI restriction enzymes and cloned into an E. coli - B. anthracis shuttle 
vector pUTE744 which contains an Ωkanamycin cassette that is flanked by two 1.2 kb plcR 
flanking regions. pUTE744 confers chloramphenicol resistance and is unstable when B. 
anthracis strains are grown without selection. The capB-lacZ fusion was inserted upstream of 
the Ωkanamycin cassette adjacent to the plcR flanking region creating pUTE1067 and 
electroporated into UT374, a markerless atxA-deletion mutant in the ANR-1 (pXO1+ pXO2-) 
background, with chloramphenicol selection. Electroporants were passaged in medium without 
selection and screened for kanamycin-resistance and chloramphenicol-sensitivity. Appropriate 
isolates were confirmed by PCR. 
 B. anthracis Ames strain derivatives (UTA35, UTA36, UTA37) were constructed 
carrying recombinant alleles of atxA, acpA, or acpB engineered to express carboxy-terminal 
FLAG-tagged proteins from the respective native loci. To construct these strains, PCR was 
used to amplify regions flanking the 3' end of each PCVR open reading frame with primers 
engineered to attach the FLAG-tag coding sequence to the 3' end of each coding sequence, 
and to incorporate 5' and 3' restriction enzyme sites. Amplicons for atxA, acpA, or acpB were 
joined by SOE-PCR and ligated into pHY304. Flanking regions for acpA corresponded to +443 
to +1452 and +1453 to +2473, relative to the translational start codon. The acpB flanking 
regions were comprised of sequences +441 to +1444 and +1445 to +2474 relative to the start 
codon. Flanking regions for atxA included sequences +462 to +1424 and +1428 to +2481 from 
the start codon. The resulting plasmids containing the PCVR allele and respective flanking 
regions were individually electroporated into the B. anthracis Ames strain. Isolates in which the 
native PCVR allele was replaced with an allele encoding a FLAG-tagged PCVR were obtained 
as described above for the creation of UTA40. 
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2.3 Native and IPTG-induced PCVR expression 
 Steady state levels of the PCVR proteins were determined using strains expressing 
FLAG-tagged proteins from native PCVR loci. Strains UTA35, UTA36, and UTA37 were 
cultivated in CACO3 for 7 h. Cell lysates were prepared as described previously (64). Sample 
volumes for SDS-PAGE were normalized by OD600 readings at sample collection and loaded on 
12.5% poly-acrylamide gels. Samples were separated by PAGE and transferred to an 
Immobilon-P membrane (Millipore, Billerica, MA, USA) and subsequently blotted with α-FLAG 
antibody (Genscript, Piscataway, NJ, USA). 
 The IPTG concentrations necessary to express plasmid-borne Phyper-spank - controlled 
recombinant PCVR alleles at protein levels comparable to those found in strains producing 
PCVRs from native promoters were determined. B. anthracis strains harboring recombinant 
atxA, acpA, or acpB alleles encoding FLAG-tagged proteins under the control of Phyper-spank in 
pUTE657 were cultured in CACO3. Cultures were induced at early exponential phase with 5 
µM, 10 µM, 20 µM, 100 µM, 150 µM, or 200 µM IPTG and harvested at early stationary phase 
(OD600). Cell lysates were prepared and samples containing IPTG-induced FLAG-tagged 
PCVRs were loaded on 12.5% poly-acrylamide gels adjacent to lysates containing FLAG-
tagged PCVRs expressed from the native locus and harvested at early stationary phase. 
Samples were separated by PAGE, transferred to a membrane, and blotted with anti-FLAG 
antibody as described previously. IPTG concentrations that yielded PCVR expression similar to 
native PCVR expression were used for subsequent RNA-Seq experiments (5 µM for atxA, 5 
µM for acpA, and 150 µM for acpB). 
 
2.4 RNA isolation for RNA-seq 
 Cultures of B. anthracis strains Ames, the Ames-derived atxAacpAacpB-null mutant 
UTA40 containing pUTE657, UTA40 (pUTE1054), UTA40 (pUTE1056), and UTA40 (pUTE992) 
were grown in CACO3. PCVR expression was induced with IPTG (5 µM for atxA and acpA 
expression and 150 µM for acpB expression) at early exponential phase and 4-ml samples 
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were harvested at early stationary phase (OD600 = 1.2-1.7). Samples were centrifuged at 
10,000 g at 4˚C and resulting pellets were resuspended in 500 µl of CACO3. An equivalent 
volume of saturated acid phenol (pH 4.3; Fisher Bioreagents, Fair Lawn, NJ) at 65˚C was 
added to each sample and transferred to screw top tubes containing 400 µl of 0.1 mm 
Zirconia/Silica beads (BioSpec Products Bartlesville, OK). Samples were lysed mechanically 
for 1 min, incubated for 5 min at 65˚C, and subsequently lysed for an additional 1 min followed 
by centrifugation at 3,000 g at 4˚C. Supernates were transferred to 500 µl of saturated acid 
phenol at 65˚C. Samples were vortexed, incubated at room temperature (RT) for 5 min, and 
centrifuged at 16,000 g for 3 min at 4˚C. One-third volume of chloroform was added to the 
aqueous phase. Following incubation for 10 min at RT, samples were centrifuged at 16,000 g 
for 15 min at 4˚C.  The aqueous phase was transferred to a new tube and RNA was 
precipitated by the addition of one-half volume diethyl-pyrocarbonate (DEPC)-treated water and 
one total volume (aqueous phase + DEPC-treated water) of isopropanol followed by incubation 
at RT for 10 min. Samples were centrifuged at 16,000 g for 15 min at 4˚C, and pellets 
containing precipitated RNA were washed with 75% ethanol. Following removal of ethanol, 
pellets were air-dried and finally resuspended in DEPC-treated water. 
 
2.5 Creation of Next Generation Sequencing (NGS) libraries for RNA-seq and sequencing 
 RNA samples were quantified using a Qubit fluorescence assay (Thermo Scientific). 
Total RNA quality was assessed using an RNA 6000 chip on an Agilent 2100 Bioanalyzer 
(Agilent Technologies).  Creation of libraries for NGS analysis used total RNA (1.0 ug). 
Samples were treated with Ribo-Zero (Epicentre) to remove ribosomal RNA prior to 
fragmentation using divalent cations and heat (940 C, 8 minutes). Libraries were created using 
an Illumina TruSeq sample preparation kit following the protocol as recommended by the 
manufacturer. Briefly, RNA samples were converted to cDNA by random primed synthesis 
using Superscript II reverse transcriptase (Invitrogen). Second strand synthesis using DNA 
polymerase I and RNAse H was performed and the double-stranded DNAs were treated with 
23 
 
T4 DNA polymerase, 5’ phosphorylated and an adenine residue was added to the 3’ ends of 
the DNA. Adapters were ligated to the ends of these target template DNAs. The adapter 
structure used by Illumina is a key element in the sequencing strategy. One end of the adapter 
has a 5’ phosphorylation and a 3’ “T” overhang that is compatible with ligation to DNA 
templates. The other end of the adapter has non-complementary ends on each DNA strand, 
resulting in a “Y”-shaped structure for the adapter. After ligation, the template DNAs were 
amplified using primers specific to each of the non-complementary sequences in the adapter. 
All libraries were indexed. The final concentration of all NGS libraries were determined using a 
Qubit fluorescence assay (Thermo Scientific) and the fragment size of each library was 
assessed using a DNA 1000 chip and an Agilent 2100 Bioanalyzer.  qPCR analysis was used 
to determine the template concentration of each library prior to clustering.  NGS sequencing 
was performed as a paired-end 50 base sequence using an Illumina HiSeq 1500 following the 
protocol recommended by the manufacturer. Quality assessment of the sequencing run was 
assessed using FastQC (http://www.bioinformatics.bbsrc.ac.UK/projects/Fastqc). 
 
2.6 RNA-seq and bioinformatic analysis 
 The Integrative Genomics Viewer (IGV) (83) (for read mapping), and Cufflinks (84) (for 
the differential expression analysis) were used to analyze RNA-Seq results. Reads were 
aligned to the B. anthracis strain ‘Ames Ancestor’, accession AE017334.2, using bowtie2 
version 2.2.5 (85) with default parameters. The bedtools genomeCoverageBed command (84) 
was used to create bedgraph files from the aligned read files in bam format. The IGVtools 
function of the Integrated Genome Viewer (IGV) (83) was used to convert the bedgraph files to 
tdf format files for use in the IGV. Read maps from the different strains were fixed to a scale of 
“0-2000” for comparison. The featureCounts function of the subread software package (86) was 
used to count reads mapped to each gene with gene as the feature type, using the annotation 
file GCA_000008445.1_ASM844v1_genomic.gff downloaded from the NCBI website. A table of 
read counts per gene per sample (3 replicates per condition) was entered into the DESeq2 
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differential expression analysis program (87) and expression level differences between each 
condition were determined. For differential gene expression analysis, sequencing files (bam 
format) were imported into Cufflinks. Triplicate sequencing results of each strain were 
compared to calculate Fragments Per Kilobase of transcript per Million fragments mapped 
(FPKM) changes using the default setting. 
 Differentially expressed genes for each complementation strain were subjected to gene 
set enrichment analysis on annotated KEGG pathways using the PATRIC Comparative 
Pathway Tool (88). Genes were selected for pathway analysis using a filter of log ratio of 2.0 or 
greater and a Z-score of 2.0.  
 
2.7 Western blotting 
 Cell lysates for detection of PCVRs by Western blot were generated as described 
previously (64). Briefly, 4-ml samples from early stationary phase cultures were centrifuged at 
5000 g for 5 min at 4˚C. Cell pellets were resuspended in KTE-PIC (10 mM Tris-HCl pH 8.0, 
100 mM KCl, 10% ethylene glycol, and EDTA-free Complete proteinase inhibitor) to a final 
volume of 450 μl and transferred to a 1.5 ml screw-cap tube containing 400 µl 0.1 mm 
Zirconia/Silica Beads (BioSpec Products, Bartlesville, OK). Cells were lysed mechanically using 
a Mini BeadBeater (BioSpec Products), centrifuged, and resuspended in SDS loading buffer 
(final concentration of loading buffer was 0.05% bromophenol blue, 0.1M DTT, 10% glycerol, 
2% SDS, and 5 mM Tris-Cl pH 6.8). Suspensions were boiled and subjected to SDS-PAGE. 
 To detect edema factor protein levels, culture supernates were passed through a 0.22-
µM nylon filter (Fisher Scientific) and boiled for 10 min. Supernatant volumes to assess edema 
factor levels were normalized by OD600 readings at sample collection. Supernates were affixed 
to a 0.2 µM nitrocellulose membrane (GE Healthcare Life Sciences, Pittsburgh, PA) by vacuum 
blotting with a slot blot apparatus (Hoefer Scientific, San Francisco, CA). Membranes were 
blocked at 4°C in TBS-T (20 mM Tris base, 137 mM NaCl, 0.1% Tween 20; pH 7.6) containing 
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2.5% BSA. Anti-EF (gift of R. J. Collier, ) and goat anti-rabbit-horseradish peroxidase conjugate 
secondary antibody (Bio-Rad, Hercules, CA, USA) were used for edema factor detection. 
 
2.8 India ink exclusion assay 
 Encapsulated cells were visualized by India ink exclusion. To induce capsule 
production, B. anthracis cells were cultivated in NBY medium supplemented with 0.8% 
dissolved bicarbonate. Cultures were incubated in 5% atmospheric CO2 to early stationary 
phase (89). An equal volume of India ink was added to 1.5 µl of culture on a microscope slide 
and viewed at 1000x magnification using a Nikon Eclipse TE2000-U microscope (Melville, NY). 
Images were captured using Metamorph (Imaging Series 6.1) software (Molecular Devices, 
Sunnyvale, CA). 
 
2.9 Co-affinity purification 
 B. anthracis UT423 strains containing plasmids with IPTG-inducible genes encoding 
affinity-tagged AtxA, AcpA, AcpB, and GFP proteins were cultured individually in 25 ml of 
CACO3 at 37˚C in 5% atmospheric CO2. Protein expression was induced with IPTG (50 µM) 
during early exponential growth phase and 20 ml of each culture was collected at early 
stationary phase. Cultures were pooled in pairs as described in Fig. 7 and Fig. 8. Pooled 
cultures were pelleted and washed with 10 mL Binding Buffer (5 mM imidazole pH 7.9, 0.5 M 
NaCl, 20 mM Tris, pH 7.15, 5 mM β-mercaptoethanol containing EDTA-free Complete Protease 
Inhibitor (PIC; Roche, Indianapolis, IN)). Cell pellets were flash frozen and stored at -80˚C. 
 Co-affinity purification was performed as described previously (64). Briefly, soluble cell 
lysates from pooled B. anthracis cultures were incubated 20 min in 5% CO2 to facilitate CO2-
dependent interactions. Lysates were mixed with NTA-Ni2+ resin to bind 6xHis-tagged proteins. 
The resin was washed to remove any non-specifically bound proteins. 6xHis-tagged proteins, 
as well as any associated proteins, were eluted from the resin using imidazole and analyzed by 
Western blot using anti-His and anti-FLAG antibodies. 
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2.10 AcpA-His and AcpB-His purification 
 Recombinant AcpA-His and AcpB-His were purified from B. anthracis using affinity 
chromatography as described previously (64). Briefly, B. anthracis UT423 strains possessing 
pUTE1090 (AcpA-His) or pUTE1091 (AcpB-His) were cultured in CACO3 in 5% CO2. Cultures 
were induced with 50 µM IPTG at early exponential phase and cells were collected at early 
stationary phase by centrifugation. Cells were resuspended in Binding Buffer supplemented 
with 1x EDTA-free Complete proteinase inhibitor (Roche), 1 mM MgCl2 and 10 units DNase I 
(Ambion, Austin, TX). Cell lysis was achieved by three passages through a French Pressure 
Cell Press (SLM Instruments, Urbana, IL) and soluble lysates were collected following 
centrifugation. Lysates were incubated with 1 ml NTA-Ni resin (Qiagen, Hilden, Germany) in 
Binding Buffer (total volume 10 ml) and incubated end-over-end for 2 h at 4˚C. The resin was 
pelleted and washed with Binding Buffer and subsequently washed with Wash Buffer 1 (40 mM 
imidazole pH 7.9, 1.0 M NaCl, 20 mM Tris pH 7.2, 5 mM β-mercaptoethanol), Wash Buffer High 
Salt (40 mM imidazole pH 7.9, 1.5 M NaCl, 20 mM Tris pH 7.2, 5 mM β-mercaptoethanol), and 
Wash Buffer 2 (75 mM imidazole pH 7.9, 1.0 M NaCl, 20 mM Tris pH 7.2, 5 mM b-
mercaptoethanol). Proteins were eluted from resin using imidazole. Protein concentration and 
purity were determined using the Bradford reagent (Bio-Rad) and SDS-PAGE with Coomassie 
staining. 
 
2.11 Bis-maleimidohexane crosslinking 
 B. anthracis UT423 strains harboring plasmids encoding AcpA-FLAG (pUTE1079) or 
AcpB-FLAG (pUTE1093) were cultured and induced with IPTG (50 µM) at early exponential 
phase. After 2 h, 20 ml of each culture was collected by centrifugation at 5000 g for 10 m at 4˚C 
and washed twice with 5 ml PBS-EDTA (1X PBS pH 7.2 containing 10 mM EDTA). Cells were 
resuspended in PBS-EDTA and lysed by mechanical disruption. Cell lysates were centrifuged 
at 10,000 g for 5 m at 4˚C to pellet insoluble debris. For each experiment, 250 µl of soluble 
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lysate was mixed with 5 µl of 20 mM bis(maleimido)hexane (BMH, Thermo Scientific, prepared 
freshly in DMSO) and incubated at 4˚C with end-over-end mixing for 2 h. Control reactions 
lacking BMH contained DMSO only. Reactions were quenched by adding cysteine to a final 
concentration of 40 mM and vortexing for 15 min RT. Samples were boiled in 1X SDS loading 
buffer (5% glycerol, 100 mM DTT, 2% SDS, 40 mM Tris-Cl pH 6.8) and separated on 12.5% 
polyacrylamide SDS gels (Bio-Rad). AcpA-FLAG and AcpB-FLAG were detected by Western 
blotting using α-FLAG antibody (Genscript). 
 Preparations of affinity-purified AcpA-His and AcpB-His used for BMH crosslinking 
experiments were purified using NTA-Ni resin and eluted using imidazole. Equivalent 
concentrations of purified AcpA-His and AcpB-His were diluted with PBS-EDTA to a final 
volume of 250 µl and BMH crosslinking was performed as described above. 
 
2.12 Mouse infections 
 All mouse protocols were approved by The University of Texas Health Science Center 
Institutional Animal Care and Use Committee and performed using accepted veterinary 
standards. Female 6- to 8-week-old A/J mice were purchased from The Jackson Laboratory 
(Bar Harbor, ME) and maintained in a pathogen-free vivarium at The University of Texas Health 
Science Center. Food and water were supplied to the mice ad libitum. The mice were housed 
three per cage and were allowed to acclimate to their surroundings for 7 days prior to being 
used in experiments. Mice were infected intravenously by using a 30-gauge needle. The tail 
vein was injected with 50 µl containing between 102 or 103 heat-sensitive CFU (vegetative 
cells). 
 
2.13 Determination of heat-resistant CFU 
 One-ml samples were obtained from cultures during transition from exponential to 
stationary (4h), and stationary (7h, 12h) growth phases. Samples were serially diluted and 
plated on LB agar before and after suspensions were heat-shocked at 65°C for 45 min. 
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Colonies were counted after overnight incubation at 37°C. The percentage of heat-resistant 
CFU/ml was calculated by dividing the number of heat-resistant CFU (post heat-shock) by the 
number of total CFU (pre-heat shock). Total heat-resistant CFU/ml values were determined by 
calculating the number of CFU/ml following heat-shock. 
 
2.14 Real-time quantitative PCR (RT-qPCR) 
 Purified RNA samples (2.5 – 10 μg) were incubated with either 5U of RQ1 DNase 
enzyme (Promega, Madison, WI) for 30 min or with 2U of DNase I enzyme (New England 
Biolabs, Ipswich, MA) for 10 min at 37°C. RQ1 DNase reactions were stopped using 0.1 
volume or 5 μl (whichever was greater) RQ1 stop buffer (Promega) and incubated at room 
temperature for 2 min. EDTA was added to a final concentration of 5 mM to stop the DNase I 
reactions. DNase-treated RNA was precipitated with 0.1 volume of 3 M sodium-acetate pH 5.2 
(Ambion, Grand Island, NY) and 2 volumes of ice-cold 100% ethanol for a minimum of 30 min 
on ice. The mixture was centrifuged at 16,000 x g for 30 min at 4°C. RNA pellets were washed 
with 1 ml of ice-cold 75% ethanol, dried in an Eppendorf Vacufuge, and resuspended in DEPC-
treated water. RNA concentrations were determined using a NanoDrop ND-1000 
Spectrophotometer.  
 RT-qPCR cDNA was synthesized by incubating 5 µg of RNA, 250 ng of random 
primers, and 10 mM dNTP Mix (final concentration) at 65˚C for 5 min followed by incubation on 
ice. 1X First-Strand Buffer (Invitrogen), 0.1 M DTT, and 200 U of SuperScript III reverse 
transcriptase (Invitrogen) were added to the mixture and incubated at RT for 5 min. The cDNA 
synthesis reaction proceeded at 50˚C for 60 min. cDNA synthesis for each sample included a 
reaction lacking reverse transcriptase to test DNA contamination. qPCR consisted of 1X iTaq 
Universal SYBR Green Supermix (BioRad), 300 nM for both forward and reverse primers (final 
concentration) (IDT), and 100 ng cDNA template. Each qPCR plate contained a no-template 
control for each sample to ensure reagents were not contaminated. qPCR plates were covered 
with Microseal "C" Film (BioRad) and incubated in a CFX96 Real Time PCR Detection System 
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(BioRad) using the following cycling conditions: 95˚C, 2 min; followed by 40 cycles of 95˚C, 15 
sec and 60˚C, 30 sec. Melt curve analysis (65˚C-95˚C at 0.5˚C increments for 2-5 sec/step) 
was performed at the conclusion of amplification cycles. Data were analyzed by CFX Manager 
(BioRad) with FAM reporter and ROX as the reference dye. Relative changes in gene 
expression were determined using the double delta Ct (∆∆Ct) method with gyrB as the 
reference gene.  
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Table 2-1.  B. anthracis strains and plasmids 
 
Name  Descriptiona            Reference or source 
 
Strains 
 
Ames  B. anthracis, Parent strain, pXO1+ pXO2+   (90) 
 
UTA40  Ames atxAacpAacpB-null mutant    This work 
 
UTA35  Ames-derived mutant with recombinant AcpA-FLAG  
  expressed from the native locus.    This work 
 
UTA36  Ames-derived mutant with recombinant AcpB-FLAG  This work 
  expressed from the native locus. 
 
UTA37  Ames-derived mutant with recombinant AtxA-FLAG  This work 
  expressed from the native locus. 
 
UTA9  Ames-derived skiA-nullc; Spr     This work 
 
UTA22  Ames-derived atxA-null      This work 
 
UTA26  Ames-derived atxA-up mutant (transversion mutation This work 
  of sequences +14 to +22)b 
 
UTA31  Ames-derived skiA-nullc/atxA-up mutant; Spr  This work 
 
ANR-1  B. anthracis, Parent strain, pXO1+ pXO2-   (77) 
 
UT423  ANR-1-derivative, capB promoter - lacZ fusion   This work 
  (PcapB-lacZ) incorporated in the plcR locus, atxA-null; Knr 
 
UT374  ANR-1-derivative atxA-null     (91) 
 
UT376  ANR-1-derivative, lef promoter - lacZ fusion (Plef-lacZ) (64) 
  at native lef locus, atxA-null 
 
Plasmids 
 
pUTE657 Expression vector derived from pDR111 and pBC16  (80) 
  with IPTG-inducible Phyper-spank; Spr Apr  
 
pUTE1054 pUTE657-derived expression vector for AcpA-FLAG This work 
  (FLAG-epitope on the C-terminus of AcpA); the acpA  
  ribosome binding site and coding region controlled by  
  Phyper-spank      
 
pUTE1079 pUTE657-derived expression vector for AcpA-FLAG This work 
  (FLAG-epitope on the C-terminus of AcpA) the atxA 
  ribosome binding site and acpA coding region controlled 
  by Phyper-spank  
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pUTE1090 pUTE657-derived expression vector for AcpA-His   This work 
  (6xHis-epitope on the C-terminus of AcpA) the atxA 
  ribosome binding site and acpA coding region controlled 
  by Phyper-spank  
 
pUTE1125 pUTE657-derived expression vector for AcpA-ΔEIIB-His  This work 
  (6xHis-epitope on the C-terminus of AcpA- ΔEIIB) the 
  acpA ribosome binding site and acpA coding region 
  controlled by Phyper-spank  
 
pUTE1056 pUTE657-derived expression vector for AcpB-FLAG This work 
  (FLAG-epitope on the C-terminus of AcpB) the acpB 
  ribosome binding site and coding region controlled by 
  Phyper-spank 
 
pUTE1093 pUTE657-derived expression vector for AcpB-FLAG  This work 
  (FLAG-epitope on the C-terminus of AcpB) the atxA 
  ribosome binding site and acpB coding region controlled 
  by Phyper-spank  
 
pUTE1091 pUTE657-derived expression vector for AcpB-His  This work 
  (6xHis-epitope on the C-terminus of AcpB) the atxA 
  ribosome binding site and acpB coding region controlled 
  by Phyper-spank 
 
pUTE1126 pUTE657-derived expression vector for AcpB-ΔEIIB-His This work 
  (6xHis-epitope on the C-terminus of AcpB-ΔEIIB) the acpB 
  ribosome binding site and acpB coding region controlled by 
  Phyper-spank  
 
pUTE992 pUTE657-derived expression vector for AtxA-FLAG  (64) 
  (FLAG-epitope on the C-terminus of AtxA) the atxA 
  ribosome binding site and coding region controlled by 
  Phyper-spank  
 
pUTE991 pUTE657-derived expression vector for AtxA-His  (64) 
  (6xHis-epitope on the  C-terminus of AtxA) the atxA 
  ribosome binding site and coding region controlled by 
  Phyper-spank  
 
pUTE1013 pUTE657-derived expression vector for GFP-FLAG             (64) 
  (FLAG-epitope on the C-terminus of GFP); the gfpmut3a 
  ribosome binding site, coding region, and sequence 
  encoding FLAG controlled by Phyper-spank 
 
pAW285 Xylose-inducible expression vector; Cmr              (92) 
 
pUTE1099 pAW285-derived expression vector for AcpA-FLAG            This work 
  (FLAG-epitope on the C-terminus of AcpA) the acpA 
  coding region controlled by PxylA 
 
pUTE1100 pAW285-derived expression vector for AcpB-FLAG            This work 
  (FLAG-epitope on the C-terminus of AcpB) the acpB 
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  coding region controlled by PxylA 
 
pUTE1096 pUTE657-derived expression vector for AtxA2-His  (93) 
  (6xHis-epitope on the C-terminus of AtxA2) the atxA 
  ribosome binding site and coding region controlled by 
  Phyper-spank 
 
pUTE1122 pUTE657-derived expression vector for AtxA2-FLAG (93) 
  (FLAG-epitope on the C-terminus of AtxA2) the atxA 
  ribosome binding site and coding region controlled by 
  Phyper-spank 
 
a Apr, ampicillin resistant; Cmr, chloramphenicol; Knr, kanamycin; Spr, spectinomycin 
b Numeric values relative to atxA P1 transcriptional start site 
c skiA was known previously as pXO2-0075 and pXO2-61 (White 2006) 
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Table 2-2. Primers used in this dissertation 
 
Name Sequence (5' to 3') Brief Description 
MJR014 CCGCGGACAAGTACATAATTGGCATTC SacII - acpA markerless deletion 
JR175a GCGTATCAAAATAAATTATCACCCTTAGTT
ATTTATTTC 
acpA markerless deletion (overlap 
primer) 
MJR017 GGCGCCGTATTTTAGATGCAACAGTG SacII - acpA markerless deletion 
& recombinant AcpA-FLAG gene 
insertion 
JR176s GGGTGATAATTTATTTTGATACGCAATAGC
TAGATTG 
acpA markerless deletion (overlap 
primer) 
MJR002 ATTGATACTACATATATCGATATCCCTTGC
TTTTAAG 
acpB markerless deletion (overlap 
primer) 
MJR015 CCGCGGTGTCTTAATTACTGGAAAGTAAC
A 
SacII - acpB markerless deletion 
MJR003 TCGATATATGTAGTATCAATAATATAGAAA
AAGCCACTT 
acpB markerless deletion (overlap 
primer) 
MT09 GGCGCCTTAATTTTAAGCAATAAAATACAT
AG 
SacII - acpB markerless deletion 
AB142 GGATCCGTCTTCTCGCACTATCAAGG BamHI - PcapB insertion 
AB143 GAGCTCTTTAGAAACAATTCACTCGCT SacI - PcapB insertion 
MJR037 CTATTTATCATCATCATCTTTATAATCTTTG
CTTGCAAAGATTCCTATTTC 
recombinant AcpA-FLAG gene 
insertion (overlap primer) 
MJR038 GGCTCGAGTAGGGGATGAATTTCAAATTA
TAC 
XhoI - recombinant AcpA-FLAG 
gene insertion 
MJR039 GATTATAAAGATGATGATGATAAATAGTAT
TTTGATACGCAATAGCTAGAT 
recombinant AcpA-FLAG gene 
insertion (overlap primer) 
MJR040 TACTCGAGAAACCTCTTAGACTTGAGGG XhoI - recombinant AcpB-FLAG 
gene insertion 
MJR041 CTATTTATCATCATCATCTTTATAATCACCA
TCTTGTAAATCTAGATAATA 
recombinant AcpB-FLAG gene 
insertion (overlap primer) 
MJR042 CCGCGGGAACAATATTTTCATTGCTCCTT
CC 
SacII - recombinant AcpB-FLAG 
gene insertion 
MJR043 GATTATAAAGATGATGATGATAAATAGTAT
CAATAATATAGAAAAAGCCAC 
recombinant AcpB-FLAG gene 
insertion (overlap primer) 
MJR095 AAAGGCGCCATTTATCTTAAGGTTATATTG
CAATATTCC 
SacII - recombinant AtxA-FLAG 
gene insertion 
MJR096 CTATTTATCATCATCATCTTTATAATCTATT
ATCTTTTTGATTTCATGAAAATCTCTTTC 
recombinant AtxA-FLAG gene 
insertion (overlap primer) 
MJR097 ATAGATTATAAAGATGATGATGATAAATAG
ATGCCCTTTAAATATTTGTTTAATGACAC 
recombinant AtxA-FLAG gene 
insertion (overlap primer) 
MJR098 AAACTCGAGCATTAGCCTTAATGTGAGTA
GAATC 
XhoI - recombinant AtxA-FLAG 
gene insertion 
MT01 GGTAGTCGACAACTAAGGGTGATAATTAT
G 
SalI - acpA rbs start codon 
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MJR056 GTCGACAGGAAAGGAGAATCAATTATAGA
CATGGAAAAAGATATTAGCCGAAAAATTG
ATTTG 
SalI - atxA rbs acpA open reading 
frame 
MJR005 AAGCATGCTAGTGGTGATGGTGATGATGT
TTGCTTGCAAAGATTCCTATTTC 
acpA His6 stop codon - SphI 
MJR001
1 
AAGCATGCTATTTATCATCATCATCTTTAT
AATCTTTGCTTGCAAAGATTCCTATTTC 
acpA FLAG stop codon - SphI 
MT05 AAGCATGCAAGCAAGGGATATCGATATAT
G 
SphI - acpB rbs start codon 
MJR057 AACTCGAGAGGAAAGGAGAATCAATTATA
GACATGGAAAAAGATATAAAAAGACAAAT
CCAAATC 
XhoI - atxA rbs acpB open 
reading frame 
MJR004 AAGCATGCTAGTGGTGATGGTGATGATGA
CCATCTTGTAAATCTAGATAATA 
acpB His6 stop codon - SphI 
MJR010 AAGCATGCTATTTATCATCATCATCTTTAT
AATCACCATCTTGTAAATCTAGATAATA 
acpB FLAG stop codon - SphI 
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Chapter III. 
 
 
 
 
 
Regulons of PRD-containing  
Bacillus anthracis virulence regulators 
reveal overlapping but distinct functions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: A portion of this chapter is derived from work published in 2018  which is cited below. I 
am first author on this publication. I have received permission by the publisher of Molecular 
Microbiology, John Wiley and Sons, to reproduce all of the manuscript in print or electronically 
for the purposes of my dissertation (License Numbers: 4284271503886 & 4342040215509). 
 
Raynor, M.J., Roh, JH., Widen, S.G., Wood, T.G., Koehler, T.M. (2018) Regulons and protein-
protein interactions of PRD-containing Bacillus anthracis virulence regulators reveal 
overlapping but distinct functions. Molecular Microbiology. doi: 10.1111/mmi.13961. 
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3.1 Introduction 
 Three PRD-Containing Virulence Regulators (PCVR), AtxA, AcpA, and AcpB, have 
been identified in Bacillus anthracis, the causative agent of anthrax. A defining characteristic of 
PCVRs is the presence of phosphoenolpyruvate:carbohydrate phosphotransferase system 
regulatory domains (PRD). The phosphotransferase system, generally involved in the transfer 
of phosphate to incoming sugar molecules, may also play a role in virulence. AtxA is the master 
virulence regulator and the most well-studied PCVR. AtxA controls transcription of the anthrax 
toxin genes, pagA (protective antigen), lef (lethal factor), and cya (edema factor). AtxA also 
affects expression of the capsule biosynthesis operon capBCADE and other genes (29, 30, 57, 
59, 64, 67). Expression of atxA is subject to complex regulation. Transcription of atxA, located 
on virulence plasmid pXO1 (182 kb), is affected by temperature, carbohydrate availability, 
redox potential, metabolic state, and growth phase (59–61, 66, 69). 
 The other two PCVRs in B. anthracis, AcpA and AcpB, are encoded by genes on 
virulence plasmid pXO2 (95 kb). AcpA and AcpB positively regulate capBCADE (29, 70). The 
amino acid sequences of these regulators are similar to that of AtxA, but structure/function 
studies of AcpA and AcpB are lacking. Initial investigations of AtxA, AcpA, and AcpB employed 
atxA-, acpA, and acpB-null mutants in a genetically reconstituted virulent pXO1+ pXO2+ strain. 
The data revealed that the regulons of the three PCVRs are partially overlapping and not 
limited to expression of the toxin and capsule genes (70). For example, in addition to the toxin 
and capsule genes, AtxA negatively regulates some chromosomal genes, including genes 
predicted to be involved in branched chain and aromatic amino acid synthesis (56). AcpA 
affects expression of pXO1-114, a gene predicted to encode a spore germination 
protein/permease. Also, AtxA and AcpA have a synergistic effect on expression of amiA, a 
peptidoglycan hydrolase, located on pXO2. AcpB appears to play a larger role in virulence than 
AcpA. In a murine model of anthrax, an acpB mutant exhibited a higher LD50 and reduced 
dissemination compared to an acpA mutant (70). 
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Extensive analyses of capBCADE regulation support a model in which all three B. 
anthracis PCVRs positively affect cap operon transcription. Data from experiments employing 
null-mutants reveal that expression of the regulators is inter-dependent and suggest functional 
similarity of AcpA and AcpB. The primary means for AtxA control of capBCADE is via positive 
regulation of acpA transcription (70). The acpA gene is located upstream of the cap locus and 
in the opposite orientation. AcpA can positively affect transcription of capBCADE in the 
absence of AtxA and AcpB. The acpB gene, located downstream of capBCADE and in the 
same orientation, is expressed as a monocistronic transcript initiated from a weak constitutive 
promoter. AcpB, like AcpA, can positively affect capBCADE expression in the absence of the 
other PCVRs. A weak transcription terminator located between capE and acpB results in co-
transcription of acpB with capBCADE in roughly 10% of transcripts, thus forming a positive 
feed-back loop.  
 It is unknown how AtxA, AcpA, and AcpB affect transcription of target genes or what 
factors influence target specificity. Clues to determining targets of some transcription factors 
can often be found in cis-acting elements upstream of the gene. Many transcription factors 
recognize particular DNA sequences, or consensus sequences, in the promoters of genes they 
regulate (94). A consensus sequence in the control regions of PCVR-regulated genes has not 
been identified and specific DNA-binding activity by AtxA has not been demonstrated. 
However, DNA structure has been implicated in AtxA gene regulation. In silico modeling of the 
toxin gene promoters predicts common structural characteristics. A region of high curvature is 
positioned near the AtxA-dependent transcriptional start sites. Two other AtxA-regulated genes, 
pXO1-90 and pXO1-91 which are positively regulated 61-fold and 25-fold, respectively, are also 
predicted to contain promoter regions of high curvature (58). These data suggest that intrinsic 
DNA curvature of AtxA-regulated promoters may contribute to AtxA-mediated gene expression. 
 The presence of three paralogous PCVRs in B. anthracis presents a unique opportunity 
to study similarities and differences in PCVR function in a single pathogen. Previously 
published investigations of the roles of AtxA, AcpA, and AcpB in B. anthracis transcription 
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employed PCVR-null mutants (29, 70). The more recently discerned inter-dependence of 
PCVR expression complicates interpretation of the data generated using individual null-
mutants. In this chapter, I show native protein expression levels of AtxA, AcpA, and AcpB in a 
fully virulent clinical isolate of B. anthracis. I created recombinant strains expressing individual 
PCVRs and determined the regulons of each factor using RNA-Seq. I identified genes 
controlled by one or more regulators, and whether PCVRs preferentially controlled genes within 
pathogenicity islands. I also examined the effects of individual regulators on expression of 
established virulence genes.  
3.2 Results 
3.2.1 Amino acid sequence and predicted domain similarity of the B. anthracis PCVRs 
 A comparison of the amino acid sequences of the B. anthracis PCVRs is shown in 
Figure 3-1A. Overall, AtxA shares about 27% amino acid sequence identity and close to 50% 
amino acid sequence similarity with AcpA and AcpB. AcpA and AcpB have 40% amino acid 
sequence identity and 62% similarity, and are more similar to each other than to AtxA. 
Structural models of AcpA and AcpB generated using Phyre2 (13) predict similar domain 
organization to AtxA (Figure 3-1B). Sequence homology between the three PCVRs is highest 
in the predicted DNA-binding domains which are comprised of two helix-turn-helix motifs at the 
amino termini. Within this region, AcpA and AcpB share 48% amino acid identity, AtxA and 
AcpA are 33% identical, and there is 29% identity between AtxA and AcpB. At the carboxy-
terminal regions of the PCVRs, the predicted EIIB-like domains of AcpA and AcpB are 32% 
identical to each other, and each share approximately 30% amino acid identity and 50% 
similarity with the respective domain within AtxA.  
Of the five predicted domains associated with each of the AcpA and AcpB amino acid 
sequences, the PRDs are the most divergent from AtxA. Although the amino acid sequences of 
the AcpA and AcpB PRD regions share 36% identity, they are 20% and 22% identical to the 
sequences of the PRDs revealed in the AtxA crystal structure. Phosphorylation of H199 and 
H379 within AtxA PRD1 and PRD2, respectively affect regulator activity (66). Phosphorylation 
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of AcpA and AcpB has not been demonstrated and histidine residues within the putative PRDs 
of AcpA and AcpB do not align with phosphorylated residues of AtxA (Figure 3-1A).  
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Figure 3-1. Amino acid sequence alignment and structures of Bacillus anthracis PCVRs 
(A) Domains identified in the AtxA crystal structure are shown as solid bars directly above the 
respective amino acid sequence. Histidines at positions 199 and 379 within AtxA, which have 
been shown to be subject to phosphorylation, are shown with black background. Potential sites 
for histidine phosphorylation within the putative PRDs of AcpA and AcpB are shown with a gray 
background. Amino acid identity and similarity are denoted by asterisk (full conservation), colon 
(strongly similar properties), or period (weakly similar properties). Alignments were completed 
using the Clustal X2 program. (B) Crystal structure of AtxA and protein threading structural 
predictions of AcpA and AcpB. Domains are color coded, and H199 and H379 of AtxA are 
labeled. Histidines within PRDs of AcpA and AcpB are indicated by blue and yellow spheres.  
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3.2.2 Native PCVR protein and transcript levels 
 The importance of AtxA, AcpA, and AcpB in expression of toxin and capsule has been 
appreciated, but individual contributions by each regulator have not been fully defined. As an 
initial step I determined the relative level of each PCVR when the parent strain was cultured in 
optimal conditions for virulence gene expression. To determine native PCVR protein levels, I 
created strains that expressed AtxA-FLAG, AcpA-FLAG, or AcpB-FLAG from the respective 
native locus. The FLAG epitope did not affect function of the native protein in in vivo reporter 
strains designed to test AtxA, AcpA, or AcpB activity. (Figure 3-2 and (64)). Strains were 
cultured in either CACO3 or NBY-CO3 in atmospheric 5% CO2. Culture in CACO3 and 5% CO2 
is ideal for atxA-mediated toxin gene expression (30), and growth in NBY-CO3 and 5% CO2 
allows optimal capsule production. Strains were harvested at the transition to stationary growth 
phase and cell lysates prepared. Cell lysates were separated by SDS-PAGE and FLAG-tagged 
proteins were visualized by western blot using α-FLAG antibody. In both media, AtxA was the 
most abundant PCVR detected (Figure 3-3). AcpA-FLAG and AcpB-FLAG were detected at 
levels much lower than AtxA-FLAG in strains cultured in CACO3 medium. Nevertheless, 
capsule production was apparent (Figure 3-3A). AcpA-FLAG and AcpB-FLAG had higher 
steady state levels when strains were cultivated in NBY-CO3 compared to culture in CACO3 
with AcpB-FLAG detected in higher abundance than AcpA-FLAG (Figure 3-3B). These results 
assume equal accessibility of the FLAG epitope by the α-FLAG antibody for each recombinant 
protein. Capsule production from cultures grown in NBY-CO3 was also more robust and 
resulted in cells with thicker capsule than from CACO3 cultures. These results indicate that 
AtxA is the most abundant of the three PCVRs in soluble cell lysates. 
 I used RNA-Seq to define the regulon of each PCVR and to determine the extent each 
PCVR plays in expression of genes related to virulence and general metabolism, and to identify 
co-regulated genes. In order to circumvent the influence of AtxA on acpA and acpB expression, 
and to ascertain the significance of each PCVR in a clinical isolate of B. anthracis, I created an  
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Figure 3-2. In vivo activity of recombinant His-tagged and FLAG-tagged AcpA and AcpB 
In an atxA-null pXO1+ pXO2- strain (UT423), expression of native, -His6, and –FLAG tagged 
recombinant AcpA and AcpB was induced with IPTG during growth in CACO3. The empty 
vector (EV) lacks both acpA and acpB. Samples were collected at the transition to stationary 
phase (4h; OD600 1.2-1.8). All strains carried the PcapB:lacZ reporter and β-galactosidase 
activity was measured as described previously (95). Error bars represent  standard deviation.  
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atxAacpAacpB-null mutant from the pXO1+ pXO2+ Ames strain (Table 2-1) and expressed 
individual PCVR-encoding genes in trans under the control of an IPTG-inducible promoter. 
PCVR expression was induced with a concentration of IPTG that yielded near-native protein 
levels.  
 To determine IPTG concentrations that yield near-native PCVR protein levels, I grew 
cultures that expressed individual FLAG-tagged PCVRs from the native locus, and cultures of 
the atxAacpAacpB-null strain carrying plasmid-borne atxA, acpA, or acpB under the control of 
an IPTG inducible promoter. Expression of each PCVR was induced at early exponential 
growth phase using a range of IPTG concentrations and all cultures were harvested at the 
transition to stationary phase. Cell lysates from strains that expressed an individual PCVR, 
either from the native locus or from the IPTG-inducible expression vector, were separated by 
SDS-PAGE and FLAG-tagged proteins were detected by western blot with anti-FLAG antibody. 
The IPTG concentration that yielded PCVR expression that most closely mirrored expression 
from the native locus was used for future experiments. 
 For RNA-Seq experiments I grew cultures of the parent strain, atxAacpAacpB-null 
strain, and atxAacpAacpB-null strains expressing individual PCVR genes from the IPTG-
inducible promoter. Cells were grown in toxin-inducing conditions, and expression of each 
PCVR in the atxAacpAacpB-null complementation strains was induced with IPTG. RNA was 
extracted for sequencing when cultures reached the transition to stationary phase. 
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Figure 3-3. Native PCVR expression and capsule production 
Strains of B. anthracis expressing AtxA-FLAG (UTA37), AcpA-FLAG (UTA35), AcpB-FLAG 
(UTA36) from the respective native locus, and the parent strain Ames were cultivated in either 
(A) CACO3 or (B) NBY-CO3 in 5% atmospheric CO2 and harvested (8 mLs per culture) at 
transition to stationary phase (OD600 1.2-1.7). Cell lysates were diluted 5-fold or 25-fold in KTE-
PIC and load volumes were normalized by OD600 reading at collection prior to separation by 
SDS-PAGE. FLAG-tagged proteins were detected by western blot with α-FLAG antibody. 
Capsule production was assessed at collection and visualized using Differential Interference 
Contrast (DIC) microscopy and India Ink staining. 
 
α-FLAG 
India Ink 
α-FLAG 
India Ink 
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 Prior to examining gene expression changes mediated by each PCVR, I assessed the 
expression levels of atxA, acpA, and acpB in the parent strain and complementation strains to: 
A) determine the relative abundance of PCVR transcripts, and B) to assess how well PCVR 
expression in each complementation strain mirrored native expression. I compared the 
fragments per kilobase of transcript per million reads (FPKM) for each PCVR in the parent, 
atxAacpAacpB-null, and complementation strains (Figure 3-4). In the parent strain, atxA and 
acpA transcripts were present at similar levels. Transcripts of acpB were roughly two-fold more 
abundant than atxA or acpA transcripts, potentially due to transcriptional read through from 
capBCADE to acpB (Figure 1-3). Expression of atxA, acpA, and acpB in the atxAacpAacpB-
null strain was not detected and complementation with either atxA or acpA expressed from an 
IPTG-inducible promoter yielded near-native expression. Expression of acpB from the IPTG-
inducible promoter yielded acpB expression several-fold higher than native acpB expression 
(Figure 3-4). Nevertheless, the IPTG concentration used to induce acpB expression generated 
AcpB protein levels commensurate with acpB expressed from the native locus. These data 
suggest that acpB transcripts expressed from the IPTG-inducible promoter may be less stable 
and/or translated less efficiently than acpB transcripts expressed from the native locus.  
3.2.3 Overlapping regulons of AtxA, AcpA, and AcpB 
 To discern differential effects mediated by each PCVR on global gene expression, I 
compared RNA sequencing reads obtained using cultures from the different strains. 
Comparison of the transcriptional profiles of the parent strain and the atxAacpAacpB-null 
mutant revealed vast differences in gene expression. Four-fold or greater differences in 
transcript levels were found for 716 genes, representing 11.6% of the genome. Gene 
expression changes of two-fold or greater were observed for 1440 genes representing 23.4% 
of the genome.   
 To determine the effects of individual PCVRs on gene expression I compared 
transcripts from the atxAacpAacpB-null mutant to those obtained from mutants expressing one 
PCVR. Venn diagrams of the PCVR regulons illustrate that B. anthracis genes can be 
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Figure 3-4. PCVR transcript levels 
Transcripts of atxA, acpA, and acpB in the parent, atxAacpAacpB-null (∆∆∆), and 
complementation strains expressing atxA (∆∆∆/atxA), acpA (∆∆∆/acpA), or acpB (∆∆∆/acpB) 
were determined by RNA-Seq following culture in CACO3 in 5% CO2. Error bars represent high 
and low confidence intervals.  
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controlled by one, two, or all three regulators (Figure 3-5). AtxA had a four-fold or greater effect 
on expression of 145 genes (Figure 3-5A); 80 were positively controlled by AtxA, while 65 
were negatively affected by AtxA. Table 3-1 lists PCVR-regulated genes with a 16-fold or 
greater change in expression (log2-fold change of 4 or greater) in the presence of at least one 
PCVR, and illustrates specific and co-regulated genes. I found several examples of genes with 
expression changes that were strongly AtxA-dependent, but unaffected by AcpA or AcpB 
(Table 3-1). For example, expression of pagAR, lef, and GBAA_pXO1_0171 was strongly 
induced by AtxA, but not affected by the other PCVRs. AtxA regulated independently a greater 
number of genes (≥4-fold) than either AcpA or AcpB. AcpA affected expression of 130 genes; 
83 were positively regulated and 47 were negatively regulated, and AcpB controlled expression 
of 49 genes; 17 were up-regulated and 32 were down-regulated. AcpA-alone controlled 
expression of amiA, an autolysin encoded by pXO2. AcpB controlled expression of 
GBAA_pXO2_0119, a pseudogene annotated as a truncated transposase. The data set 
included co-regulated genes that were affected similarly by AcpA and AcpB, but to a different 
degree by AtxA. Both AcpA and AcpB positively affected expression of GBAA_pXO2_0059, but 
expression of this gene was not affected by AtxA.  
Expression of GBAA_pXO2_0061 and GBAA_pXO2_0122 was strongly affected by AcpA and 
AcpB, yet weakly controlled by AtxA. For co-regulated genes, there was a predominance of 
genes controlled by AtxA and AcpA. For genes regulated four-fold or greater, 31 genes were 
controlled by AtxA and AcpA, 15 genes were co-regulated by AtxA and AcpB, and 5 genes 
were co-regulated by AcpA and AcpB. Many genes were controlled by all three regulators, and 
in some cases each PCVR had comparable effects on target genes. The numbers of genes in 
the regulons increased substantially when I included genes with expression that changed two-
fold or greater. These results reveal the vast effects of the PCVRs on B. anthracis gene 
expression and indicate a high degree of functional similarity among the regulators.  
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Figure 3-5. Venn diagrams of PCVR regulons 
(A) Gene expression changes of ≥2-fold, ≥4-fold, and ≥16-fold in the atxAacpAacpB-null strain 
(UTA40) complemented with AtxA, AcpA or AcpB. (B) Gene expression changes of ≥4-fold 
organized by genetic element. 
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3.2.4 Loci of PCVR-regulated genes 
 To determine if genes controlled by AtxA, AcpA, or AcpB are linked, I first determined 
whether highly-regulated genes mapped to pXO1, pXO2, or the chromosome. Table 3-1 lists 
PCVR-regulated genes with a 16-fold or greater change in expression (log2-fold change of four 
or greater) in the presence of at least one PCVR. Figure 3-5B shows Venn diagrams of the 
PCVR regulons associated with each genetic element for genes regulated at least four-fold. Of 
203 transcripts associated with pXO1, 15 were altered at least four-fold: 13 by AtxA and 2 by 
AcpA. No pXO1-derived transcripts were affected four-fold or greater by AcpB. Transcripts 
regulated by more than one PCVR were not detected, with the exception of cya and bslA, 
which were highly regulated by AtxA and showed a relatively small level of control by AcpA 
(see Table 3-1). 
Read maps (Figure 3-6) revealed that many of the regulated transcripts from pXO1 
were associated with the 35-kb region that lies within a larger 44.8-kb pathogenicity island (96). 
Of the 47 genes from which I detected transcripts in this region, 12 were AtxA-controlled. 
These genes included the three toxin genes and the spore germination genes gerXA, gerXB, 
and gerXC, encoding germination receptors (97). The native atxA locus is also within this 35-kb 
region. The bslA gene, encoding an S-layer protein that mediates adhesion to host cells (55) is 
the only highly expressed AtxA-regulated gene on pXO1 located outside of the pathogenicity 
island. 
 I detected transcripts for 110 genes on pXO2, of which 21 were regulated four-fold or 
greater by at least one of the three PCVRs (Figure 3-5B). The highly-regulated genes 
clustered within a 35.5-kb region of the plasmid which includes the capsule biosynthetic operon 
capBCADE followed by the weakly co-transcribed acpB gene. Other PCVR-controlled genes in 
this region of pXO2 include pagR2, a paralog of the pXO1-encoded transcription factor pagR1 
(98, 99), and multiple genes of unknown function (Figure 3-6 and Table 3-1). The acpA and 
acpB genes are also located in the 35.5-kb region.                                             
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Table 3-1. Genes most highly regulated by the PCVRs 
Genes listed showed a Log2-fold change of ≥4 (≥16-fold) in at least one complementation 
strain; AcpA (UTA35), AcpB (UTA36), and AtxA (UTA37) when compared to the 
atxAacpAacpB-null strain (UTA40).  Genes that appear to be co-transcribed indicated by 
bracket. 
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Figure 3-6. Sequencing reads mapping to PCVR-regulated loci 
Bedgraphs show normalized sequencing reads mapped to pXO1 (A), pXO2 (B), and the 
chromosome (C). Regions enriched for PCVR-regulated genes indicated above graph in 
kilobases.   
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 With the exception of pagR2, for pXO2 genes controlled by all three PCVRs, AcpA and 
AcpB exerted comparable effects, while AtxA had a lower level of control (Table 3-1). Other 
highly-regulated genes on pXO2 included the surface-layer N-acetylmuramoyl-L-alanine 
amidase gene, amiA, controlled solely by AcpA, and a gene of unknown function pXO2_0119, 
which was only affected by AcpB.  
 A significantly smaller proportion of PCVR-regulated genes mapped to the 
chromosome. Of 5593 transcripts, 198 were altered four-fold or greater by one or more PCVRs. 
Clustering of PCVR-regulated chromosome genes was not apparent, however transcript reads 
suggested some operons (Table 3-1) and functional relationships. PCVR-controlled 
chromosomal genes included multiple genes predicted to be associated with metabolic 
networks. Among the most highly-regulated chromosomal genes were many genes associated 
with branched chain amino acid (BCAA) synthesis and uptake (Table 3-1).  Previous reports 
show that AtxA negatively affected expression of genes involved in branched chain amino acid 
synthesis (56). My analysis identified AcpB as an additional negative regulator of these genes. 
Of the 17 genes implicated in BCAA biosynthesis, expression of 13 of these genes is repressed 
by AtxA and AcpB. 
I examined the read maps for evidence of autogenous control of the PCVR genes. For 
each of the PCVR genes, levels of transcripts mapping to sequences directly upstream of the 
native open reading frame did not differ in the null mutant, parent strain, and complemented 
strain, indicating no autogenous control. However, in agreement with previously published 
studies (29), AtxA positively affected acpA transcript levels and AcpA positively increased acpB 
transcripts. Notably, the level of acpB transcripts originating from the IPTG-inducible 
expression vector in the acpB complementation strain was higher than that generated by the 
native locus in the parent strain. Yet, both strains produced comparable amounts of AcpB (data 
not shown), suggesting that acpB transcripts expressed from the inducible promoter have 
reduced stability or are not translated as efficiently as transcripts expressed from the native 
locus.  
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Figure 3-7. Heat map and dendrogram of hierarchical  clustering among PCVR regulons 
Gene expression on pXO1 (A), pXO2 (B), and the chromosome (C) in each complementation 
strain; AcpA (UTA35), AcpB (UTA36), and AtxA (UTA37) relative to the atxAacpAacpB-null 
strain (UTA40). Relative fold changes in expression are presented in Log2 scale with up-
regulated genes in red and down-regulated genes in green. Hierarchical clustering analysis of 
completed by GENE-E.  
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 Overall, with the exception of the large number of highly AtxA-regulated genes on 
pXO1, I did not observe notable relationships between specific PCVRs and genetic elements 
(plasmids and chromosome loci). Moreover, hierarchical clustering of the PCVRs and their 
regulons did not reveal a correlation between relative PCVR similarity and co-regulated genes  
 (Figure 3-7). The data indicate that AcpA and AcpB elicit similar gene expression patterns for 
regulated genes on pXO1 and pXO2 genes, whereas the AtxA effect is more distinct. 
Interestingly, for regulated genes on the chromosome AtxA and AcpA caused similar 
expression changes, while AcpB elicited more distinct changes in gene expression. I also noted 
that highly-regulated genes on the plasmids were affected positively by the PCVRs, while 
chromosomal genes displaying 16-fold or greater regulation were affected negatively. 
 
3.2.5 Effects of individual PCVRs on established virulence genes 
 The genes most highly-regulated (log2-fold change of 4-fold or greater)by at least one 
PCVR are listed in Table 3-1. In agreement with previous reports of AtxA control of toxin gene 
transcription (30, 49, 57, 71, 100–103), transcripts of lef, cya, and the pagAR operon exhibited 
a log2-fold change of 4.47 or higher in the presence of AtxA. AcpB did not affect toxin gene 
expression, while AcpA had a modest, yet statistically significant effect on expression of cya, 
encoding EF. In other studies, AcpA was found to have no effect on toxin expression (56, 101). 
To further investigate AcpA control of cya, I tested culture supernates for EF using western 
blotting (Figure 3-8). EF production by the atxAacpAacpB-null mutant was markedly less than 
that of the parent strain. Cultures of the null mutant harboring individual PCVR genes were 
induced with varying concentrations of IPTG to approximate native levels of PCVR expression, 
or over-expression of the PCVRs. At both levels of induction, EF was detected in supernates of 
the null mutant complemented with atxA. Interestingly, EF was not detected in culture 
supernates when either AcpA or AcpB were induced to native or high levels. These results 
support my RNA-Seq data that AtxA is the major regulator of cya expression. Despite a small 
effect on cya transcript levels by AcpA, edema factor was not  
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Figure 3-8. Edema Factor Production by the individual PCVRs 
Expression of recombinant atxA, acpA, and acpB was induced with IPTG to yield either native 
or overexpressed steady state protein levels (Native - 5 µM, 5 µM, 150 µM respectively;  
Overexpressed - 50 µM, 50 µM, 500 µM respectively) during growth in CACO3 in 5% CO2.  
Samples of culture supernatants were subjected to slot blot Western analysis using rabbit  
anti-EF serum raised against B. anthracis edema factor.  
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detected in culture supernates of the null mutant complemented with acpA. Further, the 
increase in edema factor production resulting from overexpression of AtxA indicates AtxA 
levels are limiting for cya expression.  
 Expression of the capsule biosynthetic operon was positively affected by all three 
PCVRs, with AcpA and AcpB having the strongest effect. The influence of AtxA on capsule 
operon expression was surprising because it was shown previously that native atxA 
transcription in pXO1+ pXO2+ strain UT500 deleted for acpA and acpB, did not produce 
capsulated bacilli (29).  However, another study demonstrated that in a Pasteur II derivative 
lacking pXO2 (thus missing acpA and acpB) and harboring plasmid-encoded capBCA under the 
control of the native promoter, overexpression of atxA results in the production of capsule 
material by cultures incubated on LB agar supplemented with bicarbonate in 20% atmospheric 
CO2 (71). Typically, to induce capsule synthesis B. anthracis is cultured in 5% CO2, which is 
thought to model the host environment (104, 105). I cultured the atxAacpAacpB-null mutant 
and PCVR-complemented strains in 5% CO2 and 20% CO2 to test for encapsulated bacilli 
(Figure 3-9A, B). In both CO2 environments, robust capsule production was observed in strains 
complemented with acpA or acpB, but not in the strain expressing only atxA. Moreover, over-
expression of atxA did not result in visible capsule formation (Figure 3-9). Combined with the 
RNA-Seq data, these results indicate that although AtxA can elevate capBCADE transcript 
levels, either transcription is not high enough to detect capsule microscopically or robust cell-
associated capsule formation by the virulent Ames strain requires additional factors that are 
regulated by AcpA and AcpB, but not AtxA.  
 Other genes related to virulence were affected by AtxA, AcpA, and AcpB. The pXO2 
pagR2 gene, which has been implicated in the attenuation of virulence in the Pasteur II vaccine 
strain (99), was positively regulated 32- to 64-fold by all three PCVRs (Table 3-1). In addition, 
transcription of the β-lactamase gene bla2, reported previously to be controlled by the 
extracytoplasmic function sigma factor–anti-sigma factor gene pair, sigP-rsiP (106), was  
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Figure 3-9. Capsule production by the individual PCVRs 
Expression of recombinant atxA, acpA, and acpB was induced with IPTG to yield native steady 
state protein levels (5 µM, 5 µM, 150 µM respectively) during growth in CACO3 in 5% CO2 (A). 
(B) Expression of recombinant atxA induced with 30 µM IPTG in UTA40 during growth in  
CACO3 in 20% CO2. (C) Overexpression of atxA with 50 µM IPTG during culture in CACO3 in  
5% CO2 . The UTA40 derivatives were induced at early exponential phase  
(2h; OD600 0.25-0.35) in during  growth in CACO3. Samples were collected at the transition to 
stationary phase (4h; OD600 1.2-1.8), stained with India Ink, and visualized using DIC  
microscopy.  
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also increased 5- to 7-fold in the AtxA, AcpA, and AcpB complementation strains compared to 
the atxAacpAacpB-null mutant.  
 
3.3 Discussion 
 In this chapter, I have reported similarities and differences of the B. anthracis PCVRs at 
the amino acid level, determined the regulon of each PCVR using RNA-Seq, examined linkage 
relationships between PCVRs and their targets, and studied the specific activity of each PCVR 
on toxin and capsule expression. 
 Native transcript levels of atxA, acpA, and acpB from B. anthracis cultured in CACO3 as 
determined using RNA-Seq show that transcripts of atxA and acpA are present at roughly 
equivalent levels, while transcripts of acpB are two-fold more abundant. These data are 
consistent with previous qRT-PCR data which examined atxA, acpA, and acpB transcript levels 
in a genetically reconstituted strain of B. anthracis (70). However, relative levels of atxA, acpA, 
and acpB transcripts do not correlate with protein abundance (Figures 3-3 & 3-4). Despite 
having transcript amounts equivalent to that of acpA, AtxA is far more abundant in soluble cell 
lysates than AcpA. Transcripts of acpB are expressed two-fold more highly than atxA or acpA, 
but AcpB is still less prevalent than AtxA in cell lysates. The ribosomal binding site (RBS) 
among the three genes is not conserved and is likely the cause for the non-linear relationship 
between PCVR transcripts and protein levels. The ribosomal binding sequence, as well as 
spacing to the ATG start codon, differs for each of the three genes. Production of AcpA and 
AcpB increases when the atxA RBS and 5' untranslated sequence are used to drive translation 
of acpA and acpB (See Chapter IV and Figure 4-1). Differences in the RBS among PCVR 
genes demonstrate post-transcriptional regulation of PCVR protein levels. It may be 
advantageous for B. anthracis to keep AcpA and AcpB protein levels at levels much lower than 
AtxA during infection. Both AcpA and AcpB are limiting for capsule production and 
overexpression of either acpA or acpB in the atxAacpAacpB-null strain produced cells with 
capsule radii much thicker than the wild-type strain. An acpAacpB mutant is avirulent in a 
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murine model of anthrax, and single deletions of either acpA or acpB result in decreased 
capsule thickness or virulence relative to the parent strain. Reduced dissemination is observed 
in an acpB-null mutant, but not in an acpA-null mutant indicating that other factors controlled by 
these two regulators are important for infection (107). The virulence of B. anthracis strains 
overexpressing acpA or acpB has not been tested, but it is likely that increased capsule 
thickness or other factors regulated by either regulator would not attenuate virulence. 
 One of the overarching questions with regard to PCVR function is what features of the 
proteins mediate target specificity. Hierarchical clustering shows there is little to no correlation 
between amino acid conservation among regulators and what genes they control. AcpA and 
AcpB generated similar expression patterns for genes located on pXO1, which were distinct 
from AtxA-mediated gene expression on pXO1. Gene expression profiles for all three 
regulators were very similar for genes located on pXO2. For chromosome-encoded genes, the 
expression profiles for AtxA and AcpA were most similar. These data suggest that other factors 
aside from amino acid sequence similarity are involved in PCVR target specificity.  
 The Koehler lab published previously that phosphorylation at H199 within AtxA is 
thought to reposition the linker between PRD1 and HTH2 of AtxA thereby affecting the HTH2-
DNA interaction (65). The phosphorylation state of AcpA and AcpB has not been determined. 
The putative PRDs of AcpA and AcpB are the most dissimilar domains when compared to the 
AtxA amino acid sequence. Histidine residues within the PRDs of AcpA and AcpB do not align 
with phosphorylated histidines at position 199 nor 379 within AtxA (Figure 3-1, (66)). 
Differential positioning of histidine residues within the PRDs of AcpA and AcpB relative to AtxA 
may be cause for differences in target specificities between these three PCVRs. It is possible 
that if phosphorylated histidine residues exist within PRD1 of AcpA and AcpB, differences in 
the location of these residues relative to the HTH2 of the DNA-binding domain may account for 
differences in target specificities observed among AtxA, AcpA, and AcpB. 
 Metal binding might also play a role in PCVR target specificity, as was demonstrated for 
Mga, the PCVR of Group A Streptococcus. Mga DNA-binding specificity is influenced by Zn2+ 
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and Ni2+ (108). The involvement of metal ions in AtxA, AcpA, and AcpB DNA-binding has not 
been tested. However, if metal ions play a similar role in B. anthracis PCVR function, amino 
acid differences between AtxA, AcpA, and AcpB could influence the DNA-binding specificity of 
these regulators. 
My data show that PCVR-regulated genes on pXO1 and pXO2 cluster within defined 
loci. On pXO1, PCVR-controlled genes clustered within a 35-kb region identified previously as 
a pathogenicity island. The pathogenicity island is flanked by IS1627 insertion elements (ISs) 
with near identical sequence similarity. This region harbors loci for several other putative ISs, 
transposases, and integrases (109) and inversions of this pathogenicity island have been 
observed in other B. anthracis strains (96). Similarly, the 35.5-kb region on pXO2 that contains 
a cluster of PCVR-regulated genes has also been suggested as a pathogenicity island (110). In 
line with PCVR control of genes within pathogenicity islands, MgaSpn, a PCVR expressed in S. 
pneumoniae, represses expression of the 12-kb rlr pathogenicity islet. This region encodes 
three sortases and a cognate transcriptional regulator which mediate bacterial colonization in 
the host pulmonary and nasopharyngeal environments (14, 111). In GAS, Mga controls 
expression of genes localized to a 47-kb region that is inclusive of emm which encodes M-
protein, as well as other Mga-regulated virulence factors. In addition to genes related to 
virulence, features associated with mobile elements, such as transposases and multiple short 
direct repeats, are also within this region (112). To my knowledge, RivR and PafR have not 
been associated with regulation of any pathogenicity islands in their respective host organisms. 
 The capsule biosynthetic operon is located within an apparent pathogenicity island on 
pXO2. The capBCA genes are not unique to B. anthracis as homologs are present in other 
members of the Bacillus genus (113). In other species capBCA homologues are regulated by 
factors other than AcpA and AcpB homologues. In B. subtilis IFO 16449, which harbors 
chromosome-encoded capBCA homologues and produces large quantities of Ƴ-polyglutamic 
acid, activity of a PcapB-lacZ reporter increases five-fold with the addition of L-glutamic acid to 
cultures of Spizizen minimal medium (114). Homologs of AtxA, AcpA, or AcpB have not been 
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identified in this strain of B. subtilis. In B. anthracis, culture in medium supplemented with 
bicarbonate in 5% atmospheric CO2 is required for capsule formation (105). Other Bacillus 
species that produce a cell-associated poly-Ƴ-D-glutamic acid capsule harbor pXO2-like 
plasmids that include the capD and capE genes at the 3' end of the capBCA operon. CapD is 
required for cell-wall anchoring of polyglutamate to the cell wall, and CapE has been proposed 
to form a complex with CapA to transport D-glutamic acid polymers across the cell membrane 
(47–49). The presence of pathogenicity islands on pXO1 and pXO2 provide evidence for 
horizontal gene acquisition in Bacillus anthracis. Considering that many virulence factors are 
acquired by horizontal gene transfer and plasmid acquisition, it is reasonable to postulate that 
these factors are added gradually over time and that transcriptional regulators associated with 
these factors both gain and loose functionality. Given that atxA, acpA, and acpB are located in 
apparent pathogenicity islands, over the course of evolution they may have gained functionality 
to control expression of genes outside of their original/initial targets providing a fitness 
advantage.  
Perhaps the most interesting disparity between the B. anthracis PCVR regulons and the 
PCVR regulons of other species is within the collection of target genes that do not encode 
classic virulence factors. Prior to my results, metabolic gene targets of PCVRs have frequently 
included genes associated with carbohydrate utilization. The S. pyogenes Mga regulon 
includes genes involved in fermentation, the mannose PTS, fructose PTS, and maltose 
utilization (115). RivR of S. pyogenes positively regulates genes required for metabolism of 
sucrose (116). In uropathogenic E. coli, PafR represses expression of genes required for 
maltose utilization (15). My data indicate that the B. anthracis PCVRs do not play a significant 
role in carbohydrate utilization. Rather, AtxA, AcpB, and to a lesser extent AcpA negatively 
regulate operons and genes associated with branched chain amino acid biosynthesis and 
transport. The physiological significance of PCVR control of metabolic genes has been 
purported to be related to diverse microenvironments of pathogens during infection. S. 
pyogenes can colonize the skin, pharynx, soft tissues, and cause invasive infections (117, 
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118). Uropathogenic E. coli can colonize both the colon and urinary tract (119). Like these 
bacteria, B. anthracis can thrive in diverse host environments, including the dermis, blood, 
cerebral spinal fluid, and many organs (120, 121). However, the significance of branched chain 
amino acid (BCAA) metabolism in these environments is not clear.  
Although minimal media for culture of B. anthracis have been described, there are few 
reports of nutritional requirements of the bacterium during infection. B. anthracis mutants 
deficient in synthesis of aromatic amino acids were less virulent than a wild-type Sterne strain 
in models of anthrax infection (90). Also, a recent study suggested that B. anthracis requires 
exogenous valine to grow in a medium that mimics serum (122). There are few reported links 
between BCAA metabolism and virulence in other pathogens. In Staphylococcus aureus, single 
deletions of brnQ alleles, predicted to encode BCAA transporters, have affected virulence. A 
brnQ1 mutant was attenuated compared to the parent strain in a murine infection model. In 
contrast, a brnQ2 mutant had a significant increase in virulence relative to parent (123). In 
Listeria monocytogenes CodY, a BCAA-responsive transcriptional regulator that has been well 
characterized in B. subtilis (68, 124), binds the coding sequence of the master virulence 
regulator, prfA, resulting in up-regulation of prfA transcription in low BCAA conditions. Mutation 
of the CodY binding sequence in prfA attenuated bacterial virulence in a murine infection model 
(125). I determined that AtxA and AcpB down-regulate expression of brnQ3 and brnQ6, which 
are annotated as BCAA transport system II carrier proteins (126). AtxA and AcpB also repress 
expression of BCAA synthetic operons. Interestingly, CodY has been implicated in AtxA protein 
stability in B. anthracis (69).  
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Carbon dioxide, protein stability,  
and PCVR interactions 
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protein interactions of PRD-containing Bacillus anthracis virulence regulators reveal 
overlapping but distinct functions. Molecular Microbiology. doi: 10.1111/mmi.13961. 
64 
 
4.1 Introduction 
 
 Based on in vitro experiments designed to study virulence gene expression in response 
to culture conditions, it is surmised that when B. anthracis enters a host at least two important 
cues, temperature and bicarbonate/carbon dioxide (HCO3/CO2, abbreviated as CO2), induce 
expression of toxin and capsule. When B. anthracis is cultured in vitro, expression of atxA is 
greater when cells are grown at 37˚C relative to 30˚C. (59). The effect of carbon dioxide on 
virulence gene expression by B. anthracis in culture has been well documented, and the 
production of toxin and capsule is highly dependent on growth in elevated CO2 relative to air. 
Cultures incubated in 5% atmospheric CO2 show a 10-fold increase in transcription of the three 
toxin genes and an increase of more than 20-fold in expression of the capsule operon (67, 
100). Carbon dioxide and bicarbonate are in dynamic equilibrium within the cell and 
concentrations of each are regulated by carbonic anhydrase and other factors. B. anthracis has 
two putative carbonic anhydrases but these enzymes do not appear to be associated with 
CO2/bicarbonate-induced toxin production because toxin gene expression is unaffected in a 
mutant in which both carbonic anhydrase genes are deleted (Koehler lab, unpublished data). 
The CO2/bicarbonate effect on virulence gene expression is specific and not simply a matter of 
the buffering capacity of dissolved bicarbonate during bacterial culture. Elevated toxin and 
capsule synthesis is not observed when cultures are grown in highly buffered media in air (41, 
105). Carbon dioxide concentrations are often higher in mammalian tissues compared to other 
environments which may be a reason why CO2 functions as a signal to promote virulence gene 
expression (16). Carbon dioxide is present at a concentration of 5.5% in human blood (127) 
which is very close to the concentration required for optimal toxin and capsule synthesis in B. 
anthracis. The mechanism for the CO2 effect has not been discerned, but the effect of 
bicarbonate in culture medium may be comparable with its physiological role. Bicarbonate is 
used by animals to guard against pH fluctuations in the blood where it is at equilibrium with CO2 
and buffers extracellular fluids (128). This functionality marks bicarbonate concentration as a 
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good indicator for the host environment, and potentially acts as a signal to modulate the activity 
of proteins involved in virulence factor expression.  
 AtxA is required for the CO2 effect on toxin and capsule induction. The effect of CO2 on 
AtxA-mediated virulence gene expression is not at the level of atxA expression because 
transcripts of atxA are unchanged in cultures incubated in ambient air, 5% CO2, or 20% CO2 
(59). Roles for CO2 in AtxA activity have been defined as described in Chapter 1 (1.5). Briefly, 
AtxA activity on the lethal factor promoter fused to lacZ increases when strains are incubated in 
medium containing dissolved bicarbonate and 5% atmospheric CO2 compared to strains grown 
in ambient air in medium lacking bicarbonate. Growth in 5% CO2 also increases the AtxA 
dimer-to-monomer ratio compared to growth in ambient air (64). Whether CO2 affects AcpA and 
AcpB activity has not been determined.  
 Multimerization by transcription factors increases the specificity of these proteins for 
their DNA target sequences and provides a mechanism to control the activity of these proteins. 
Dimerization allows for the proper orientation of DNA-binding regions of each monomer to 
facilitate efficient DNA-binding. This is especially relevant when the transcription factor must 
recognize a palindromic DNA sequence (129). The activity of many transcription factors is also 
governed by multimerization in response to cofactor/ligand binding, phosphorylation, or other 
signals that convey the physiological state of the cell. In actinomycete bacteria, dimerization of 
the BldD transcription factor, which controls multicellular differentiation progression in 
sporulating bacteria, is mediated by tetramers of c-di-GMP (130). Finally, multimerization of 
Mga, is controlled by phosphorylation (11).  
 In B. anthracis, the ability of AtxA to form dimers is essential for activity, such that 
mutants of AtxA that cannot dimerize are inactive (described in detail in Chapter 1 (1.5)). The 
EIIB-like domain at the carboxy terminus of AtxA is required for dimer formation (Figure 1-2). 
AtxA crystallized as a dimer with each monomer in an anti-parallel arrangement. The dimer 
interface occurred mainly between PRD2 of monomer one and the EIIB-like domain of 
monomer two (64, 65).  The importance of dimerization for AtxA activity provides rationale to 
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study the multimerization states of AcpA and AcpB. Moreover, if AcpA and AcpB are able to 
form homomultimers, the amino acid conservation among the regulators may allow 
heteromultimers to form. 
 Phosphorylation of PRD-containing proteins can control multimerization, as well as 
interactions with other PTS components. There are several cases where the phosphorylation 
state of the PEP-dependent phosphotransferase system (PTS) EIIB component can mediate 
interactions with PRD-containing transcriptional regulators (9). In at least one system, the 
transcriptional regulator interacts with a membrane-bound EIIB component thereby 
sequestering the regulator to the membrane. In B. subtilis the transcriptional activator of the 
mannitol operon, MtlR, interacts with the nonphosphorylated EIIBMtl domain of the membrane-
bound mannitol-specific PTS permease. The interaction of MtlR with the EIIBMtl domain occurs 
via the carboxy-terminal EIIB-EIIA region of MtlR and is required for MtlR activation (131).  
 In B. anthracis, phosphorylation of histidines within AtxA at positions 199 and 379 in 
PRD1 and PRD2, respectively has been demonstrated. Additionally, phosphomimetic and 
phosphoablative mutations at positions 199 and 379 affect AtxA activity and dimerization (65, 
66). It has yet to be determine what factor(s) phosphorylate AtxA, and experiments to identify 
any proteins that interact with AtxA were largely restricted to soluble proteins. It is unknown 
whether AtxA interacts with any membrane components. 
 In this chapter I show that like AtxA, the activity of AcpA and AcpB is CO2-responsive, 
but that CO2 does not affect protein stability or solubility. I also present data that answer 
questions about homomeric and heteromeric interactions among the PCVRs and how these 
interactions influence activity.  
 
4.2 Results 
4.2.1 Induced expression of acpA and acpB in B. anthracis cultures 
 I determined previously that native protein levels of AtxA, AcpA, and AcpB in the fully 
virulent Ames strain were not equivalent and AtxA was detected in far greater quantity than 
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AcpA or AcpB (Figure 3-3). To directly compare the activities of the three regulators in vivo, I 
wanted to express the individual regulators at comparable levels. In order to overcome 
differences in PCVR steady state levels and to uncouple PCVR gene expression for differing 
transcriptional control elements, I used an inducible expression system to study PCVR function. 
Each PCVR open reading frame with the respective native ribosomal binding site (RBS) and 5' 
leader sequence was cloned downstream of an IPTG-inducible hyper-spank promoter encoded 
by a low-copy plasmid. Each PCVR was engineered to express a carboxy-terminal 6xHis or 
FLAG epitope to facilitate detection by western blot. IPTG-inducible expression constructs were 
introduced into an atxA-null mutant of the ANR-1 strain (pXO1+ pXO2-) to alleviate the need to 
work in the fully virulent Ames strain (pXO1+ pXO2+). Strains were cultured in CA medium 
supplemented with 0.8% bicarbonate in 5% CO2 atmosphere (CACO3) and protein expression 
was induced with the indicated IPTG concentrations at early exponential growth phase (Figure 
4-1A, B, C). Samples for western blots were collected at the transition to stationary phase. 
PCVR protein levels increased following IPTG addition. AtxA-His was detected with IPTG 
concentrations of 40µM and 400µM. AcpA-His and AcpB-His were only detectable when 
cultures were induced with 400 µM IPTG, and both proteins were less abundant than AtxA-His 
induced with the same IPTG concentration.  
 The RBS among the three genes is not conserved and is likely the cause for the 
differences in protein levels (Figure 4-1D). The ribosomal binding sequences, as well as 
distances from the ATG, differ for each of the three genes, likely affecting translation efficiency. 
To improve acpA and acpB translation efficiency and increase protein expression I created 
IPTG-inducible expression constructs in which the native RBS and 5' leader sequence was 
replaced with the complementary sequence from atxA. Production of AcpA-His and AcpB-His 
increased when the atxA RBS and 5' leader sequence is used to drive translation of acpA and 
acpB (Figure 4-1E, F). These data show that in addition to several factors affecting 
transcription of these regulators, regulation occurs at the level of translation. 
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4.2.2 AcpA and AcpB activity in B. anthracis cultures 
 I developed a system to quantitatively assess AcpA and AcpB activity in B. anthracis. 
Transcriptional analyses indicate AcpA and AcpB strongly regulate expression of the 
capBCADE operon, which encodes genes required for synthesis of the poly-γ-D-glutamic acid 
capsule. A region inclusive of 1 kb upstream from the capB translational start codon was fused 
to a promoter-less lacZ gene and incorporated into the nonfunctional plcR locus on the 
chromosome of an atxA-null B. anthracis strain to create the PcapB-lacZ transcriptional 
reporter strain UT423. Activity assays were performed in the ANR-1 strain background (pXO1+ 
pXO2-) (Table 2-1). Plasmids bearing IPTG-inducible alleles of acpA or acpB engineered to 
express a carboxy-terminal 6xHis tag were introduced into UT423. 
 I first tested whether AcpA and AcpB had dose-dependent activity on PcapB-lacZ and 
determined the linear range for activity (Figure 4-2A-D). Expression of acpA and acpB was 
induced using IPTG and translation occurred via the respective native ribosomal binding site 
and 5' leader sequence (Figure 4-2A, B), or the atxA ribosomal binding site and 5' leader 
sequence (Figure 4-2C, D) which increases protein production. Dose-dependent production of 
AcpA-His and AcpB-His was observed for all expression constructs, and AcpB-His translated 
using the atxA RBS and 5' leader sequence was more abundant in cell lysates than AcpB-His 
translated from the native RBS and 5' leader sequence (Figure 4-2B, D). However, dose-
dependent β-galactosidase activity was not observed when the atxA RBS and 5' leader 
sequence was used for translation (Figure 4-2C, D). It is unclear how the atxA RBS and 5' 
leader sequence disrupts the link between protein abundance in cell lysates and AcpA and 
AcpB activity on the PcapB-lacZ reporter. Only AcpB-His that was translated from the native 
RBS and 5' leader sequence yielded dose-dependent β-galactosidase activity. Given that the 
acpB RBS and 5' leader sequence yielded dose-dependent AcpB activity on PcapB-lacZ, I 
tested whether expression of acpA with the acpB RBS and 5' leader sequence would result in 
dose-dependent AcpA activity (Figure 4-2E, F). Expression of acpA with the acpB RBS and 5' 
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leader sequence yielded dose-dependent AcpA-His expression as well as dose-dependent 
activity.  
 
4.2.3 Carbon dioxide effect on regulator activity 
 AtxA, AcpA, and AcpB are paralogous transcriptional regulators that share a high 
degree of amino acid sequence similarity, and the regulons of these proteins indicate some 
functional similarity. The molecular mechanism by which these proteins promote transcription is 
unknown, but AtxA activity has been shown to increase when B. anthracis strains are cultivated 
in medium containing dissolved bicarbonate and 5% CO2 (64). Given that the B. anthracis 
PCVRs are paralogues and that CO2 concentration is an important host-related signal that 
promotes expression of virulence genes in B. anthracis and some other mammalian pathogens, 
I wanted to investigate whether AcpA and AcpB were also CO2-responsive. Initially, I compared 
β-galactosidase activity from strains producing AcpA-His or AcpB-His cultivated in 
CACO3 in 5% CO2 (Figure 4-2B, F) or CA-Air (CA medium lacking bicarbonate in ambient air) 
(Figure 4-2G, H). Production of His-tagged proteins was variable, including when the same 
amount of IPTG was used to induce the same protein in CACO3 or CA-Air. However, a 
comparison of activity from CACO3 and CA-Air samples with proteins present at similar levels 
regardless of the amount of IPTG shows that AcpA-His activity on PcapB-lacZ is higher when 
cells are cultured in CACO3. The same was true for AcpB-His. To more definitively test the 
effects of culture in elevated CO2 versus culture in ambient air on AcpA and AcpB activity, I 
cultured strains separately in three growth conditions: 1) CA-Air, 2) CACO3 in 5% atmospheric 
CO2, and 3) CACO3 in 20% atmospheric CO2. In an attempt to have consistent protein levels in 
all growth conditions, different amounts of IPTG dependent on the protein being expressed and  
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Figure 4-1. Induced PCVR expression 
B. anthracis strains containing PCVR proteins translated from the native ribosomal binding site; 
AtxA-His (pUTE991), AcpA-His (pUTE1055), or AcpB-His (pUTE1092), or the atxA ribosomal 
binding site AcpA-His (pUTE1090), AcpB-His (pUTE1091) were cultivated in CACO3. Protein 
expression was induced at indicated IPTG concentrations during early exponential growth 
phase and samples were collected at the transition to stationary phase. Cell lysate load 
volumes were normalized to the OD600 reading at collection. AcpA-His and AcpB-His proteins 
were detected by immunoblotting with α-His antibody. 
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growth medium were used to induce expression. Cultures were induced at early exponential 
growth phase and samples were harvested for protein detection and measurement of β-
galactosidase activity at the transition to stationary phase. Figure 4-3 shows AcpA-His and 
AcpB-His levels in the different growth media and corresponding β-galactosidase activity. 
AcpA-His activity increased 8- to 10-fold when cells were cultured in CO2 compared to culture 
in ambient air. AcpB-His appeared to follow the same trend, but inconsistent protein levels 
complicate data interpretation. Interestingly, both AcpA-His and AcpB-His required much more 
IPTG to yield detectable amounts of protein when cultures were cultivated in CA-Air compared 
to CACO3. 
 To determine whether culture in CA-Air reproducibly results in diminished steady state 
PCVR levels, and to test whether AtxA levels are also affected, I grew cultures of UT423 
harboring IPTG-inducible plasmids engineered to express acpA, acpB, or atxA in CA-Air, 
CACO3 in 5% CO2, and CACO3 in 20% CO2. Expression of acpA, acpB, and atxA was induced 
with 40 µM IPTG in all media to observe medium-dependent changes in protein abundance. 
Indeed, levels of AcpA-FLAG, AcpB-FLAG, and AtxA-FLAG were all severely diminished when 
strains were cultured in CA-Air compared to culture in either concentration of atmospheric CO2 
in CACO3 (Figure 4-4).  
 The B. anthracis PCVRs are soluble proteins and my experiments examining how CO2 
affects the activity of these regulators have focused on the soluble fraction of cell lysates. 
However, some PRD-containing proteins are sequestered to the membrane as a means of 
modulating activity (131). Therefore, I tested whether AcpA-FLAG and AcpB-FLAG were 
being sequestered to the insoluble fraction during culture in CA-Air. I grew strains containing  
AcpA-FLAG or AcpB-FLAG in CA-Air, CACO3 in 5% CO2, and CACO3 in 20% CO2. Cell lysates 
were generated and the soluble and insoluble fractions were separated by centrifugation. The 
insoluble fraction was washed and resuspended in 8M urea to increase solubility. Lysates were 
separated by SDS-PAGE and proteins were detected by western blot.  
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Figure 4-2. In vivo activity of AcpA-His and AcpB-His 
The β-galactosidase activity of AcpA-His and AcpB-His was measured in an atxA-null strain 
harboring a PcapB-lacZ reporter (pXO1+ pXO2-) (UT423) during culture in CACO3 (A-D, F) or 
CA-Air (G, H). Translation of acpA and acpB occurred from the native RBS (A) pUTE1055, (B) 
pUTE1092, the atxA RBS (C) pUTE1090, (D) pUTE1091, or the acpB RBS (G) pUTE1103, (H) 
pUTE1092. Putative RBS (in red) and 5' leader sequences (sequence between RBS and ATG) 
used to drive translation of PCVRs (E). Protein expression was induced at indicated IPTG 
concentrations during early exponential growth phase and samples were collected at the 
transition to stationary phase. β-galactosidase activity of B. anthracis strains was determined 
as described previously (95). Cell lysate load volumes were normalized to the OD600 Neither 
AcpA-FLAG nor AcpB-FLAG were detected in the soluble or insoluble fractions  
following culture in CA-Air. reading at collection. AcpA-His and AcpB-His proteins were 
detected by immunoblotting with α-His antibody.  
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 To ensure that the IPTG-inducible promoter, Phyperspank, used to express atxA, acpA, and 
acpB was not sensitive to culture in CA-Air or CACO3 I grew B. anthracis strains containing an 
IPTG-inducible GFP-FLAG expression plasmid. Individual cultures were incubated in both 
media and GFP-FLAG expression was induced with IPTG. Western blots of cell lysates 
showed that GFP-FLAG was present at equivalent levels when B. anthracis was cultured in 
either CA-Air or CACO3. In summary, I have shown that culture in CA-Air dramatically 
decreases steady state levels of the B. anthracis PCVRs when expressed from an IPTG-
inducible promoter, these proteins were not detected in either the soluble or insoluble fraction 
of cell lysates when cultured in CA-Air, and that the IPTG-inducible Phyperspank promoter used to 
express the PCVRs functioned equivalently in CA-Air and CACO3. 
 One possibility for the significant reduction in steady state levels of the B. anthracis 
PCVRs during culture in CA-Air is that the proteins were degraded in these growth conditions. 
Transcriptional regulators are a part of the main regulatory proteins in the cell and their activity, 
as well as their concentration, are often tightly regulated. The half-lives of some bacterial 
transcription factors can be as short as one minute, as is the case with cII in Escherichia coli 
(132). It is therefore possible that the stability of the B. anthracis PCVRs is affected by growth 
conditions.  
 To test PCVR protein stability I performed a modified pulse-chase experiment in which I 
grew cultures induced for expression of AcpA-FLAG or AtxA-FLAG in CACO3. One hour after 
induction with IPTG I pelleted, washed, and resuspended the cells in an equivalent volume of 
either spent CA-Air or spent CACO3 medium, both lacking IPTG and containing a sub-inhibitory 
concentration of chloramphenicol to inhibit nascent protein synthesis. Spent media consisted of 
filter sterilized media from separate same-age cultures that were harvested at the time of media 
change. Cultures were incubated for five hours following media change. Samples were 
collected for western blot analysis at hourly time points. I compared FLAG-tagged protein levels 
from the CACO3 → CA-Air cultures to cultures never shifted from CACO3 (Figure 4-5). AcpA-
FLAG and AtxA-FLAG levels in cultures cultivated entirely in CACO3 were not significantly 
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diminished following removal of IPTG and the addition of chloramphenicol. This result suggests 
that AcpA-FLAG and AtxA-FLAG are stable proteins in these growth conditions. Interestingly, 
shifting CACO3 cultures to CA-Air did not dramatically affect AcpA-FLAG or AtxA-FLAG protein 
levels indicating culture CA-Air does not negatively affect protein abundance. My inability to 
detect the B. anthracis PCVRs expressed from the IPTG-inducible promoter when strains are 
cultivated in CA-Air does not seem to be physiologically relevant, and may be an artifact of 
using the atxA RBS and 5' leader sequence to drive translation. Moreover, experiments 
designed to examine AtxA production from the native promoter in CA-Air, and CACO3 in 5% 
and 20% CO2 indicate that AtxA is present at the same level in all growth conditions (59).  
 
4.2.4 Relative activities of the B. anthracis PCVRs on in vivo reporters 
 The Plef-lacZ reporter (UT376) has been used to measure in vivo activity of AtxA (64). 
With the creation of the PcapB-lacZ reporter (UT423) I was able to measure the in vivo 
activities of AtxA, AcpA and AcpB. My RNA-Seq data indicate AtxA alone positively regulates 
lethal factor expression. AcpA and AcpB were the major regulators of capsule expression, with 
AtxA having a smaller effect. In the RNA-Seq experiment, the genes encoding AtxA, AcpA, and 
AcpB were induced with IPTG to produce near-native protein levels. Given the relatedness of 
the PCVRs I tested whether PCVR overexpression would reveal functional similarity among the 
regulators with regard to activity on Plef and PcapB. I grew cultures of UT376 and UT423 
harboring IPTG-inducible expression plasmids for AcpA-FLAG, AcpB-FLAG, and AtxA-FLAG in 
CACO3 and overexpressed each regulator with a concentration of IPTG that induced higher 
than native protein expression levels. I harvested cells and measured β-galactosidase activity 
in each strain. Figure 4-6 shows the β-galactosidase activity mediated by each regulator from 
the two reporters. Importantly, there is no β-galactosidase activity in strains harboring only the 
empty vector indicating no other factors have activity on either reporter. As expected, AtxA-
FLAG alone controlled expression of Plef; neither AcpA-FLAG nor AcpB-FLAG had activity on 
this promoter (Figure 4-6A). These results 
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Figure 4-3. AcpA and AcpB CO2-dependent activity 
Cultures of UT423, containing expression plasmids for AcpA-His (pUTE1103) and AcpB-FLAG 
(pUTE1092) were cultivated in CA-Air, CACO3 in 5% CO2 atmosphere, and CACO3 in 20% CO2 
atmosphere. Protein expression was induced by varying concentrations of IPTG (pUTE1103-
Air [200 µM], -CO2 [50 µM]; pUTE1092-Air [300 µM], -CO2 [150 µM]) at early exponential 
growth phase and cells were harvested two hours after induction at the transition to stationary 
phase. Empty vector represents the expression plasmid. β-galactosidase activities resulted 
from expression of the PcapB-lacZ reporter. Cell lysate load volumes were normalized for 
OD600 reading at collection, and proteins were detected via immunoblot with α-His antibody or 
an antibody for the β subunit of RNA polymerase; a load control. 
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Figure 4-4. Effects on steady state protein levels by culture in CA-Air vs. CACO3 
(A) Cultures of UT423 containing expression plasmids for AcpA-FLAG (pUTE1090), AcpB-
FLAG (pUTE1091), or AtxA-FLAG (pUTE992) were cultivated in CA-Air, CACO3 in 5% CO2, or 
CACO3 in 20% CO2. Expression of FLAG-tagged proteins was induced with 40 µM IPTG at 
early exponential growth phase and cells were harvested at the transition to stationary phase. 
Cell lysate load volumes were normalized to OD600 reading at collection and proteins were 
detected by immunoblotting with α-FLAG antibody. UT423 cultures expressing AcpA-FLAG 
(pUTE1090) (B) or AcpB-FLAG (pUTE1091) (C) were induced with IPTG and harvested as 
indicated above; EV = Empty Vector (pUTE657). Cell lysates were centrifuged to pellet the 
insoluble fraction. The soluble fraction was removed and the insoluble fraction was then 
washed and resuspended in 8M urea for one hour to increase solubility. Proteins were then 
separated by SDS-PAGE and visualized by immunoblotting with α-FLAG antibody. (D) UT423 
cultures harboring an IPTG-inducible GFP-FLAG expression plasmid (pUTE1013) were 
cultivated in either CA-Air or CACO3 in 5% CO2. Protein expression was induced with 30 µM 
IPTG at early exponential growth phase and cells were harvested at the transition to stationary 
phase. Cell lysates were used for immunoblotting with α-FLAG antibody as stated above. 
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are consistent with my RNA-Seq data. Both AcpA-FLAG and AcpB-FLAG had activity on the 
PcapB-lacZ reporter (Figure 4-6B). These data are also consistent with my dose-dependent 
activity experiments using the PcapB-lacZ reporter, as well as my RNA-Seq results. However, 
AtxA-FLAG did not have activity on PcapB-lacZ. My RNA-Seq data indicate AtxA increased 
expression of capB by a log2-fold change of 3.86 (~14 fold). To ensure that the DNA sequence 
necessary for AtxA-mediated control of capB expression was present in the reporter construct I 
compared the DNA sequence at which capBCADE transcripts initiated using transcript read 
maps generated by my RNA-Seq experiment. Transcripts of capBCADE generated by 
complementation with acpA, acpB, and atxA start ~500 bp upstream of the capB translational 
start codon. Our lab and others published previously that PCVR control of capBCADE occurs 
primarily from two transcriptional start sites, 530 bps and 424 bps upstream of the capB 
translational start site, and a third less active start site 595 bps upstream of capB (70, 71). The 
PcapB-lacZ reporter included 1 kb upstream of the capB translational start codon indicating the 
DNA sequence required for AtxA control of capB is present in the reporter. It is possible that an 
unknown pXO2-encoded factor is required for AtxA activity on PcapB.  
Taken together, these results indicate that PCVR control of Plef is in agreement with 
RNA-Seq results such that AtxA positively regulates Plef, and that overexpression of acpA or 
acpB does not result in activity of this promoter. Moreover, my results suggest that additional 
factors may be required for AtxA activity on PcapB. 
 
4.2.5 B. anthracis PCVR homomultimerization and the role of the intrinsic functional 
domains 
 The importance of AtxA multimerization with regard to activity has been 
explained in detail in Chapter 1 (1.5) and above (4.1). The significance of AcpA or AcpB 
multimerization has 
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Figure 4-5. Stability of AcpA-FLAG and AtxA-FLAG in CACO3 and CA-Air 
B. anthracis cultures containing IPTG-inducible expression plasmids for AcpA-FLAG and AtxA-
FLAG were cultivated in CACO3 medium. Protein expression was induced with 30 µM IPTG at 
early exponential growth phase. One hour after induction, cells were pelleted, washed, and 
resuspended in an equivalent volume of either spent CACO3 or spent CA-Air medium, both 
containing a sub-inhibitory concentration of chloramphenicol (15 µg/ml) and no IPTG. Cultures 
were incubated in spent medium for five hours and samples were taken for western blot 
analysis at hourly time points. (A & B) OD600 readings throughout the growth curve. Western 
blots of samples taken hourly of AcpA-FLAG (pUTE1090) (C) or AcpB-FLAG (pUTE1091) (D) 
blotted with α-FLAG antibody.  
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Figure 4-6. Activities of B. anthracis PCVRs on PcapB-lacZ and Plef-lacZ  
Cultures of UT376 (Plef-lacZ) (A) and UT423 (PcapB-lacZ) (B), harboring genes encoding 
AcpA-FLAG (pUTE1090), AcpB-FLAG (pUTE1091), and  AtxA-FLAG (pUTE992) driven by an 
IPTG-inducible promoter were cultured in CACO3. EV = empty vector (pUTE657). Cells were  
collected 2 h after induction with IPTG.   
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not been tested. AcpA and AcpB have been shown to: 1) have amino acid sequence similarity 
to AtxA, 2) co-regulate a subset of genes in the AtxA regulon, and 3) have increased activity 
when cultures of B. anthracis are cultivated in 5% CO2 in medium containing bicarbonate. To 
explore protein-protein interactions involving AcpA or AcpB I first tested whether these proteins 
self-associate. 
 To determine if AcpA and AcpB multimerize, I employed co-affinity purification and 
chemical crosslinking methods. First, I tested whether FLAG-tagged AcpA and AcpB were able 
to co-purify with 6xHis-tagged counterparts via nickel affinity purification. I grew individual 
cultures in CACO3 expressing recombinant AcpA or AcpB with either a carboxy terminal 6xHis 
or a FLAG epitope. Strains expressing FLAG-tagged GFP served as controls. Recombinant 
proteins were expressed from a plasmid-borne IPTG-inducible promoter in an atxA-null B. 
anthracis strain lacking pXO2, the native plasmid carrying the acpA and acpB genes. Cultures 
were pooled in the following pairs: (1) AcpA-His and AcpA-FLAG, (2) AcpA-His and GFP-
FLAG, and (3) AcpA-FLAG and GFP-FLAG, (4) AcpB-His and AcpB-FLAG, (5) AcpB-His and 
GFP-FLAG, and (6) AcpB-FLAG and GFP-FLAG. Lysates generated from pooled cultures were 
subjected to affinity purification using NTA-Ni resin and proteins were detected using western 
blotting. In Figure 4-7A, B lanes 1-3 show that prior to affinity purification all tagged proteins 
were present in the appropriate pool. Lanes 4-6 show eluates from the NTA-Ni resin. AcpA-
FLAG coeluted with AcpA-His and AcpB-FLAG coeluted with AcpB-His (Figure 4-7A, B). GFP-
FLAG functioned as a negative control for non-specific interactions. These results demonstrate 
that AcpA and AcpB form homomultimers in vitro. 
 I also used chemical crosslinking to test for multimerization of the tagged proteins. Bis-
maleimidohexane (BMH) crosslinks free cysteine residues irreversibly within 13 Å and was 
employed previously to demonstrate AtxA multimerization (64). AcpA has cysteine residues at 
positions 33, 321, 342. Cysteine residues of AcpB are at positions 33, 34, 332, and 465. Cell 
lysates containing either AcpA-FLAG or AcpB-FLAG were treated with BMH, and proteins were 
separated by SDS-PAGE and visualized using western blotting with α-FLAG antibody (Figure 
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4-7C). For each protein, a single band was detected slightly above the 50-kDa marker in BMH-
treated and untreated lysates. A band near the 100-kDa marker was detected only in lysates 
treated with BMH. The predicted molecular weight for each PCVR is 57 kDa; therefore the 
approximate 100-kDa bands suggested dimers of AcpA or AcpB crosslinked by BMH. To 
confirm that the observed complexes were indeed homomeric, I affinity-purified AcpA-His and 
AcpB-His using NTA-Ni resin and crosslinked using BMH. The migration pattern of crosslinked 
purified AcpA-His was similar to that of AcpA-FLAG present in crosslinked cell lysates with 
bands near 50 kDa (monomer) and 100 kDa (dimer) (Figure 4-7D). The comparable 
experiment using AcpB was not possible because affinity-purified AcpB-His became insoluble 
following treatment with BMH. These data provide further evidence that like AtxA, AcpA and 
AcpB form homomultimers and crosslink as dimers. 
 To determine if the EIIB-like domains of AcpA and AcpB are required for dimerization 
and activity, as is true for AtxA (64), I created carboxy-terminal truncation mutants lacking the 
EIIB-like domain. The EIIB-like domain of AtxA is defined by amino acids 385-475. Structural 
modeling using the amino acid sequence of AcpA and AcpB predict the EIIB-like domain to be 
amino acids 390 - 483 for AcpA and 391 - 482 for AcpB. I deleted the respective domain in 
AcpA and AcpB and engineered the recombinant truncated proteins to have a carboxy-terminal 
6xHis tag. Cell lysates containing either full-length or truncated His-tagged AcpA or AcpB were 
subjected to BMH crosslinking. The full-length proteins displayed the typical dimer bands (~100 
kDa). The migration of AcpA-∆EIIB-His and AcpB-∆EIIB-His was unaffected after crosslinking; 
only a ~40 kDa band was present (Figure 4-8A), indicating lack of dimer formation in the 
absence of the C-terminal domains. 
 To test the activity of the AcpA and AcpB truncation mutants I used the PcapB-lacZ 
reporter strain UT423. Plasmids encoding full-length and truncation mutants of AcpA-His and 
AcpB-His, were expressed individually in the reporter strain via an IPTG-inducible promoter. 
Activity of the full-length and truncation mutants was quantified by measuring β-galactosidase 
activity in cell lysates following IPTG induction of each gene. Figure 4-8B shows relative 
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Figure 4-7. Homomultimerization AcpA and AcpB 
Lysates from B. anthracis atxA-null pXO1+ pXO2- strains (UT423) containing plasmids that 
encode IPTG-inducible (A) AcpA-His (pUTE1090), AcpA-FLAG (pUTE1079), or GFP-FLAG 
(pUTE1013); (B) AcpB-His (pUTE1091), AcpB-FLAG (pUTE1093), or GFP-FLAG (pUTE1013) 
were co-incubated as indicated, then co-affinity purified with Ni2+-NTA resin. Proteins present in 
the mixed lysates prior to (Load, lanes 1-3) and after purification (Eluate, lanes 4-6) were 
subjected to SDS-PAGE and Western blot with α-His and α-FLAG antibodies as indicated. 
Arrows indicate the predicted sizes of AcpA-His, AcpA-FLAG, AcpB-His, AcpB-FLAG, and 
GFP-FLAG; (C) FLAG-tagged AcpA (pUTE1079) and AcpB (pUTE1093) were induced by IPTG 
in a B. anthracis atxA-null pXO1+ pXO2- strain. Lysates were incubated with or without the 
crosslinking agent BMH and subjected to SDS-PAGE and Western blot. Proteins were detected 
with α-FLAG antibody. (D) Affinity purified AcpA-His  from B. anthracis ANR-1 (pUTE1090) 
incubated with or without BMH and subjected to SDS-PAGE and Western blot. Proteins were 
detected with α-His antibody. 
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activities of both full-length and truncated AcpA-His and AcpB-His. β-galactosidase activity was 
observed for full-length AcpA-His and AcpB-His, but neither EIIB truncation mutant showed 
activity. This indicates that, like AtxA, AcpA and AcpB require the EIIB-like domain for 
multimerization and activity. 
 After confirming that the EIIB-like domain has similar function among the three 
regulators, I designed experiments to determine how the other PCVR functional domains 
contribute to regulator activity. The DNA-binding domains of the three B. anthracis PCVRs 
have the highest sequence similarity with AcpA and AcpB sharing 48% amino acid identity, 
33% identity between AtxA and AcpA, and 29% identity between AtxA and AcpB. It is unclear 
whether the DNA-binding domain alone confers target specificity for PCVR-regulated genes, or 
whether input from other domains is required. Analysis of the AtxA crystal structure suggest 
that phosphorylation at H199 within PRD1 may influence positioning of the DNA-binding 
domain, thereby affecting target specificity (65).  
To test whether the DNA-binding domains alone are sufficient for target specificity I 
created chimeric proteins in which I exchanged DNA-binding domains (DBD) among the 
PCVRs. In total I created four chimeras, AtxADBDAcpAPRD+EIIB, AtxADBDAcpBPRD+EIIB, 
AcpADBDAtxAPRD+EIIB, AcpBDBDAtxAPRD+EIIB. To make the AtxADBDAcpAPRD+EIIB and 
AtxADBDAcpBPRD+EIIB chimeras I used the AtxA crystal structure to identify an unstructured linker 
region between the DBD and PRDs (Figure 4-9), consisting of amino acids 164 to 176 (13 
amino acids). Genes encoding chimeric proteins were engineered to express a carboxy-
terminal 6xHis epitope to facilitate detection, and were under transcriptional control of an IPTG-
inducible promoter. Strains of the PcapB-lacZ reporter and the Plef-lacZ reporter harboring 
individual chimera expression plasmids, were cultured in CACO3 and cells were harvested at 
the transition to stationary phase to assess β-galactosidase activity (Figure 4-10). Both the 
AtxADBDAcpAPRD+EIIB and AtxADBDAcpBPRD+EIIB chimeras were detected in soluble cell lysates 
following induction with IPTG (Figure 4-10A-D). However, neither chimera had activity on Plef-
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lacZ nor PcapB-lacZ. Neither the AcpADBDAtxAPRD+EIIB nor AcpBDBDAtxAPRD+EIIB chimeras were 
stably produced (Figure 4-10E, F).  
 A possible reason for the lack of activity by the two chimeras is that they were folded 
improperly. One way to measure PCVR activity, and by extension activity of the chimeras, is to 
test their ability to multimerize. Multimerization is required for activity of all three B. anthracis 
PCVRs, and at least for AtxA, contact between two monomers occurs between the EIIB-like 
domain of one monomer and PRD2 of the other monomer (65). As an indirect method of 
measuring proper protein folding by each chimera, I tested whether full-length AcpA-FLAG 
could interact with AtxADBDAcpAPRD+EIIB-His using co-affinity purification. I tested 
AtxADBDAcpAPRD+EIIB-His for interaction with AcpA-FLAG because it was the most stable of the 
two chimeras. I combined culture lysates of B. anthracis strains containing full-length AcpA-
FLAG and AtxADBDAcpAPRD+EIIB-His. AcpA-His and GFP-FLAG were used as controls. Lysates 
were pooled in the pairs as shown in Figure 4-11. Pooled lysates were incubated with a NTA-
Ni resin, washed, eluted with imidazole, and detected by western blot. Lanes 1-5 show that all 
proteins are present in lysates prior to incubation with the NTA-Ni resin. Eluates from the NTA-
Ni resin are shown in lanes 6-10. Lane 6 shows that AcpA-FLAG did not co-elute with 
AtxADBDAcpAPRD+EIIB-His, however AcpA-FLAG co-eluted with the positive control AcpA-His 
(lane 7). The model for AtxA multimerization is that the EIIB-like domain of one monomer 
interacts with PRD2 of the other monomer. If this holds true for AcpA, then the domains 
required for AcpA-AcpA interaction remain intact in the AtxADBDAcpAPRD+EIIB-His chimera and 
theoretically should not disrupt multimerization. These data suggest that although the 
AtxADBDAcpAPRD+EIIB-His chimera is stably produced, it is not properly folded. 
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Figure 4-8. Multimerization and activity of AcpA and AcpB EIIB-like domain truncation mutants 
UT423 strains expressing AcpA-ΔEIIB-His (pUTE1125), AcpA-FLAG (pUTE1079), AcpB-ΔEIIB-
His  (pUTE1126), or AcpB-FLAG (pUTE1093) were cultured in CACO3 in 5% CO2 atmosphere 
and induced with 30-50 µM IPTG. (A) Cell lysates containing IPTG-induced proteins were 
treated with crosslinking agent BMH or vehicle alone (DMSO). Molecular weights of protein 
standards are listed. (B) The β-galactosidase activity of B. anthracis strains harboring the 
PcapB-lacZ reporter and IPTG-induced AcpA and AcpB variants was determined as previously 
described (95).  Errors represent ±1 SD.  
  
86 
 
  
 
Figure 4-9. AtxA crystal structure and structural models of B. anthracis chimeric PCVRs 
(A) Crystal structure of AtxA with the five domains indicated by color: winged helix-turn-helix 
(WH) motif, a helix-turn-helix (HTH) motif, two PTS regulation domains (PRD1 & PRD2), and 
an Enzyme IIB-like (EIIB-like) motif. Black arrow points to the unstructured region of AtxA 
(cyan) that was used to link the AtxA DBD to PRD1 of either AcpA or AcpB, and to link AtxA 
PRD1 to the DBD of AcpA or AcpB. (B) pUTE1123, (C) pUTE1114, (D-E) Structural models of 
chimeric PCVRs, domain color indicates the donor protein. 
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Figure 4-10. Dose-dependent expression and activity of PCVR chimeras 
Cultures of B. anthracis reporter strains UT376 (Plef-lacZ) (A, C) and UT423 (PcapB-lacZ) (B, 
D, E, F) containing expression plasmids for AtxADBDAcpAPRD+EIIB (pUTE1123) (A, B), 
AtxADBDAcpBPRD+EIIB (pUTE1114) (C, D), AcpADBDAtxAPRD+EIIB (E), AcpBDBDAtxAPRD+EIIB were 
induced with IPTG. Cells were collected in the transition to stationary phase for chimera activity 
assays and western blotting with α-His antibody. Chimera activity was measured as β-
galactosidase activity from either Plef-lacZ or PcapB-lacZ. Cell lysate load volumes for western 
blots were normalized to OD600 reading at time of collection. 
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Figure 4-11. PCVR chimera multimerization 
Lysates from B. anthracis strains producing AtxADBDAcpAPRD+EIIB-His (pUTE1123), AcpA-His 
(pUTE1090), AcpA-FLAG (pUTE1073), and GFP-FLAG (pUTE1013) induced with 50-100 µM 
IPTG were used in co-affinity purification with a NTA-Ni resin. Westerns blots of soluble cell 
lysates (lanes 1-5) and eluted proteins (lanes 6-10) were probed with α-His and α-FLAG 
antibodies. 
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4.2.6 Heteromultimerization of PCVRs 
 Given the amino acid sequence similarity between AtxA, AcpA, and AcpB and the 
formation of homomultimers, I questioned whether the PCVRs could interact with each other to 
form heteromultimers. As done for the homomultimerization assays, I tested mixed culture 
lysates containing recombinant proteins with C-terminal 6xHis or FLAG epitopes for co-affinity 
purification with NTA-Ni resin. The lysates contained pairs of differentially tagged PCVRs. 
Results are shown in Figure 4-12. AcpA-FLAG co-eluted from the NTA-Ni resin with AtxA-His 
(lane 5), indicating that these two proteins can interact. The amount of co-eluted AcpA-FLAG 
was small compared to the amount of eluted AtxA-His. Increasing the ratio of AcpA-FLAG to 
AtxA-His by using a higher IPTG concentration to induce the AcpA-FLAG (lane 2) level yielded 
an increased amount of co-eluted AcpA-FLAG (lane 6). AcpA-FLAG was not detected in 
eluates lacking AtxA-His (lane 7) indicating non-specific resin binding did not account for the 
presence of AcpA-FLAG in eluates. In similar experiments, I tested for AtxA-AcpB and AcpA-
AcpB interactions, but no heteromeric protein interactions were detected. 
 The complex interdependent control of atxA, acpA, and acpB gene expression and the 
formation of PCVR homo- and hetero-multimers suggest that the stoichiometry of the 
regulators is important for optimal transcription of target genes. I tested for the effect of AtxA 
over-expression on transcription from the capB promoter, which in my RNA-Seq experiments 
was highly regulated by AcpA and AcpB, but showed a much lower induction by AtxA (Table 3-
1). We cultured strains that co-expressed AtxA and AcpA (Figure 4-13A), or AtxA and AcpB 
(Figure 4-13B) in strain UT423 which carries the transcription reporter PcapB::lacZ. AtxA 
expression was controlled by an IPTG-inducible promoter, while AcpA and AcpB expression 
was under the control of a xylose-inducible promoter. AcpA and AcpB levels were monitored 
using western blotting, and capB promoter activity was quantified as β-galactosidase activity. 
Increasing levels of AtxA relative to AcpA correlated with a decrease in β-galactosidase activity   
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Figure 4-12. Heteromultimerization by PCVRs 
Lysates from B. anthracis atxA-null pXO1+ pXO2- strains (UT423) 
containing plasmids that encode IPTG-inducible AtxA-His (pUTE991), AcpA-FLAG 
(pUTE1079), or GFP-FLAG (pUTE1013); were co-incubated as indicated, then co-affinity 
purified with Ni-NTA resin. Proteins present in the mixed lysates prior to (Load, lanes 1-3) 
and after purification (Eluate, lanes 4-6) were subjected to SDS-PAGE and Western blot with 
α-His and α-FLAG antibodies as indicated. Arrows indicate the predicted sizes of AtxA, 
AcpA, and GFP. 
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Figure 4-13. AtxA effect on AcpA and AcpB activity 
UT423 strains co-expressing AtxA-His (pUTE991) from an IPTG inducible promoter 
and AcpA-FLAG (pUTE1099) or AcpB-FLAG (pUTE1100) from a xylose inducible promoter 
were cultured in CACO3 in 5% CO2 atmosphere.  Across six cultures IPTG was added in the  
indicated concentrations to incrementally increased AtxA-His expression, while AcpA-FLAG 
or AcpB-FLAG expression levels were kept constant with 1% xylose in all cultures.  Asterisks  
represent a significant decrease in activity at the indicated [IPTG] compared to 10 µM IPTG 
 (P value <0.05). β-galactosidase activity of these strains harboring the PcapB-lacZ reporter  
was  determined as described previously (95). Error bars represent ±1 SD.  
   
93 
 
(Figure 4-13A). At IPTG concentrations of 30 µM, 40 µM, and 50 µM, AtxA significantly 
decreased AcpA activity on PcapB::lacZ compared to an uninduced culture (0 µM). Although 
the data trended toward a modest affect of AtxA overexpression on AcpB activity, no 
statistically significant difference was observed (Figure 4-13B). These data indicate that PCVR 
function is affected by regulator stoichiometry in cell cultures. 
 
4.3 Discussion 
 My data reveal that atxA, acpA, and acpB are regulated at the translational level, and 
culture in 5% atmospheric CO2 positively affects AcpA and AcpB activity, as shown previously 
for AtxA. Neither the solubility nor stability of the PCVRs was affected by culture in ambient air 
relative to elevated CO2. I have determined that AcpA and AcpB form homomultimers, and like 
AtxA, multimerization is required for activity of these two proteins. Importantly, I show that 
heteromultimers of AtxA and AcpA could be detected in vitro, and this interaction may result in 
modulation of AcpA activity. 
 Culturing in 5% or greater CO2 atmosphere in medium supplemented with 0.8% 
bicarbonate results in optimal toxin and capsule synthesis (57) presumably by increasing the 
activities of AtxA, AcpA, and AcpB. Culture in 20% CO2 did not significantly increase regulator 
activity above the level observed during culture in 5% CO2 suggesting that the effect CO2 has 
on activity is saturated at a concentration of 5%. The molecular mechanism by which CO2 
affects the activity of these regulators is unknown. With regard to AtxA, B. anthracis cultures 
grown in elevated CO2-bicarbonate contain more dimers of AtxA compared to cultures grown in 
air leading to an increase in AtxA activity (64). It is possible that AtxA binds bicarbonate or CO2. 
There are precedents for CO2/bicarbonate affecting protein activity. With regard to transcription 
factors, the Citrobacter rodentium protein RegA is a regulator that has increased binding affinity 
for target DNA in the presence of bicarbonate (133). Bicarbonate is thought to enhance the 
DNA binding affinity of RegA by inducing a conformational change, however a defined 
bicarbonate binding pocket has yet to be identified (134).  RegA does not share significant 
94 
 
amino acid sequence homology to AtxA, AcpA, nor AcpB, and it is unknown whether similar 
conformational changes occur in these regulators when bicarbonate is present. 
 Another possible mechanism for CO2-controlled PCVR activity is that CO2 competes 
with another ligand at a binding pocket within AtxA, AcpA, and AcpB. AtxA dimerization occurs 
constitutively in ambient air, but it is the ratio of dimers to monomers that increases with 
elevated CO2. It is possible that a small molecule binds to AtxA causing some level of 
constitutive dimerization that is increased competitively by CO2 at high concentration. The 
enzyme RuBisCo which functions in carbon fixation in some species of bacteria competitively 
binds oxygen and CO2 at its active site. Increasing the CO2 concentration increases the carbon 
fixation ability of RuBisCo (135). AtxA structural predictions have not identified any regions 
similar to the RuBisCo CO2 binding pocket, leaving the mechanism of CO2/bicarbonate 
influence on AtxA dimerization unknown. 
 Clues to how CO2 influences dimerization may be found in the family of enzymes called 
β-carbonic anhydrases. These enzymes catalyze the reversible interconversion of CO2 and 
HCO3−. A member of the β-carbonic anhydrase family in Pseudomonas aeruginosa, psCA3, 
was crystallized in complex with CO2 using pressurized cryo-cooled crystallography. The 
enzyme crystallized as a dimer with a CO2 molecule in the active site of each monomer. A third 
CO2 molecule was detected buried in the dimer interface. The location of the third CO2 
molecule was expected to be more stable due to multiple stabilizing interactions compared to 
the CO2 molecule in the active site  (136). The AtxA crystal structure was not solved using 
these crystallization conditions, but it is possible that CO2 may bind within the AtxA dimer 
interface providing increased stability. 
 Previous investigations and my current results show that the increase in regulator 
activity observed when B. anthracis is cultivated in elevated CO2 compared to ambient air is 
likely due to increased dimer stabilization and not changes in PCVR stability or solubility. 
Modified pulse-chase experiments designed to assess whether PCVR stability was affected by 
culture in CACO3 in 5% CO2 compared to CA-Air showed switching cultures from CACO3 in 5% 
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CO2 to CA-Air did not affect the stability of these proteins compared to cultures maintained in 
CACO3 in 5% CO2 throughout growth. In fact, both AcpA and AtxA appear to be very stable 
following removal of IPTG and cessation of protein synthesis by chloramphenicol. These 
results are similar to steady state AtxA-FLAG and AcpA-FLAG levels expressed from their 
respective native loci throughout the growth phase in fully virulent B. anthracis Ames strain 
(pXO1+ pXO2+). During culture in CACO3, samples taken at hourly intervals from one hour after 
the start of culture to six hours after culture initiation show that AcpA-FLAG levels are 
consistent at all time points. AtxA-FLAG levels increase from one hour to three hours after 
culture initiation and then remain steady through six hours. I could not detect AcpB-FLAG in 
these experiments. These data indicate that atxA and acpA expressed from their respective 
native loci produce proteins that are detectable throughout exponential and stationary growth 
phase, suggesting that the activities of these proteins are beneficial to the cell during these 
stages of growth in these culture conditions. 
 Structure/function studies to elucidate the function of intrinsic domains within the 
PCVRs indicate that, like AtxA, the EIIB-like domain of AcpA and AcpB functions in 
multimerization, and that multimerization is required for activity. Predictions from the AtxA 
crystal structure relate phosphorylation of H199 within PRD1 may affect positioning of the DNA-
binding domain and influence target specificity. Phosphorylation of AcpA and AcpB has not 
been demonstrated. Although comparisons of the AcpA and AcpB amino acid sequences and 
structure predictions are highly suggestive of the presence of PRDs, the placement of 
histidines within the PRDs differ between the three regulators, suggesting large differences in 
the potential phosphorylation sites (Figure 3-1) (66). If indeed the AcpA and AcpB PRDs 
control PCVR function, the relationships between phosphorylation and protein structure may 
differ between the PCVRs, affecting their target specificity and relative activity. 
 Experiments designed to test the target specificity of chimeric regulators in which the 
DNA-binding domain was swapped with that of other PCVRs were unsuccessful. The 
AtxADBDAcpAPRD+EIIB and AtxADBDAcpBPRD+EIIB chimeras were detected in soluble cell lysates but 
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did not have activity on either in vivo reporter possibly due to improper folding. Chimeras with 
either the AcpADBD or AcpBDBD were not detected in soluble cell lysates. The lack of AcpA and 
AcpB crystal structures complicates identification of unstructured regions in which to make 
domain boundaries to generate chimeras. Once the crystal structures of AcpA and AcpB are 
solved, accurate domain interfaces can be determined which will likely increase the stability of 
chimeric proteins.  
 In addition to experiments designed to assess how individual domains affect PCVR 
activity, I also examined interactions between different PCVRs and assessed affects of 
interactions on PCVR activity. Results from my co-affinity purification experiments reveal that 
AtxA can interact with AcpA, and the relative amounts of FLAG-tagged PCVRs in eluates 
suggested that AtxA has a stronger affinity for itself than for AcpA. I was unable to detect AtxA-
AcpB or AcpA-AcpB interactions in the same conditions. The AtxA homodimer structure 
suggests interactions between amino acids within PRD2 of one monomer and amino acids of 
the EIIB-like domain of the other monomer (65). Of the eight amino acids implicated in the 
AtxA-AtxA interaction; L375, T382, L386 and N389 of one monomer, and I403, Y407, E413 and 
K414 of the second monomer, three of these residues are dissimilar in AcpA and AcpB. T382 
of AtxA is a glutamic acid residue in AcpA and AcpB, and L386 of AtxA is a lysine in AcpA and 
AcpB. N389 of AtxA is an isoleucine residue in AcpA and a serine in AcpB. These differences 
may contribute to the apparent weak heteromeric interaction between AtxA-AcpA relative to the 
AtxA-AtxA interaction. 
 I artificially altered AtxA/AcpA stoichiometry and assessed the effect on expression of 
the co-regulated gene, capB. In my experiment, increasing AtxA expression decreased AcpA 
activity on the PcapB–lacZ reporter. The data support a model in which in vivo PCVR 
stoichiometry can alter expression of PCVR targets. My RNA-Seq data show that capB 
transcription is more strongly affected by AcpA than by AtxA. When both PCVRs are present, 
an in vivo heteromeric interaction may result in reduced AcpA activity. Interestingly, AcpB 
activity on the transcriptional reporter was not significantly decreased by co-expression of AtxA, 
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in agreement with a model in which AtxA-AcpB heteromultimer formation is weak or does not 
occur. Alternatively, AtxA may compete with AcpA, but not AcpB, for occupancy of the capB 
promoter. Further investigation of protein-protein and protein-DNA interactions will probe the 
molecular basis for cap operon control by the three PCVRs. 
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The roles of AtxA orthologs in an anthrax-
like Bacillus cereus strain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: This work was performed in collaboration with Dr. Allison O'Brien's group at The 
Uniformed Services University of the Health Sciences. In the Introduction of this chapter (5.1) I 
summarize work performed in the O’Brien laboratory. My work is presented in the Results (5.2). 
Portions of the writing in this chapter were drawn from:   
 
Scarff, J.M., Raynor, M.J., Seldina, Y., Ventura, C.L., Koehler, T.M., O'Brien, A.D. (2016) The 
Roles of AtxA Orthologs in Virulence of Anthrax-like Bacillus cereus G9241. Molecular 
Microbiology. doi: 10.1111/mmi.13478 
 
I have received permission by the publisher of Molecular Microbiology, John Wiley and Sons, to 
reproduce all of the manuscript in print or electronically for the purposes of my dissertation 
(License Number: 4284271503886)  
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5.1 Introduction 
 Bacillus anthracis and Bacillus cereus are pathogenic members of the B. cereus 
subgroup of related Bacilli. B. anthracis is the causative agent of anthrax, and B. cereus is 
frequently associated with food poisoning as well as opportunistic and nosocomial infections. 
Many virulence factors produced by these organisms are plasmid-associated, and plasmid 
number in B. cereus group members varies ranging from 1 to 12 with sizes from 2 to 600 kb 
(137). The anthrax toxin structural genes and capsule biosynthesis operon are located on 
plasmids pXO1 and pXO2, respectively in B. anthracis. B. cereus produces an emetic toxin, 
cereulide, the gene of which is encoded by plasmid pCER270 (16, 138).  
 Plasmids with high sequence identity to pXO1 and pXO2 have been found in other B. 
cereus group members. Several B. cereus isolates from food, dairy, and clinical samples carry 
plasmids with large regions of homology and synteny to pXO1, but lack the 44.8-kb 
pathogenicity island containing the toxin structural genes and atxA (137). Plasmids with high 
identity to pXO1 and pXO2 have been detected in B. cereus strains recovered from great apes 
that succumbed to an anthrax-like disease. These plasmids contained genes encoding the 
anthrax toxins, poly-γ-D-glutamic acid capsule, and the respective regulatory genes (atxA, 
acpA, and acpB) (18).  
 One particular B. cereus strain with a pXO1-like plasmid is of particular interest as it 
contains two atxA alleles. B. cereus strain G9241 was obtained from a welder in Louisiana 
afflicted by an anthrax-like respiratory illness. Strain G9241 contains three plasmids, pBCXO1, 
pBC210, and pBClin29. Plasmid pBCXO1 has high sequence similarity to pXO1 and encodes 
homologues of the anthrax toxin genes with more than 96% amino acid identity to the B. 
anthracis toxin genes. An atxA allele (atxA1) is also encoded by pBCXO1, producing AtxA1 
predicted to have 100% amino acid identity to AtxA produced by B. anthracis. Genes required 
for synthesis of a hyaluronic acid capsule are encoded by the hasACB operon also located on 
pBCXO1. Plasmid pBC210 does not have homology to pXO2 and does not encode acpA, 
acpB, nor genes to produce a polyglutamate capsule. In addition to genes encoding a 
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protective antigen paralogue, PA2, an ADP-ribosyltransferase, Certhrax, and the bps locus 
required for synthesis of a tetrasaccharide capsule, pBC210 harbors an atxA allele, atxA2. The 
atxA2 gene product has 79% amino acid identity and 91% similarity to AtxA produced by B. 
anthracis (Figure 5-1). The discovery of AtxA2, an orthologue of AtxA, provides an opportunity 
to assess how amino acid differences between the two proteins affect activity and 
multimerization. 
 To study the roles of the AtxA orthologs in capsule and toxin expression, Dr. O'Brien's 
group created isogenic single and double mutants of atxA1 and atxA2 in strain G9241. The 
impact of AtxA1 and AtxA2 on production of the hyaluronic acid (HA) capsule encoded by 
hasACB, and the tetrasaccharide (TS) capsule encoded by the bps locus was assessed using 
the quantitative real-time polymerase chain reaction (qRT-PCR) and by observing capsule 
phenotypes of the mutants. AtxA1 positively affected expression of hasACB and bpsA. AtxA2 
promoted expression of bpsA, but did not affect expression of hasACB. Capsule visualization 
data were consistent with the qRT-PCR results. The HA capsule was only produced in strains 
containing AtxA1. The TS capsule was detected in strains containing either AtxA1 or AtxA2 
indicating functional similarity with respect to expression of this capsule. The atxA1atxA2 
double mutant had reduced transcripts of hasACB and bpsA compared to the parent, and 
neither capsule was produced by the double mutant. These data demonstrate that AtxA1 
regulates HA capsule production, and that either AtxA1 or AtxA2 is adequate for TS capsule 
production. 
 To assess the roles of AtxA1 and AtxA2 in toxin expression in strain G9241, Dr. 
O'Brien's group measured transcript levels of the protective antigen homologue pagA located 
on pBCXO1 in the atxA1 and atxA2 mutants. Transcripts of pagA were reduced by 19-fold in 
the atxA1 mutant and 58-fold in the atxA1atxA2 mutant, relative to the parent strain. The atxA2 
mutant did not affect pagA expression. However, complementation of the atxA1atxA2 mutant 
with either atxA1 or atxA2 restored parent levels of pagA. Western blots of culture supernates 
from the different strains show that toxin levels from the atxA1 and atxA1atxA2 mutants were 
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less abundant than from the parent. The atxA2 mutant and parent strains produced similar 
toxin levels. These data indicate that toxin production is primarily regulated by AtxA1 in B. 
cereus strain G9241. 
 Given the different effects of AtxA1 and AtxA2 on toxin and capsule production, Dr. 
O'Brien's group tested the virulence of the different mutants in two murine models of anthrax; 
A/J mice which are immunodeficient and susceptible to toxigenic but noncapsulated B. 
anthracis strains, and C57BL/6 mice which are immunocompetent and susceptible to B. 
anthracis strains that produce toxin and capsule (139–143). A/J mice inoculated 
subcutaneously with spores of the atxA1 mutant exhibited a mean time-to-death (MTD) that 
was approximately two days later than that observed for mice inoculated with an equivalent 
dose of parent strain spores. The MTD for A/J mice challenged with spores from the atxA2 
mutant did not differ from the parent strain. There were no survival differences following 
intranasal inoculation of A/J mice with spores of the parent, atxA1, and atxA2 mutants. The 
atxA1atxA2 mutant was avirulent when inoculated subcutaneously or intranasally. 
 Immunocompetent C57BL/6 mice challenged intranasally with spores of the atxA1 
mutant had a significantly longer MTD relative to the parent strain, but no difference in MTD 
was observed when spores of the parent and atxA2 strains were administered. There was no 
difference in MTD of C57BL/6 mice challenged subcutaneously with spores of the parent, 
atxA1, or atxA2 strains. In vivo capsule production in mice challenged subcutaneously with 
spores of the parent and mutant strains indicate that AtxA1 is required for HA capsule 
formation and either AtxA1 or AtxA2 is sufficient for elaboration of the TS capsule. These 
virulence studies show that at least one AtxA ortholog is required for virulence in B. cereus 
strain G9241, and that AtxA1 may play a larger role in virulence than AtxA2. 
 In this chapter I discuss my contributions to the collaborative effort to investigate the 
roles of AtxA1 and AtxA2 in the regulation of capsule and toxin expression in B. cereus strain 
G9241. I measured and compared AtxA1 and AtxA2 activity on the lethal factor promoter. I also 
assessed the multimerization capabilities of AtxA2. 
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5.2 Results 
5.2.1 Activity of AtxA and AtxA2 
 To assess whether AtxA2 can act as a transcriptional regulator I used the Plef-lacZ 
reporter (UT376) to measure transcriptional activity, as was done previously for AtxA in B. 
anthracis (Hammerstrom 2011).  I measured the activity of AtxA-His and AtxA2-His expressed 
from a plasmid-borne IPTG-inducible promoter in cultures of UT376.  Previous investigations 
showed that addition of the 6xHis epitope to the carboxy terminus of AtxA did not affect activity 
of AtxA (Hammerstrom 2011).  Expression of AtxA-His and AtxA2-His was induced to similar 
levels with IPTG (30 µM and 100 µM, respectively) as shown by western blot probed with an 
antibody against the 6xHis epitope (Figure 5-2). I found that β-galactosidase activity in the 
AtxA2-His expression strain was approximately five-fold lower than activity in the AtxA-His 
expression strain (Figure 5-2). These data indicate that AtxA positively affects lef transcription 
to a significantly greater degree than does AtxA2-His.  Moreover, AtxA2-His required three-fold 
more IPTG to reach levels comparable to AtxA-His, which suggest that AtxA2-His is less stable 
than AtxA in B. anthracis. 
5.2.2 Multimerization of AtxA proteins. 
 AtxA activity requires dimerization of the protein and mutants that fail to dimerize are 
inactive (Hammerstrom 2011). To test homomultimer formation by AtxA2, I used co-affinity 
purification to detect protein-protein interactions. B. anthracis ANR-1 atxA-null strains that 
expressed AtxA-His, AtxA-FLAG, AtxA2-His, AtxA2-FLAG, or GFP-FLAG were pooled and 
lysed in pairs:  (1) AtxA2-His and AtxA2-FLAG, (2) AtxA-His and AtxA-FLAG, (3) AtxA2-His and 
GFP-FLAG, and (4) AtxA2-FLAG and GFP-FLAG, as indicated in figure 5-3A.  AtxA 
dimerization has been demonstrated previously, so pair (2) served as a positive control (64).  
GFP-FLAG was used as a negative control.  His-tagged proteins were 
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Figure 5-1. Amino acid alignment of AtxA homologues 
Domains identified in the AtxA crystal structure are shown as solid bars directly above the 
respective amino acid sequence. Histidines at positions 199 and 379 within AtxA, which have 
been shown to be subject to phosphorylation, are shown enlarged and in bold. Amino acid 
identity and similarity are denoted by asterisk (full conservation), colon (strongly similar 
properties), or period (weakly similar properties). Alignments were completed using the Clustal 
X2 program.  
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Figure 5-2. In vivo activity of AtxA-His and AtxA2-His  
The β-galactosidase activity of B. anthracis strains harboring the Plef-lacZ reporter  and IPTG-
inducible atxA alleles was determined as described previously (95). In an atxA-null strain 
(UT376), production of AtxA-His (pUTE1097) and AtxA2-His (pUTE1096) was induced using 30 
µM and 100 µM IPTG respectively during growth in CaCO3. The empty vector sample was 
derived from UT376 (pUTE657) that lacks atxA. Samples were obtained at the transition to 
stationary phase (4h; OD600 1.2-1.7). Standard error shown.  
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captured with NTA-Ni resin, eluted with imidazole, and detected by western blot. All of the 
appropriate tagged proteins were present in pooled lysates prior to incubation with the NTA-Ni 
resin (Figure 5-3A, lanes1-4).  Protein complexes that contained a 6xHis epitope bound to the 
NTA-Ni resin were eluted with imidazole (Figure 5-3A, lanes 5-8). As expected, AtxA-FLAG co-
eluted with AtxA-His (Figure 5-3A, lane 6). AtxA2-FLAG co-eluted with AtxA2-His, represented 
by a faint band in the anti-His western blot (Figure 5-3A, lane 5).  The AtxA2-FLAG band was 
much less intense than that of the AtxA-FLAG band that co-eluted with AtxA-His (Figure 5-3A, 
lane 5 versus lane 6).  These data suggest that AtxA2 can form homomultimers, but that the 
AtxA2 homomeric interaction is weaker than that of AtxA homomultimers. 
 As a parallel approach to test AtxA2 homomultimerization, I employed protein 
crosslinking with bis(maleimido)hexane (BMH).  BMH reacts specifically with free cysteines 
within 13 Å to irreversibly crosslink the residues.  AtxA has cysteines at positions 96, 161, 202, 
356, 370, and 402, and crosslinking by BMH at C402 results in homomeric protein dimers (64). 
AtxA2 has the same cysteine residues as AtxA, except for C161, which is an alanine residue. 
Cell lysates from individual cultures that expressed 6xHis-tagged recombinant AtxA, AtxA-
H379D, and AtxA2 were treated with BMH, subjected to SDS-PAGE, and probed with an anti-
His antibody via western blot.  In the absence of the crosslinker, AtxA-His migrated as a dense 
band near the 50-kDa marker in each of the lysates (Figure 5-3B). The predicted molecular 
weights of the three AtxA variants is 55.6 kDa. The crosslinking of two AtxA-His proteins was 
indicated by a band of the size commensurate with an AtxA dimer (110 kDa) detected in the 
AtxA-His lysate treated with BMH (Figure 5-3B).  The H379D amino acid mutation in AtxA 
abolishes dimerization (65), and only monomer was detected in the BMH-treated lysate from 
the AtxA-H379D-His mutant (Figure 5-3B).  Similarly, BMH treatment of lysates containing 
AtxA2-His did not produce a band suggestive of a dimer.  Smears of apparent high molecular 
weight cross-reactive protein were present in the cross-linked AtxA-His and AtxA2-His lysates, 
an observation that suggests that each AtxA protein has the capacity to form some higher-
ordered protein-protein interactions. 
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 The capacity for AtxA and AtxA2 to form heterodimers was also investigated with co-
affinity purification.  B. anthracis ANR-1 atxA-null strains that expressed AtxA-His, AtxA-FLAG, 
AtxA2-His, or GFP-FLAG via an IPTG-inducible expression plasmid were pooled and lysed in 
pairs as depicted in figure 5-4.  Lysates were incubated with NTA-Ni resin and eluted with 
imidazole, then separated by SDS-PAGE and analyzed by western blot.  As expected, AtxA 
multimerization was demonstrated by detection of AtxA-FLAG in AtxA-His eluates (Figure 5-4; 
lane 6).  GFP-FLAG was not detected in any eluates, which indicated that non-specific proteins 
were washed from the NTA-Ni resin and that the 6xHis and FLAG epitopes did not interact.  
The presence of AtxA-FLAG in AtxA2-His eluates revealed that, in these conditions, AtxA-
FLAG formed a stable interaction with AtxA2-His.  Taken together, the BMH crosslinking and 
co-affinity purification data suggest a model in which AtxA2 forms weak or unstable 
homomultimers relative to AtxA homomultimers, and AtxA2 forms a relatively stable 
heteromultimer with AtxA. 
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Figure 5-3. Dimerization of AtxA2 
(A) Lysates from B. anthracis atxA-null strains (UT376) containing AtxA2-His (pUTE1096), 
AtxA2-FLAG (pUTE1122), AtxA-His (pUTE991), AtxA-FLAG (pUTE992), or GFP-FLAG 
(pUTE1013) induced with IPTG were subjected to co-affinity purification using NTA-Ni resin. 
western blots probed with α-His or α-FLAG were performed on soluble cell lysates (Load, lanes 
1-4) and purified proteins (Eluate, Lanes 5-8). (B) Cultures of UT376 containing AtxA-His, AtxA-
H379D-His, or AtxA2-His (pUTE1096) were induced with 50 µM, 50 µM, and 100 µM IPTG 
respectively. Cell lysates were treated with cross-linking agent BMH. SDS-PAGE (4-15%) and 
western blots using anti-His antibody were used to detect AtxA-His and AtxA2-His. 
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Figure 5-4. Specific binding of AtxA2-His to AtxA-FLAG 
Lysates from B. anthracis atxA-null strains (UT376) containing AtxA-His (pUTE991), AtxA2-His 
(pUTE1096), AtxA-FLAG (pUTE992), or GFP-FLAG (pUTE1013) induced with IPTG were 
subjected to co-affinity purification using NTA-Ni resin. Western blots probed with α-His or α-
FLAG were performed on soluble cell lysates (Load, lanes 1-5) and purified proteins (Eluate, 
Lanes 6-10).  
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5.3 Discussion 
 In this chapter I have presented my data comparing the activity and multimerization 
states of the AtxA orthologs, AtxA1 and AtxA2, from B. cereus strain G9241. My data reveal 
differences in activity and multimerization of the two AtxA orthologs which are likely mediated 
by dissimilarities in the amino acid sequences of AtxA and AtxA2. 
 There are clear similarities with regard to functional relationships that exist among the 
B. anthracis PCVRs and the B. cereus strain G9241 AtxA orthologs. In B. anthracis, my RNA-
Seq and transcriptional reporter data indicate that AtxA controls toxin gene expression, with 
AcpA and AcpB having little to no effect (-), yet several other genes are coregulated by all three 
proteins. Toxin western blots from atxA1- and atxA2-null B. cereus strains indicate that AtxA1 
primarily regulates toxin expression with AtxA2 having no effect on toxin production. 
Considering that AtxA1 and AtxA2 share 76% amino acid identity and 91% similarity, and share 
greater sequence conservation than AtxA has to AcpA and AcpB, the molecular requirements 
for toxin expression appear considerably stringent. Despite AtxA2 having no effect on toxin 
expression, either AtxA1 or AtxA2 was sufficient for expression of the TS capsule indicating 
functional similarity with regard to expression of the bps locus and suggests that AtxA2 
functionality is promoter dependent.  
 A linear representation of the five domains of AtxA and a comparison of AtxA and AtxA2 
amino acid sequences is shown in figure 5-1. There are 37 amino acids that are not conserved 
between AtxA and AtxA2, only four of which are in the amino-terminal DNA-binding domains of 
the protein. The remainder of the non-conserved amino acids are located in the PRDs and the 
EIIB-like multimerization domain. Notably, the phosphorylation sites of AtxA, H199 of PRD1 
and H379 of PRD2, that are known to affect AtxA activity (65, 66) are conserved in AtxA and 
AtxA2 (represented in bold in figure 5-1). In the current model for AtxA structure and function, 
phosphorylation of H199 enhances AtxA activity, while phosphorylation at H379 prevents 
dimerization and abrogates AtxA function (65). The crystal structure of AtxA shows that several 
amino acids interact at the dimer interface, and, with the exception of the asparagine to serine 
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change at position 389, these residues are conserved among the proteins. Nevertheless, 
despite this conservation of residues, I was unable to detect robust homomultimerization of 
AtxA2 using coaffinity purification and crosslinking. Amino acid differences in AtxA2 may result 
in conformational changes that affect accessibility of the histidine residues for phosphorylation 
and/or alter the positions of residues that interact at the dimer interface and lead to reduced 
dimerization and activity of AtxA2. It is also possible that a slight alteration in the AtxA2 
structure changes the position of C402, a residue that is required for BMH-mediated 
crosslinking of two AtxA molecules (64).  
My data also suggest that AtxA2 may be less stable than AtxA. When atxA and atxA2 
expression were controlled by the same IPTG-inducible promoter, three-fold more IPTG was 
required to induce AtxA2 to a level comparable to AtxA. Finally, it is also possible that, for 
reasons not yet clear, dimerization may not be essential for AtxA2 function. Future studies of 
AtxA2 should involve phosphomimetic and phosphoablative mutations at positions 199 and 379 
to determine whether potential phosphorylation at these sites affects AtxA2 in a manner 
comparable to AtxA in B. anthracis. 
 My data support a model in which AtxA/AtxA homomultimers have the highest activity 
and AtxA2/AtxA2 homomultimers have the lowest activity. I propose that AtxA/AtxA2 
heteromultimers have an intermediate activity that does not have a dramatic impact on AtxA-
mediated transcriptional regulation due to low abundance and/or stability of the heteromultimer. 
Given that it is unknown how the amino acid differences alter activity between the two AtxA 
orthologs it is important to identify other pXO1-like plasmids harboring atxA alleles with 
sequence changes from atxA in B. anthracis. Examining amino acid conservation between 
orthologs coupled with activity assays could identify specific amino acids required for optimal 
activity. 
 Plasmids with homology to pXO1 and pXO2, encoding PCVR orthologs, have been 
identified in pathogenic bacilli other than B. anthracis. In Cameroon and the Ivory Coast, B. 
cereus strains harboring pXO1-like and pXO2-like plasmids were recovered from great apes 
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that succumbed to an anthrax-like disease. These strains contained homologues of the anthrax 
toxin genes, poly-γ-D-glutamic acid capsule biosynthesis genes, in addition to atxA, acpA, and 
acpB. However, regulation of capsule expression in these strains is distinct from that of B. 
anthracis. Culture of the CA and CI B. cereus strains on bicarbonate agar in a CO2-enriched 
atmosphere resulted in encapsulated cells. Interestingly, capsule formation was also observed 
when the CA and CI strains were cultured on blood or LB agar in ambient air, while B. anthracis 
control cultures did not form capsules in these culture conditions. The ability to synthesize a 
capsule in subclones of the CA and CI strains correlated with the presence or absence of 
capBCADE suggesting that the observed capsule is not the result of other capsule biosynthesis 
genes. Toxin production by the CI strain was akin to that of B. anthracis and dependent on 
culture conditions inclusive of bicarbonate and elevated CO2  (18). The uncoupling of capsule 
formation and culture conditions containing bicarbonate and CO2 is both novel and interesting, 
and suggest that regulatory elements aside from AcpA and AcpB control capsule expression in 
the CA and CI strains. My research into AcpA and AcpB function show that these two 
regulators have low activity in strains cultured in medium lacking bicarbonate and ambient air. It 
is unlikely that the capsule regulators in the B. cereus  have gain of function mutations enabling 
increased activity in ambient air as the sequence conservation with the B. anthracis 
homologues is almost identical. Future studies on capsule expression in this strain should 
compare the regulatory region of capBCADE from the CA and CI strains with that of B. 
anthracis. Clues to cis and/or trans-acting factors that influence capBCADE expression could 
be identified. 
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Dual role for AtxA: control of sporulation 
and anthrax toxin production 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: This work was performed in collaboration with Dr. Jennifer Dale and others at The 
University of Texas Health Science Center at Houston. In the Introduction of this chapter (6.1) I 
summarize work performed with the coauthors. My work is presented in the Results (5.2). 
Portions of the writing in this chapter were drawn from: 
 
Dale, J.L., Raynor, M.J., Dwivedi, P., and Koehler, T.M. (2012) cis-acting Elements Controlling 
Expression of the Master Virulence Regulatory Gene atxA in Bacillus anthracis. Journal of 
Bacteriology. doi:10.1128/JB.00776-12. 
 
Dale, J.L., Raynor, M.J., Ty, M.C., Hadjifrangiskou, M., Koehler, T.M. (2018) A dual role for the 
Bacillus anthracis master virulence regulator AtxA: control of sporulation and anthrax toxin 
production. Frontiers in Microbiology. doi: 10.3389/fmicb.2018.00482. 
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6.1 Introduction 
 
 While B. anthracis is commonly thought of as the anthrax pathogen, this bacterium also 
occupies niches outside of mammalian hosts. Vegetative cells of B. anthracis have been 
recovered on and around plant roots in the soil, and from the guts of earthworms (24, 144). The 
spore, however, is thought to be the primary form of B. anthracis outside the host environment. 
Spores are resistant to heat, desiccation, and other environmental conditions. The spore is the 
infectious form of the bacterium and enters the host via inhalation, ingestion, or skin abrasion 
leading to different types of anthrax dependent on the route of infection. Spores of B. anthracis 
have not been observed within infected hosts where conditions that promote virulence factor 
expression, such as high partial pressure of CO2, diminish sporulation efficiency (145). It is not 
until the host succumbs to anthrax and begins to decompose, exposing B. anthracis to the 
exterior environment, that vegetative cells begin to form spores. The cycling between spore 
and vegetative forms is an important part of the bacterial lifestyle and is necessary for transfer 
of the bacterium to new hosts. 
 Control of sporulation is managed by several trans-acting factors that have been 
characterized primarily in the model Bacillus, Bacillus subtilis. CodY is a pleiotropic regulator of 
stationary phase genes and is highly conserved in Bacillus species. In B. subtilis, CodY 
repressed expression of genes required for sporulation during exponential growth phase when 
nutrients were in excess (146). AbrB is a transition-state regulator that prevents untimely 
expression of genes required for survival in stationary phase, including sporulation genes 
(147). During the transition into stationary phase, AbrB-mediated repression of genes 
necessary for sporulation is relieved by inhibition of abrB expression by Spo0A (148). Spo0A is 
the master response regulator for expression of genes required for survival in stationary phase. 
Spo0A is activated following phosphorylation by a complex phosphorelay that is initiated in 
response to nutrient limitation (149). The phosphorelay is triggered by autophosphorylation of 
sensor histidine kinases, and the specific signal of nutrient limitation required for induction is 
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unknown. Homologues of CodY, AbrB, and Spo0A are present in B. anthracis and are thought 
to play similar roles to those demonstrated in B. subtilis. 
 B. anthracis produces a unique pXO2-encoded element of the sporulation pathway, 
pXO2-0075 annotated as SkiA for "sporulation kinase inhibitor" (the gene encoding SkiA is 
referenced in the literature as pXO2-61). SkiA shares homology with the signal sensor domain 
of the B. anthracis sensor histidine kinase BA2291, and overexpression of skiA negatively 
affects sporulation. It is hypothesized that overexpression of skiA titrates away a signal from 
BA2291 negatively affecting the phosphorelay required to phosphorylate and activate Spo0A 
(150). Expression of skiA was shown to be positively regulated by AtxA in previous microarray 
studies (56) and in my RNA-Seq experiment, thus SkiA may provide a mechanism for AtxA to 
regulate sporulation. 
 In a joint effort with Dr. Jennifer Dale, Dr. Maria Hadjifrangiskou, and Maureen Ty we 
used two different culture conditions to model growth of B. anthracis in the host and ex vivo 
environments and examined sporulation efficiency, toxin production, and atxA expression. Dr. 
Dale is the primary author of the publication resulting from these experiments. To examine 
sporulation in B. anthracis two culture conditions were employed: a rich medium in air (PA-air), 
and a semi-defined minimal medium containing dissolved bicarbonate and incubated in 5% 
atmospheric CO2 (CACO3). Culture in PA-air has been shown to promote efficient sporulation 
as observed outside the host environment, whereas culture in CACO3 has been used to model 
the host environment and is conducive to toxin and capsule expression (44, 49, 151, 152). 
Culture in PA-air resulted in an increase heat-resistant colony forming units (CFU) over time, a 
result consistent with sporulation. However, culture in CACO3 yielded heat-resistant CFU less 
than 1% of that measured in PA-air cultures indicating growth in CACO3 is not conducive for 
sporulation. Western blots to show lethal factor levels in culture supernates indicate lethal 
factor is not detectable in samples taken from PA-air cultures, but were abundant in CACO3-
grown cultures. Consistent with AtxA control of lethal factor production, AtxA was detected in 
low levels and decreased over time during culture in PA-air. Conversely, AtxA levels increased 
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during culture in CACO3 and peaked at the transition to stationary growth phase. These data 
reveal an inverse relationship between sporulation and toxin production. Morever, production of 
AtxA is dependent upon culture conditions. 
 To delineate the relationship between AtxA and sporulation in the fully virulent B. 
anthracis Ames strain (pXO1+ pXO2+) mutants that express AtxA at different levels were 
employed. Parent, atxA-null, and atxA-up (contains a mutation in the atxA promoter resulting in 
5- and 7-fold increases in lethal factor and AtxA levels, respectively, relative to the parent) 
strains were grown in CACO3 and PA-air and spores were visualized by phase contrast 
microscopy. Compared to the parent and atxA-null strains, the atxA-up mutant exhibited both a 
delay and decrease in sporulation efficiency in both culture conditions. In the ANR-1 
background (pXO1+ pXO2-) the atxA-up mutant did not exhibit a defect in sporulation, 
suggesting that factors on pXO2 contribute to the atxA-up sporulation defect in the Ames strain. 
 A pXO2-encoded gene, pXO2-0075 (previously designated pXO2-61), is predicted to 
encode a protein with homology to the signal sensor domain of sporulation sensor histidine 
kinase, an integral component of the sporulation phosphorelay. Previous studies indicate that 
AtxA positively regulates pXO2-0075, and that pXO2-0075 overexpression results in a 
significant decrease in sporulation (56, 150). A pXO2-0075-null mutant exhibits sporulation 
patterns similar to the parent and atxA-null strains when cultured in PA-air, and early 
endospore formation in CACO3 cultures. Importantly, the sporulation defect in the atxA-up 
mutant is suppressed by deletion of pXO2-0075, indicating pXO2-0075 mediates the defect in 
sporulation. Given this activity pXO2-0075 was renamed skiA for "sporulation kinase inhibitor". 
 The possible link between AtxA and sporulation extends beyond regulation of skiA 
expression. Many regulators that control expression of genes necessary for sporulation also 
influence atxA at the level of transcription or posttranslationally. CodY, which represses genes 
needed in stationary phase during exponential growth, controls AtxA protein levels 
posttranscriptionally by an unknown mechanism. A codY-null mutant has diminished AtxA 
levels and is avirulent in a murine model of anthrax (69). AbrB is the only trans-acting factor 
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demonstrated to bind directly to the atxA promoter region, and represses transcription during 
early exponential growth phase. An abrB-null mutant exhibited increased AtxA levels in soluble 
cell lysates compared to the parent. Spo0A also increases atxA expression by repressing 
transcription of abrB (61, 62, 75). 
 The atxA promoter region provides limited clues about other factors affecting atxA 
expression. Transcription of atxA initiates from two start sites; P1, the dominant start site, 
positioned 99 nucleotides upstream of the translational start codon, and P2 located 650 
nucleotides upstream of P1 (30, 66) (Figure 6-1A). The AbrB consensus sequence consists of 
43 nucleotides and resides 25 to 67 nucleotides upstream of the P1 transcriptional start site 
(61). A putative consensus sequence for the housekeeping sigma factor SigA is upstream of 
the P1 and P2 transcription start sites (30), 
 In a collaborative effort involving Dr. Jennifer Dale, Dr. Prabhat Dwivedi, and me, we 
sought to delineate roles for cis-acting elements associated with regulation of atxA 
transcription, and to test for other trans-acting factors affecting atxA expression. Dr. Dale is the 
primary author for this work and completed the majority of the experiments. As an initial 
experiment to determine roles for cis-acting elements in the atxA promoter the putative SigA 
consensus sequence at the dominant atxA transcription start site, P1, was mutated. Mutation of 
the consensus sequence abolished transcription from P1. These results suggest that SigA-
RNAP transcribes atxA from the P1 transcription initiation site. 
 Next Dr. Dale tested whether trans-acting factors other than AbrB bind the atxA 
promoter. Electrophoretic mobility shift assays (EMSA) using abrB- and sigH-null soluble cell 
lysates and a radiolabeled atxA promoter probe indicated a trans-acting factor other than AbrB 
and SigH bound specifically to the atxA promoter resulting in a DNA mobility shift. Similar 
experiments with an atxA probe containing a mutated SigA consensus sequence resulted in a 
DNA mobility shift indicating the trans-acting factor was a regulatory element other than SigA-
RNAP.  
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 To map the putative binding site of the trans-acting factor, 5' and 3' deletions of the atxA 
promoter were fused to a promoterless lacZ gene. Loss of DNA sequences -13 to +31, relative 
to the P1 transcription start site (+1) resulted in a 15-fold increase in β-galactosidase activity 
compared to the full length promoter, suggesting a repressor binds downstream of the atxA 
promoter. In EMSA experiments deletion of sequences -13 to +31 resulted in a nonspecific 
DNA shift suggesting the sequence is required for repressor site binding.  
 In silico analysis of the atxA promoter revealed an imperfect 9-bp palindrome within the 
sequences -13 to +31. A specific DNA shift was not observed in EMSAs using an atxA 
promoter probe containing a partial mutation of the palindromic sequence. Mutation of the 
palindromic sequence resulted in a 7-fold increase in β-galactosidase activity when the mutated 
atxA promoter was transcriptionally fused to a promoterless lacZ gene and introduced into B. 
anthracis.  
  To test whether the increase in atxA promoter activity results in elevated AtxA protein 
levels the palindromic sequence was mutated in the native atxA promoter. AtxA protein levels 
in the mutant (renamed atxA-up) were 6.6-fold higher than that of the parent. Toxin levels in 
culture supernates of the atxA-up mutant increased relative to the parent; lethal factor (5.4-
fold), edema factor (8.9-fold), and protective antigen (2-fold). These data show that a partial 
mutation of the atxA repressor binding site results in elevated production of AtxA and the 
anthrax toxin genes. 
 In this chapter, I present my data in which I examined the effect AtxA has on sporulation 
through transcriptional control of skiA. I show sporulation efficiencies of skiA and atxA mutants 
in conditions favorable to toxin expression and conditions that favor sporulation. I measured 
transcript levels of skiA in atxA mutant backgrounds in both culture conditions. I also assessed 
the virulence of the atxA-up mutant in a murine model of anthrax. 
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6.2 Results 
6.2.1 AtxA modulates sporulation efficiency through SkiA 
 To elucidate the relationship between AtxA, SkiA, and sporulation I cultured strains 
harboring deletions of atxA or skiA, or that overexpressed atxA in culture conditions conducive 
to either sporulation or toxin expression and quantified the respective sporulation efficiencies at 
different time points. Sporulation efficiency was quantified by enumeration of heat-resistant 
(HR) colony forming units/ml (CFU). During culture in PA medium in ambient air (PA-air) 
(sporulation conditions), the most striking observation is the dramatic difference in HR CFU 
between the atxA-up mutant and the parent strain (Ames) (Figure 6-2A). Cultures of the parent 
strain produced approximately 1 x 105 HR CFU to 1 x 108 HR CFU over the time course, while 
the atxA-up mutant produced 2- to 3-log fewer HR CFU. As stated in section 6.1, the atxA-up 
mutant exhibited increased steady state AtxA levels relative to the parent strain.  Deletion of 
skiA in the atxA-up background resulted in near parent levels of HR CFU. Complementation 
with skiA in the ∆skiA/atxA-up background restored the sporulation defect demonstrating that 
increasing atxA expression negatively affects sporulation efficiency via SkiA. Single and double 
mutants of atxA and skiA did not cause dramatic alterations in sporulation efficiencies. 
 I measured skiA expression levels in the different atxA mutants to examine whether 
increases and decreases in atxA expression modulated skiA transcription. Reverse 
transcriptase polymerase chain reaction (RT-PCR) results show skiA transcripts were 5-fold 
more abundant in the atxA-up mutant and seven-fold lower in the atxA-null mutant compared to 
the parent strain at 4h (Figure 6-2B). At 7h, skiA transcripts were more abundant than at 4h. 
Transcripts of skiA were 11-fold greater in the atxA-up mutant relative to the parent strain, while 
skiA transcripts in the atxA-null mutant were comparable to those of the parent strain. These 
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Figure 6-1. Schematic representation of the atxA promoter region 
(A) Transcription start sites are indicated as P1 or P2. The nine base pair palindrome is 
indicated between +3 and +21 relative to the P1 transcription start site. (B) The palindromic 
sequence is denoted by bold, underlined letters. Nucleotides mutated using site-directed 
mutagenesis are denoted by lowercase, gray lettering. Modified from a publication I co-
authored with Jennifer Dale. She created this schematic and I have used it with her permission. 
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Figure 6-2. Spore quantification and skiA transcript levels in PA-air 
(A) Heat-resistant CFU/ml of parent and mutant derivatives. (B) RT-qPCR of skiA transcripts at 
transition-to-stationary (4h) and stationary (7h) phases of growth normalized to the parent 
control. These data represent average values of detectable transcripts from three independent 
cultures. Asterisks denote p-values ≤ 0.05 relative to parent.     
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results demonstrate when B. anthracis is cultured in PA-air (sporulation conditions) 
overexpression of atxA leads to an increase in skiA transcription, causing a skiA-dependent 
defect in sporulation efficiency. 
 Next, I quantified sporulation efficiencies of the atxA and skiA mutants in CA medium 
supplemented with bicarbonate in 5% CO2 atmosphere (CACO3) (toxin-inducing conditions).  
Culture in CACO3 yielded less HR CFU, indicative of reduced sporulation efficiency, compared 
to culture in PA-air. Numbers of HR CFU for CACO3 cultures were 1- to 2-log fewer than PA-air 
cultures. Interestingly, cultures of the atxA-up strain did not have a defect in sporulation 
efficiency until stationary phase (7h) (Figure 6-3A). The atxA- and skiA-null mutants had 
significantly higher sporulation efficiency than the parent at 7h. A 2-log difference in HR CFU 
was observed between the mutants and the parent strain. As observed during culture in PA-air, 
the ∆skiA/atxA-up mutant produced HR CFU similar to that of the parent strain, and 
complementation with skiA restored the sporulation defect. 
 To assess skiA expression in the mutant backgrounds during culture in CACO3 I 
measured transcript levels using RT-PCR. Transcript levels of skiA produced by the parent and 
atxA-up mutant were similar, with less than a 2-fold difference in relative levels (Figure 6-3B). 
The atxA mutant showed a dramatic decrease in skiA transcript levels, roughly 57-fold lower at 
transition phase (4h) and 25-fold lower at stationary phase (7h) compared to the parent strain. 
In summary, strains with low or undetectable skiA transcripts (atxA- and skiA-null strains) 
exhibited increased numbers of HR CFU compared to strains with native or elevated skiA 
expression (parent and atxA-up strains). These data suggest that culture in conditions 
mimicking the host environment (toxin induction conditions) results in decreased sporulation 
efficiency relative to culture in conditions conducive to sporulation, and the influence AtxA has 
on sporulation is likely mediated through SkiA.  
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6.2.2 Elevated atxA expression does not result in increased virulence. 
 Given the increases in AtxA and toxin levels observed in samples from the atxA-up 
mutant (91), in addition to the sporulation defect, we tested whether the mutant exhibited 
increased virulence in a murine model of anthrax (Figure 6-4). I injected vegetative cells of B. 
anthracis parent strain (ANR-1), and isogenic atxA-null and atxA-up strains into the tail veins of 
6- to 8-week old female A/J mice. A/J mice are complement deficient and therefore more 
susceptible to toxigenic B. anthracis strains compared to murine models with intact immune 
systems (141). Mean time to death (MTD) did not differ significantly between mice inoculated 
with 102 CFU of the parent or atxA-up mutant. Mice succumbed to infection with the parent and 
atxA-up strains with a MTD of approximately 113 and 119h, respectively. The atxA-null mutant 
was avirulent. These results indicate that increases in AtxA protein and toxin levels observed in 
the atxA-up mutant in vitro do not result in a virulence phenotype. 
 
6.3 Discussion 
 In this chapter, I have presented data indicating atxA expression levels are important for 
proper cell development in different environments. Conditions within the mammalian host 
environment are ideal for both atxA expression and activity. Body temperatures within 
mammals can range from 36˚C to 39˚C and expression of atxA increases six-fold when B. 
anthracis is incubated at 37˚C compared to 30˚C (59). Carbon dioxide concentrations within the 
blood of mammals is around 40 mmHg, which is close to 5% and 85-90% of CO2 within 
mammals exists in the form of bicarbonate HCO3- (153). AtxA dimerization and activity increase 
when B. anthracis is cultured in medium containing dissolved bicarbonate in 5% CO2 
atmosphere (64). The availability of nutrients in the host environment due to the activity of 
lethal toxin and other virulence factors produced by B. anthracis (see section 1.4) may lead to a 
physiological state in which genes required during stationary phase, notably sporulation genes, 
are repressed by transition state regulators. Nutrient availability, temperature, and high partial 
pressure of CO2 may result in 
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Figure 6-3. Spore quantification and skiA transcript levels in CACO3 
(A) Heat-resistant CFU/ml of parent and mutant derivatives. (B) RT-qPCR of skiA transcripts at 
transition-to-stationary (4h) and stationary (7h) phases of growth normalized to the parent 
control.  These data represent average values of detectable transcripts from three independent 
cultures. Asterisks denote p-values ≤ 0.05 relative to parent.     
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Figure 6-4. Virulence of parent and atxA mutants 
Survival curves of A/J mice inoculated intravenously with vegetative B. anthracis are shown. 
Mice were injected via the tail vein with inocula of following strains: parent (circles; n = 6) 
inoculum = 1.5 x 102 CFU, atxA-up (triangles; n = 6) inoculum = 1.9 x 102 CFU, and atxA-null 
(squares; n = 3) inoculum = 1.5 x 103 CFU. I performed the animal infections used to generate 
these data. Jennifer Dale created this figure and I have used it with her permission. 
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increased atxA expression and protein activity, resulting in expression of skiA and inhibition of 
sporulation. Moreover, the cerebrospinal fluid and blood from mammals that succumbed to 
anthrax corroborate in vitro studies as vegetative bacilli have been detected in these samples, 
but not spores (154). 
 In contrast to culture conditions that induce toxin expression, conditions conducive to 
sporulation (PA-air) include low CO2 partial pressure (145). The CO2 concentration in ambient 
air is at roughly 0.04%, more than 100-fold lower than what is observed within the host 
environment (155). AtxA activity is low in these conditions as referenced by the absence of 
lethal factor in culture supernates from B. anthracis strains cultured in PA-air. Interestingly, 
AtxA protein levels are also reduced in B. anthracis strains cultured in PA-air compared to 
culture in CACO3 despite incubation of both cultures at 37˚C (156). Transcription of skiA in the 
parent strain during culture in PA-air is similar levels observed in the atxA-null strain indicating 
that skiA expression is low in these culture conditions. These data are particularly relevant 
since B. anthracis resides in the soil environment where environmental conditions can quickly 
become unfavorable for survival of vegetative cells. The low CO2 concentration of ambient air 
in the soil environment may result in B. anthracis vegetative cells with low AtxA activity, and by 
extension low skiA expression. The transition state regulators, which respond to nutrient 
availability, could function as the primary key holders for sporulation when B. anthracis is in the 
soil environment. In the host environment, when AtxA is more active, positive regulation of skiA 
could function as an added inhibitor of sporulation. 
 In addition to the influence AtxA has on sporulation via skiA, a more well-known role for 
AtxA is as a positive regulator of toxin expression. Mutation of a putative repressor binding site 
in the atxA promoter led to a seven-fold increase in β-galactosidase activity from a PatxA-lacZ 
reporter. Importantly, AtxA protein levels and toxin production were increased in the "atxA-up" 
strain harboring the repressor site mutation compared to the parent strain (91). Despite 
elevated toxin production detected during in vitro culture of the atxA-up mutant, an increase in 
virulence was not observed in this strain relative to the parent in a murine model of anthrax. It is 
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possible that the increases in atxA expression and toxin production observed in vitro do not 
occur in vivo. Alternatively, AtxA and toxin production by the parent strain in vivo may not be 
limiting for anthrax disease progression, and increases in toxin levels have no effect.  
 The other B. anthracis PCVRs, AcpA and AcpB, do not have a significant effect on skiA 
expression. Sporulation efficiency in strains with altered acpA or acpB expression has not been 
quantified, however abnormalities in sporulation have not been observed in sporulating cultures 
of these strains. Capsule production was unaffected in the atxA-up and skiA mutants. It is 
curious that lethal factor levels were elevated in the atxA-up mutant relative to the parent, but 
capsule thickness was unaffected. Expression of acpA was not measured in the atxA-up 
mutant, and it is possible that the 6.6-fold increase in AtxA in this mutant does not result in an 
increase in acpA transcripts which would suggest AtxA levels are not limiting for acpA 
expression. My data support the interpretation that overexpression of AcpA results in cells with 
increased capsule thickness compared to native acpA expression. 
 With respect to PCVR function, these data suggest a model in which AtxA plays an 
important role in toxin expression and suppression of sporulation in toxin inducing conditions 
through control of skiA. AcpA and AcpB appear to play more limited roles and function primarily 
in capsule production having no apparent effect on sporulation. Future studies should focus on 
in silico analysis of genes with unknown functions in the AcpA and AcpB regulons. Analysis of 
the predicted amino acid sequences for these AcpA- and AcpB-regulated genes may reveal 
homology to proteins of known function ascribed to specific gene networks or cellular 
processes. These studies could highlight other impacts AcpA and AcpB have on cellular 
physiology. 
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7.1 Noteworthy results and significance of B. anthracis PCVRs 
 Bacillus anthracis produces three proteins that are members of an emerging class of 
Gram-positive transcriptional regulators termed PRD-containing Virulence Regulators (PCVRs). 
A defining characteristic of this class of regulators is the presence of 
phosphoenolpyruvate:carbohydrate phosphotransferase system regulatory domains (PRD). 
The phosphotransferase system, generally involved in the transfer of phosphate to incoming 
sugar molecules, may also play a role in virulence. AtxA, named for its control of anthrax toxin 
gene expression, is the master virulence regulator in B. anthracis and is the archetype PCVR. 
Cells lacking atxA are significantly attenuated in murine models of anthrax (30, 91). AtxA 
shares amino acid similarity with two less well-studied regulators, AcpA and AcpB, which 
independently positively control transcription of the capsule biosynthetic operon, capBCADE. 
Deletion of acpA results in cells with smaller capsule diameters, and acpB-null strains have 
reduced dissemination compared to the parent strain in a murine model of anthrax. An 
acpAacpB mutant is non-capsulated and avirulent in a murine infection model (29, 107). 
 My research has revealed similarities and differences among AtxA, AcpA, and AcpB 
with regard to gene regulation and structure-function relationships. In chapter three I describe 
my efforts to determine the regulons of the PCVRs in strains expressing individual regulators at 
near native levels. My data show that multiple plasmid and chromosomal genes are PCVR 
controlled, with AtxA, AcpA, and AcpB having a ≥4-fold effect on transcript levels of 145, 130, 
and 49 genes respectively. Several genes are coregulated by two or three PCVRs. In chapter 
four I present data concerning the relative in vivo activities of each PCVR on PcapB-lacZ and 
Plef-lacZ reporter fusions in B. anthracis, the effect of CO2 on the solubility and stability of the 
PCVRs, the impact functional domains have on regulator activity, and finally multimerization 
studies. In vivo reporter results are largely consistent with RNA-Seq data such that AtxA alone 
had activity on Plef-lacZ, and AcpA and AcpB had more activity on PcapB-lacZ than AtxA. The 
concentration of CO2 during culture did not affect PCVR stability nor solubility. Similar to AtxA, 
homodimer formation was observed for AcpA and AcpB and was dependent on the EIIB-like 
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domains. In co-expression experiments, AcpA activity was reduced by increased levels of AtxA. 
Experiments presented in chapter five characterize the activity and multimerization potential of 
an atxA orthologue, AtxA2, identified in a virulent B. cereus. Compared to AtxA from B. 
anthracis, AtxA2 has less activity. The reduced activity of AtxA2 is potentially due to reduced 
homodimer formation. Data presented in chapter six further define the effects of AtxA 
expression levels on virulence and sporulation. B. anthracis mutants that overexpress atxA, 
resulting in increased AtxA and toxin production in vitro, do no not have increased virulence in 
a murine model of anthrax. Finally, AtxA proteins levels can alter sporulation efficiency through 
control of skiA expression. 
 The presence of three PCVRs in B. anthracis provides the opportunity to perform a 
comparative analysis of paralogues with shared and different functions. My studies, focusing on 
the mechanistic basis for overlapping and distinct target genes of AtxA, AcpA, and AcpB 
advance our knowledge of virulence gene expression in B. anthracis, while contributing to our 
understanding of this newly-discovered class of transcriptional regulators.  My work defining the 
regulons of these proteins combined with protein-protein interaction experiments hone our 
model for PCVR-mediated gene expression in B. anthracis. PCVR activity is increased in the 
presence of bicarbonate and high CO2 concentration affecting expression of genes located on 
the chromosome, pXO1, and pXO2. Expression of co-regulated genes can be affected 
differently by each PCVR. Homodimers of each PCVR are the most prevalent, but a small 
percentage of AtxA-AcpA heteromultimers may be present affecting expression of select 
genes. In Figure 7-1 I present a model for virulence gene expression in B. anthracis which is 
based on previous data and new revelations discovered during my dissertation research. 
 
7.2 Model for virulence gene regulation in B. anthracis 
 AtxA is epistatic to AcpA and AcpB, and transcription of atxA is influenced by 
environmental and physiological signals. Many of these signals are related to conditions  
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Figure 7-1. Comprehensive model of virulence gene regulation in B. anthracis 
CO2-dependent transcriptional start sites are red, and low-level constitutive start sites are black. 
Thickness of arrows from proteins to transcript start sites show degree of regulation with thick arrows 
indicating a large effect and thin arrows representing a small effect on expression. The multicolored 
arrow from AtxA-AcpA to the capBCADE transcript start site denotes the AtxA-mediated decrease of 
AcpA activity on PcapB. Protein interactions determined for each PCVR are denoted. The broken arrow 
from capE to acpB transcriptional start site represents a low level of transcriptional read through. 
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encountered within the host environment. The median range for mammalian body temperature 
is between 35˚C and 37.9˚C (157), and glucose is the energy source used for cellular 
respiration in animals.  Growth of B. anthracis at 37˚C and in medium containing glucose are 
two environmental conditions that promote atxA transcription (59, 63). Temporal regulation of 
atxA expression is affected by cellular redox state and growth phase such that AtxA levels 
increase during early exponential growth phase (60, 61). An undefined repressor also affects 
atxA expression and is thought to function primarily in conditions favoring sporulation ((91), 
Dale 2018 in revision). 
 Following translation, AtxA is subject to other mechanisms that alter steady-state 
protein levels and activity. The transition-state regulator CodY indirectly influences AtxA protein 
levels post-translationally in soluble cell lysates. In a codY-null strain, AtxA was not detected in 
cell lysates by western blot (69). AtxA activity is affected by phosphorylation of H199 and H379 
within PRD1 and PRD2, respectively. Phosphomimetic and phosphoablative mutations at H199 
and H379 suggest that phosphorylation at H199 allows for optimal AtxA activity, whereas 
phosphorylation at H379 abolishes AtxA activity (65, 66). Carbon dioxide/bicarbonate are 
physiological signals positively affecting AtxA activity by increasing the dimer-to-monomer ratio 
(64). When conditions required for optimal expression and activity of AtxA are met, AtxA-
regulated genes, including the toxin structural genes, are expressed.  
 Expression of acpA and acpB is presumed to be much less complex than atxA. A low 
basal level of expression of acpA and acpB is maintained by constitutive promoters at each 
gene locus. This low level of expression is insufficient for capsule production (29, 70). In 
conditions suitable for AtxA activity (an environment with elevated CO2/bicarbonate), AtxA 
promotes acpA expression from an AtxA-dependent promoter. My RNA-Seq data show that 
AtxA promotes transcription of acpA; transcripts increase by a log 2-fold change of 4.2. AcpA 
promotes expression of the capsule biosynthetic operon, capBCADE, and increases transcripts 
by a log 2-fold change of 8.7. Cotranscription of acpB with capBCADE was reported to occur in 
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roughly ten percent of capBCADE transcripts (70). AcpB increased transcripts of capBCADE by 
a log 2-fold change of 8.2.  
AtxA positively affects capsule synthesis indirectly through control of acpA and acpB, 
yet some capsule production is observed in strains lacking AtxA. In a B. anthracis strain 
containing pXO1 and pXO2, deletion of atxA results in cells that produce little to no capsule 
when cultured in CA medium supplemented with bicarbonate in 5% CO2 atmosphere (capsule-
inducing conditions) (29, 56). Although expression of acpA and acpB is significantly lower in the 
atxA-null strain compared to the parent, AcpA and AcpB are likely present in low abundance. 
My results show culture in CACO3 increases AcpA and AcpB activity compared to culture in 
CA-Air, and suggest that the thin capsule produced by an atxA-null strain is due to "active" 
AcpA and AcpB present in low quantities.  
 
7.3 AtxA, AcpA, and AcpB: a case for divergent evolution 
 Similarities with regard to PCVR activity and protein interactions suggest the PCVRs 
have related ancestry. Analysis of the amino acid sequence of AtxA, AcpA, and AcpB indicate 
that AcpA and AcpB are more closely related to each other than either is to AtxA. AcpA and 
AcpB have 40% amino acid sequence identity and 62% similarity, while AtxA shares about 
27% amino acid sequence identity and close to 50% amino acid sequence similarity with AcpA 
and AcpB. Consistent with amino acid sequence conservation, structural models of AcpA and 
AcpB suggest that both proteins have similar domain organization to AtxA. Functionally, the 
three proteins are all able to form homodimers and their respective activities are increased 
when cells containing each protein are cultured in 5% CO2 in medium containing dissolved 
bicarbonate. Strong sequence similarity alone is considered to be sufficient evidence for 
common ancestry (158). Phylogenetic analysis of amino acid sequences models the 
substitutions that have occurred over the course of evolution and derives a representation of 
evolutionary relationships between sequences (159–161).   
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Figure 7-2. Phylogram of AtxA, AcpA, and AcpB 
Numbers indicate phylogenetic distances. Phylogenetic analysis completed using Simple 
Phylogeny.  
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Analysis of the AtxA, AcpA, and AcpB amino acid sequences supports AcpA and AcpB being 
more closely related to each other, than either are to AtxA (Figure 7-2). 
 Gene duplication and successive divergence is a mechanism to generate genes with 
novel functions within genomes, and acpA and acpB likely result from an atxA gene duplication 
event. Gene duplication can occur by at least two mechanisms: homologous recombination and 
replicative transposition. For homologous recombination to occur, >100 bp direct-order 
sequence repeats must exist between potential sites for recombination (162). B. anthracis is 
characterized as a low G-C organism with an average A-T content of 66.5%. Some loci 
encompassing genetic rearrangements can have enriched A-T content as high as 70% (163). 
It's a miracle B. anthracis can keep its genome together. Given the abundance of A-T rich loci 
in the B. anthracis genome it is possible that regions of homology exist between the atxA locus 
on pXO1 and the capBCADE locus on pXO2 allowing for homologous recombination to occur 
and duplication of atxA. This initial gene duplication event likely resulted in the progenitor gene 
for acpA as AtxA and AcpA coregulate more targets than AtxA and AcpB. A second duplication 
event likely created acpB from acpA. 
 Alternatively, atxA gene duplication could have occurred by replicative transposition. 
Transposition is dependent upon a recognizable target sequence and insertion elements (ISs), 
and a functional transposase. Several putative ISs and genes annotated as integrases and 
transposases have been identified on pXO1 (109). In replicative transposition, DNA sequences 
containing atxA could be duplicated and inserted into a target DNA sequence on pXO2. In this 
model, DNA sequences containing atxA would be duplicated by replicative transposition and 
inserted into a target upstream of the capBCADE locus on pXO2 to create the progenitor for 
acpA. Successive replicative transposition or homologous recombination events could have led 
to duplication of acpA to create acpB. This potential mechanism for gene duplication is 
plausible because pXO2 also contains several annotations for putative ISs and transposases, 
many near the capsule biosynthetic operon locus. Interestingly, transposable elements can 
also support homologous recombination by serving as movable regions of homology (162).  
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 Following duplication of atxA, I propose that the resulting copy (the progenitor of acpA) 
assumed both novel and shared functionality compared to AtxA through the accumulation of 
mutations over time. Following some degree of functional divergence of AcpA from AtxA, a 
duplication event created the progenitor of acpB which accumulated mutations to have shared 
and unique function compared to AtxA and AcpA. Phylogenetic analysis of PCVR amino acid 
sequences and RNA-Seq support my model for the order of PCVR gene duplication events in 
B. anthracis (Figures 7-2, 3-5). AtxA and AcpA significantly coregulate expression of 31 genes 
(log 2-fold ≥4), compared to 15 genes controlled by both AtxA and AcpB. Five genes were 
coregulated by AcpA and AcpB. Assuming symmetrical divergence, equivalent accumulation of 
mutations over time between paralogues, I would have expected AcpA and AcpB to have a 
greater number of shared targets. However, the number of coregulated genes is likely low due 
to the dramatically fewer number of genes controlled by AcpB compared to AtxA and AcpA.  
 Future studies aimed at understanding the divergence of AtxA, AcpA, and AcpB should 
focus on identifying genes targets that are regulated directly by the PCVRs. My regulon studies 
were unable to differentiate direct versus indirect effects on gene expression. ChIP-Seq would 
identify direct PCVR targets and would define more clearly regulon profiles. Hierarchical 
clustering data presented in figure 3-6 is likely skewed by genes regulated indirectly by the 
PCVRs. Hierarchical clustering of gene expression profiles regulated directly by each PCVR 
may more closely align with amino acid sequence conservation, such that AcpA and AcpB 
expression profiles are the most similar on all three genetic elements. 
 
7.4 Evolutionary advantage to cross-talk between genetic elements 
 The influence of plasmid-encoded PCVRs on chromosome-encoded branched chain 
amino acid genes is one of several examples of cross-talk between genetic elements in B. 
anthracis. My RNA-Seq data reveal that cross-talk appears to be multi-directional. In one 
direction, plasmid-encoded AtxA, AcpA and AcpB affect expression of genes located on the 
chromosome. In another direction, the well-studied chromosome-encoded transition state 
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regulator, AbrB, affects expression of atxA on pXO1 (61). It is unclear whether chromosome-
encoded factors regulate any pXO2-encoded genes. However, intra-genomic gene regulation 
may serve as a mechanism to coordinate expression of several gene networks required for 
host colonization. Given that many virulence factors are acquired by horizontal gene transfer 
and plasmid acquisition, it is reasonable to postulate that these factors are added gradually 
over time and that transcriptional regulators associated with these factors both gain and loose 
functionality. Considering atxA, acpA, and acpB are located in apparent pathogenicity islands, 
over the course of evolution they may have gained functionality to control expression of genes 
outside of their original/initial targets providing a fitness advantage. 
 
7.5 PCVR paralogues in other organisms may have shared functionality 
 The B. anthracis PCVRs represent a unique opportunity to study the interplay of three 
paralogues in one organism. My research regarding AtxA, AcpA, and AcpB functionality has 
identified functions unique to each regulator as well activities shared among all three proteins. 
However, B. anthracis is not the only bacterium to produce PCVR paralogues. Group A 
streptococcus (GAS) is a pathogenic bacterium that causes several diseases including strep 
throat, impetigo, and necrotizing fasciitis. Like Bacillus anthracis, GAS can colonize a wide 
range of host tissues and must regulate virulence factor expression in response to host cues 
(117). Virulence determinants produced by GAS include a hyaluronic acid capsule, secreted 
proteases, and cell wall-anchored proteins that inhibit host defenses (12). GAS produces two 
PCVRs, Mga and RivR, that share 22% amino acid sequence identity and 49% similarity. Mga 
is the most well-characterized PCVR in GAS, and regulates expression of M protein; a major 
adhesin used during host colonization, a complement factor C5a peptidase, and other virulence 
factors (117). RivR is a negative regulator of the hasABC operon, encoding a hyaluronic acid 
capsule, and grab which encodes a protein G-related α2-macroglobulin-binding protein (GRAB) 
that binds a human protease inhibitor. There are conflicting reports of RivR having either a 
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positive effect or no effect on expression of two genes in the Mga regulon; scpA, encoding the 
C5a peptidase, and the gene encoding M protein emm (12, 116). 
 Comprehensive transcriptomic studies and biochemical assays elucidated the Mga 
regulon and molecular mechanism for activity. While RivR has not been studied to the same 
extent as Mga, similarities and difference between the B. anthracis PCVRs and GAS PCVRs 
are apparent. Both Mga and AtxA promote expression of adhesins in their respective 
organisms; M protein in GAS, BslA in B. anthracis. PCVRs of both organisms affect capsule 
expression; B. anthracis regulators promote capsule production and RivR of GAS negatively 
affects capsule synthesis. Negative regulation of capsule production by RivR is thought to play 
an important role in GAS infection. A GAS rivR deletion mutant has reduced adherence to a 
keratinocyte cell line relative to that of the parent strain due to the enhanced capsule 
elaborated by the mutant strain. Treatment with hyaluronidase restored adherence of the rivR 
mutant indicating that capsule production is a tradeoff between immune avoidance and 
adherence to host cells (12). Considering my data demonstrating that AtxA alone cannot 
promote capsule expression and can negatively affect AcpA activity on PcapB-lacZ, similar 
considerations regarding optimal capsule expression may be applicable to B. anthracis. 
 
7.6 Concluding remarks 
 Future studies of the B. anthracis PCVRs should aim to build on my work to uncover 
molecular mechanisms that account for the overlapping and divergent function of the 
regulators. AtxA is likely the progenitor PCVR in B. anthracis and acpA and acpB genes likely 
arose from gene duplication events. The regulators retained some initial functionality, but also 
developed specific functions through the accumulation of mutations over time. Undoubtedly, 
the molecular basis behind functional similarity and differences resides in amino acid 
conservation among the regulators. Amino acid differences exist in all five predicted domains 
among AtxA, AcpA, and AcpB, but I propose that dissimilarities in the DNA-binding domains 
and/or PRDs are responsible for PCVR functional differences. My approach to determine the 
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specific effects of the DNA-binding domains and PRDs on PCVR activity involved creation of 
protein chimeras. However, my results were inconclusive due to two chimeric regulators, 
AcpADBDAtxAPRD+EIIB and AcpBDBDAtxAPRD+EIIB, that were not detectable in soluble cell lysates. 
The two other chimeras, AtxADBDAcpAPRD+EIIB and AtxADBDAcpBPRD+EIIB, were detectable in cell 
lysates, but did not have activity on PcapB-lacZ or Plef-lacZ.  
 Future studies to define the impact the DNA-binding domain and PRDs have on PCVR 
activity would be aided by two advancements: (1) the crystal structures of AcpA and AcpB need 
to be solved, and (2) the phosphorylation states of AcpA and AcpB need to be determined. 
Crystal structures for AcpA and AcpB would define domain boundaries and unstructured 
regions more definitively than structural predictions and alignments with the AtxA crystal 
structure. These data would facilitate the creation of more stable, and potentially more active, 
chimeras. It is possible that the redesigned chimeras would be transcriptionally inactive as was 
observed with the AtxADBDAcpAPRD+EIIB and AtxADBDAcpBPRD+EIIB proteins. These results would 
suggest that specific DNA-binding-domain - PRD1 pairing is required for activity. 
Heteromultimerization experiments with chimeric and full-length PCVR proteins could indicate 
whether the chimeras are folded properly. 
 Determination of the phosphorylation states of AcpA and AcpB would complement any 
results relating the PRDs of these proteins with activity. PRD-containing transcriptional 
regulators have been shown to be phosphorylated at specific histidines within the PRDs and in 
EIIA- and EIIB-like domains (9). If AcpA and AcpB are phosphorylated, phosphoablative 
mutations at amino acids likely to be phosphorylated (histidines within PRDs, and cysteines or 
histidines within the EIIB-like domain) would indicate at which residue phosphorylation 
occurred. These data, combined with AcpA and AcpB crystal structures, would illuminate how 
phosphorylation ultimately affects PCVR activity. Predictions from the AtxA crystal structure 
suggest that phosphorylation of H199 within PRD1 may affect positioning of the DNA-binding 
domain and influence target specificity. It is hypothesized that phosphorylation of H379 
abolishes dimer formation by destabilizing the interaction between PRD2 of monomer one and 
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the EIIB-like domain of monomer two (65). Amino acid alignments show that histidines within 
the PRDs of AcpA and AcpB do not align with phosphorylated histidines in AtxA, and whether 
or not the residues occupy similar locations in 3D space has not been determined. Differences 
in the locations of phosphorylated histidines in AcpA and AcpB could affect positioning of the 
respective DNA-binding domains, and/or the stability of multimeric protein interactions. 
Alternatively, AcpA or AcpB may not be phosphorylated suggesting that the DNA-binding 
domain alone confers target specificity. 
 PCVR expression is complex and different cis- and trans-acting factors contribute to 
different relative amounts of AtxA, AcpA, and AcpB within cells of B. anthracis (Figure 3-3). My 
results show that artificially altering PCVR stoichiometry can effect expression of target genes 
(Figure 4-13). One way to test whether the complex regulation of PCVR expression is relevant 
for virulence is to swap PCVR gene loci. PCVR open reading frames could be swapped among 
PCVR loci such that cis- and trans-acting factors that control the expression of one PCVR 
would control the expression of a different PCVR (Figure 7-3). This would likely lead to altered 
PCVR protein levels in addition to dramatic changes in virulence gene expression. In the strain 
depicted in Figure 7-3B, acpA is in the native atxA locus, acpB is in the native acpA locus, and 
atxA is in the native acpB locus. Given the relative PCVR protein levels observed in the parent 
strain (Figure 7-3A, 3-3), I would expect AcpA to be the most abundant PCVR during culture in 
CACO3. High levels of AcpA would lead to elevated expression of capBCADE as well as 
cotranscription of atxA. AtxA would positively regulate acpB expression and AcpB would further 
promote capsule production. This strain would likely exhibit a thicker capsule and reduced toxin 
expression compared to the parent strain. The strain represented in Figure 7-3C would 
presumably have high levels of AcpB leading to high expression of capBCADE and 
cotranscription of acpA. The atxA gene is in the native acpA locus and AtxA positively regulates 
acpA expression. Thusly, in this mutant AtxA would be in a positive feedback loop. I predict this  
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Figure 7-3. PCVR locus-activity relationships 
CO2-dependent transcriptional start sites are red, and low-level constitutive start sites are black. Arrows 
from proteins to transcript start sites indicate positive regulation. The broken arrow from capE to acpB 
transcriptional start site represents a low level of transcriptional read through. (A) PCVR loci in the parent 
strain. (B & C) Strains in which the open reading frames encoding AtxA, AcpA, and AcpB have been 
exchanged. 
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strain would express a thicker capsule than the parent strain, in addition to higher toxin levels. 
 The impact these locus mutations could have on various cellular processes would be 
extremely interesting to explore. Modulation of AtxA levels has already been demonstrated to 
impact sporulation efficiency. The effects on virulence of these mutant strains could be tested 
in animal models of anthrax. The results of these studies could indicate an optimal level of 
expression for each PCVR that allows the bacterium to thrive in the host and soil environments.
 The ability of an organism to thrive depends to a large extent on its ability to adapt to 
changing environments and successfully colonize new niches. Adaptation can spawn the 
creation of genes with new functions to cope with the environmental changes. For the two most 
well-characterized virulence factors in B. anthracis, AtxA has sole control over expression of 
anthrax toxin, but is a poor regulator of capsule expression. Duplication of atxA eventuated the 
creation of acpA and acpB. Positive regulation of acpA by AtxA allows for AtxA control of toxin 
and capsule synthesis. AcpA and AcpB expanded their roles beyond regulators of capsule 
production to control expression of non AtxA-regulated genes. Future investigations addressing 
domain-specific differences among the regulators will broaden our understanding of the 
molecular bases for PCVR activity and provide insight into the physiological and evolutionary 
significance of these major gene control elements of B. anthracis and other pathogens. 
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